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Methionine  y-Iyase  (MGL)  from  Trichomonas  vaginalis  has  been  crystallised  and 
the  structure  solved  by  molecular  replacement  at  2.2  A.  The  enzyme  has  a  similar 
overall  secondary  structure  arrangement  as  the  search  model,  cystathionine  ß- 
Iyase  from  Escherichia  coli,  but  differs  in  the  active  site.  In  addition  to  the 
holoenzyme,  the  structure  of  the  enzyme  in  complex  with  the  acetylenic  suicide 
inhibitor  L-propargylglycine  has  also  been  solved.  This  has  revealed  the 
mechanism  of  inhibition  by  this  compound.  It  has  also  provided  insights  into  the 
catalytic  mechanism  of  the  enzyme  and  allowed  the  postulation  of  a  scheme  for  its 
action.  Particularly,  this  predicts  core  roles  for  active  site  tyrosine  and  cysteine 
residues  (111  and  113,  respectively). 
To  test  the  hypothesised  mechanism  of  catalysis,  seven  site-directed  mutants 
were  produced.  The  activities  of  the  mutants  were  determined  and  the  structure 
solved  for  one  of  the  most  interesting.  The  resulting  data  confirm  the  mode  of 
action  of  L-propargylglycine  and  also  reveal  a  proton  relay  which  activates  the 
important  active  site  cysteine  which  mediates  much  of  the  enzyme  activity.  This 
mechanism  is  substantially  different  from  that  proposed  for  other  members  of  the 
same  family  of  enzymes  and  explains  the  substrate  specificity  of  MGL.  The 
structure  also  reveals  a  potential  role  for  the  enzyme.  The  active  site  cysteine  is 
positioned  ideally  to  form  an  internal  persüiphide  with  a  sulphur  atom  released 
from  the  substrate.  This  implies  a  possible  role  for  the  enzyme  in  iron-sulphur 
cluster  formation  in  an  analogous  fashion  to  the  enzyme,  cysteine  desulphurase. 
ll A  cDNA  clone,  isolated  from  a  T.  vaginalis  library,  with  high  level  of  homology  to 
cysteine  synthase  has  been  subcloned  and  recombinant  protein  expressed  in  E. 
coll.  The  purified  recombinant  enzyme  possesses  both  cysteine  synthase  activity 
and  the  "activated  serine  suiphydrase"  activity  previously  described  in  the 
parasite.  Southern  blot  analysis  suggests  the  presence  of  just  a  single  copy  of 
the  gene  in  the  parasite,  with  other  closely  related  homologues  also  being 
present.  Antibodies  raised  against  the  purified  enzyme  revealed  that  there  are  at 
least  two  isoenzymes  present  in  parasite  lysates.  Cultivation  of  the  parasite  in 
medium  supplemented  with  L-cysteine  has  revealed  reduced  expression  of  the 
enzyme.  This  is  the  first  demonstration  of  part  of  the  de  novo  synthesis  of 
cysteine  in  the  T.  vaginalis. 
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xx CHAPTER  1.  INTRODUCTION 
1.1  Biology  of  Trichomonads 
Trichomonads  are  flagellated  parasitic  protozoa  that  infect  a  large  variety  of 
organisms.  The  life  cycle  is  generally  uncomplicated  with  only  a  single  stage 
identified.  True  cysts  have  been  seen  only  in  species  parasitic  in  reptiles  and 
amphibians  although  pseudocysts  are  found  more  commonly  in  other  species. 
There  is  no  known  sexual  process  and  reproduction  is  by  binary  fission.  It  is 
generally  accepted  that  only  three  species  infect  humans  all  of  which  are  highly 
site  specific.  Trichomonas  vaginalis,  the  subject  of  this  study,  infects  the 
urogenitary  tract  of  males  and  females,  Trichomonas  tenax  occurs  in  the  oral 
cavity  and  Pentatrichomonas  hominis  occurs  in  the  large  intestine.  Only  T. 
vaginalis  is  considered  pathogenic.  The  taxonomic  lineage  for  this  parasite  is: 
Eukaryota,  Parabasalidae,  Trichomonadida,  Trichomonas  vaginalis. 
1.2  Cell  Biology  of  T.  vaginalis 
T.  vaginalis  in  free  culture  is  between  10  to  20µm  in  length  and  ovoid  in  shape. 
During  interactions  with  host  tissues  or  cultured  cells,  however,  the  parasite 
exhibits  irregular  forms  (Heath,  1981).  Figure  1.1  illustrates  the  basic  cellular 
structure  of  the  parasite. 
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Figure  1.1:  Schematic  diagram  of  trichomonad  cell.  AR  -  anterior  flagella,  K-  kinetosomes  (basal 
bodies  of  flagella),  P-  pelta,  C-  costa,  N-  nucleus,  G-  parabasal  apparatus,  PF  -  parabasal  fibril,  H 
-  hydrogenosome,  Ly  -  secondary  lysosome,  ER  -  rough  endoplasmic  reticulum,  Ax  -  axostyle,  UM  - 
undulating  membrane,  RR  -  recurrent  flagellum.  Figure  reproduced  from  Kulda  et  al.,  1986. 
Equipped  with  five  flagella  the  parasite  is  capable  of  rapid  movement.  Four 
flagella  are  located  anteriorly  with  the  fifth  attached  along  the  length  of  the 
organism  to  form  an  undulating  membrane.  The  parasite  is  also  able  to  exhibit 
amoeboid  movement  when  in  contact  with  epithelial  cells  forming  pseudpodia  for 
attachment  and  motility.  The  cell  has  a  complex  cytoskeleton.  In  particular  an 
axostyle  formed  of  parallel  microtubules  stretches  the  length  of  the  organism  and 
protrudes  posteriorly  and  a  striated  costa  extends  below  the  undulating 
membrane.  There  is  a  modified  Golgi  complex  which  is  integrated  with  root  fibrils 
to  form  the  parabasal  apparatus.  There  is  a  large  nucleus  and  the  cytoplasm  also 
contains  vacuoles,  vesicles,  ribosomes  and  glycogen  granules.  There  is  a 
2 conspicuous  lack  of  mitochondria,  glycosomes  or  peroxisomes  within  the 
cytoplasm  and  instead  the  parasite  possesses  hydrogenosomes  (Lindmark  and 
Müller,  1973).  These  organelles  are  peculiar  to  fungi  and  anaerobic  protozoa  and 
play  a  pivotal  role  in  metabolism  within  the  parasite. 
1.3  Hydrogenosomes 
Hydrogenosomes  of  T.  vaginalis  are  double  membrane-bound  spherical 
organelles  which,  unlike  mitochondria,  lack  cristae.  Around  0.5  -  1.0  µm  in 
diameter  there  are  typically  30  to  40  in  each  cell.  They  are  normally  located  near 
the  axostyle  and  costa  away  from  the  cell  membrane.  Their  name  is  derived  from 
the  hydrogen  evolved  from  them  due  to  activity  of  their  marker  enzyme 
hydrogenase  (Müller,  1993).  Hydrogenosomes  were  first  described  in 
trichomonads  (Lindmark  and  Müller,  1973)  and  have  since  been  found  exclusively 
in  protists  and  lower  fungi  without  mitochondria  which  inhabit  anaerobic  or 
microaerophilic  environments  (Snyers  et  al.,  1982;  van  Bruggen  eta!.,  1983; 
Yarlett  et  al.,  1986;  Paul,  et  al.,  1990;  Fenchel  and  Finlay,  1991).  Also  unlike 
mitochondria,  it  is  largely  accepted  now  that  T.  vaginalis  hydrogenosomes  lack 
DNA  (Clemens  and  Johnson,  2000). 
1.4  Evolutionary  Position  of  T.  vaginalis 
In  addition  to  the  interest  in  the  parasite  due  to  its  human  pathogenicity  and 
prevalence,  it  is  also  studied  because  of  its  possible  evolutionary  lineage.  It  is 
argued  that  it  appears  to  be  a  representative  of  a  very  early  divergence  from  the 
main  line  of  eukaryotic  evolution.  This  postulation  is  based  upon  phylogenetic 
trees  derived  from  small  subunit  ribosomal  RNA  (Sogin  et  al.,  1996),  the 
3 possession  of  70S  ribosomes  (rather  than  80S)  and  the  lack  of  mitochondria  and 
possession  of  hydrogenosomes.  Evidence  based  upon  the  sequences  of  heat 
shock  protein  (HSP)  genes  has  also  been  given  (Bui  et  al.,  1996;  Germot  et  al., 
1996).  Arguments  ensue  from  the  question  as  to  whether  hydrogenosomes  are 
degenerate  mitochondria  (Cavalier  Smith,  1987),  have  evolved  alongside 
mitochondria  from  a  common  progenitor  organelle  or  arisen  completely 
independently  via  a  separate  event  (Whately  et  al.,  1981).  The  situation  is  far 
from  clear  though  and  perhaps  the  only  fact  that  is  definite,  is  that,  at  the  moment, 
nobody  knows  (Embley  and  Hirt,  1998). 
1.5  Clinical  Aspects  of  T.  vaginalis  Infection 
Reports  on  the  manifestations  and  frequency  of  infection  are  notoriously  difficult 
to  interpret  at  times  due  to  the  source  of  the  information.  For  example,  a  distorted 
view  of  the  prevalence  of  the  disease  can  be  given  if  the  data  are  collected  from 
an  STD  (Sexually  Transmitted  Disease)  clinic  or  gynaecologist.  Patients 
presenting  to  a  gynaecologist  are  likely  to  be  symptomatic  and  seeking  treatment 
whereas  those  at  an  STD  clinic  may  be  attending  because  of  a  symptomatic 
partner  or  by  contact  tracing.  Thus  although  certain  facts  are  apparent,  the  true 
pathological  burden  of  the  organism  is  very  difficult  to  quantify. 
1.5.1  Diagnosis 
Diagnosis  of  trichomonosis  is  complicated  by  the  broad  spectra  of  symptoms 
exhibited  and  the  similarities  to  vaginitis  resulting  from  other  sources,  such  as 
bacterial  vaginosis.  The  most  successful  method  for  positive  diagnosis  of 
trichomonad  infection  is  wet  mounted  microscopic  examination  and  cultivation, 
4 with  detection  levels  of  95%  achievable  (Kreiger  et  al.  1988).  Despite  the  fact  that 
this  is  a  time  consuming  and  labour  intensive  process,  efforts  to  design  a  system 
based  upon  T.  vaginalis  nucleic  acids,  such  as  PCR  based  systems  (Riley  et  al., 
1991;  Paterson  et  al.,  1999)  and  fluorescent  in-situ  hybridisation  (FISH)  (Muresu 
et  al.,  1994)  have  gone  largely  unnoticed. 
1.5.2  Pathology 
Common  'manifestations  of  the  disease  in  females  are  a  vaginal  discharge  and 
vulvovaginal  irritation  at  frequencies  of  up  to  75%  and  25%,  respectively.  The 
classical  disease  symptoms  are  described  as  a'  frothy,  malodorous,  green 
discharge  but  this  is  seen  in  few  symptomatic  women.  Dysuria  is  often  present  in 
sufferers  and  less  common  is  abdominal  pain.  The  majority  of  males  appear  to  be 
asymptomatic  carriers  of  the  disease,  a  state  which  can  last  up  to  four  months 
(Kreiger  et  al.  1993),  but  complain  most  frequently  of  mild  urethritis.  An  added 
concern  is  that  trichomonosis  appears  to  be  a  risk  factor  for  HIV  transmission, 
through  the  effects  the  parasite  has  on  host  immune  mechanisms  (Laga  et  al., 
1993;  Martin  et  a/.,  1999). 
1.5.3  Trichomonosis  Occurrence 
Trichomonosis  is  the  most  prevalent  non-viral  sexually  transmitted  disease  in  the 
world  (McLellan  et  al.,  1982).  The  most  recent  estimates  from  the  WHO  predicted 
an  estimated  170  million  new  cases  for  1995.  The  distribution  of  the  disease 
varies  significantly  with  the  local  population.  Known  risk  factors  include  multiple 
sexual  partners,  history  of  sexually  transmitted  disease,  non  use  of 
contraceptives,  black  race  and  co-existent  infection  with  Neisseria  gonormheae 
5 (Cossack,  1989).  Transmission  of  the  disease  is  only  via  sexual  intercourse  with 
no  documented  cases  of  infection  by  any  other  means  despite  evidence  that  the 
parasite  remains  viable  for  short  periods  on  moist  objects  (Whittington,  1957; 
Burch  et  al.,  1959).  Infection  with  T.  vaginalis  varies  widely.  An  estimated  25- 
50%  of  females  are  asymptomatic  but  up  to  a  third  of  patients  develop  symptoms 
within  six  months  (Rein,  1990). 
1.5.4  Treatment 
The  treatment  of  trichomonosis  is  essential  to  avoid  further  transmission  to  sexual 
partners  and  complications  arising  from  the  infection.  Metronidazole  is  the  drug 
treatment  of  choice,  usually  administered  in  a  single  oral  dose:  One  of  the  5- 
nitroimidazole'group  of  compounds,  others  such  as  ornidazole  and  tinidazole  are 
also  used  occasionally.  Metronidazole  exerts  its  effect  via  the  reduction  of  its 
nitro  group  by  the  pyruvate:  ferredoxin  oxidoreductase  of  the  parasite  and  the 
concomitant  production  of  cytotoxic  intermediates  (Edwards,  1993).  Other 
treatments  have  'a  much  lower  degree  of  efficiency  and  are  generally  more  difficult 
to  administer  and  thus  not  generally  considered.  However,  although  there  is  no 
direct  evidence  for  any  carcinogenic  or  teratogenic  properties  of  the  toxic 
intermediates  of  metronidazole,  use  of  the  drug  is  avoided  during  pregnancy. 
1.5.5  Drug  Resistance 
The  extent  to  which  drug  resistance  is  a  problem  in  clinical  terms  is  difficult  to 
quantify.  In  1989  the  Centre  for  Disease  Control  in  the  United  States  estimated 
that  5%  of  T.  vaginalis  isolates  exhibited  some  form  of  resistance  to 
metronidazole.  There  have  been  reports  of  at  least  100  metronidazole  resistant 
6 isolates  in  the  United  States  of  America  (  Müller  et  al.,  1980;  Kellock  and 
O'Mahoney,  1996;  Land  and  Johnson,  1999)  and  a  substantial  number  in  Europe 
as  well  (Heyworth  et  al.,  1980;  Kulda  et  al.,  1982;  Meri  et  al.,  2000).  The 
consequences  of  widespread  resistance  to  the  5-nitroimidazoles  are  serious  and 
they  highlight  the  need  for  further  research  into  the  organism  and  possible  drug 
targets. 
1.5.6  Immunity  to  T.  vaginalis 
There  is  no  protective  immunity  from  prior  infection  with  the  parasite,  although  T. 
vaginalis  specific  antibodies  have  been  detected  in  patients  (Coyne  et  al.,  1975; 
Cogne  et  al.,  1985).  However  these  observations  are  complicated  by  results 
showing  the  immunoprecipitation  of  large  numbers  of  T.  vaginalis  proteins  by  sera 
from  infected  and  non-infected  patients  (Davis-Hayman  et  al.,  2000).  There  is 
also  evidence  of  non-specific  host  immune  responses  being  activated,  such  as 
neutrophils  and  complement.  However,  the  persistent  infection  that  typically 
occurs  in  females  highlights  the  inadequacies  of  these  mechanisms.  It  has  been 
possible  to  induce  a  protective  response  in  mice  after  subcutaneous  immunisation 
with  whole  parasites  and  subsequent  intravaginal  challenge  (Abraham  et  al., 
1996). 
1.6  Biochemistry  of  T.  vaginalis 
1.6.1  In  vitro  growth 
Studies  on  all  aspects  of  the  biochemistry  and  molecular  biology  of  the  organism 
have  relied  upon  successful  cultivation  in  vitro  to  provide  adequate  starting 
7 material.  The  parasite  is  thought  of  as  an  aerotolerant  anaerobe  and  yet  it  grows 
optimally  in  low  amounts  of  oxygen  (Paget  and  Lloyd,  1990).  It  has  been 
demonstrated  by  many  different  investigators  that  the  organism  requires  a  wide 
range  of  nutrients.  These  include  carbohydrates  (Read,  1957),  fatty  acids 
(Roitman  et  aL,  1978),  purines  (Heyworth  et  al.,  1982),  pyrimidines  (Wang  and 
Cleng,  1984),  iron  (Gorrell,  1985),  vitamins  (Hollander  and  Leggett,  1985)  and 
amino  acids  (Rowe  and  Lowe,  1986).  These  nutritional  requirements  are  met  in 
vivo  by  the  vagina  and  environment  (Huggins  and  Petri,  1981)  but  interestingly 
the  parasite  has  been  shown  to  be  able  to  phagocytose  different  cell  types 
including  mammalian  cells  and  bacteria  (Francioli  et  al.,  1983;  Rendbn- 
Maldonado  et  al.,  1998).  Whether  this  ability  is  used  primarily  to  supplement 
nutrition  or  as  a  defence  mechanism  is  unknown. 
The  most  widely  used  types  of  media  for  all  trichomonad  cultivation  are  undefined. 
They  each  have  a  similar  composition  and  contain  elements  such  as  peptone, 
yeast  extract  and  serum  (for  example,  Diamond,  1957).  A  number  of  semi-defined 
media  have  been  proposed  for  various  species  and  a  defined  medium  for  T. 
vaginalis  cultures  also  exists  (Linstead,  1981). 
1.6.2  Carbohydrate  Metabolism 
T.  vaginalis  has  a  fermentative  metabolism  in  common  with  other  anaerobic 
protozoa  such  as  Giardia  lamblia  and  Entamoeba  histolytica..  The  major  end  , 
products  are  a  mixture  of  acids  (e.  g.  acetate,  succinate  and  lactate)  and  alcohols 
(e.  g.  ethanol)  (Müller,  1988).  The  parasite  is  thought  to  be  heavily  reliant  upon 
glycolysis  for  the  production  of  ATP  with  the  end  products  able  to  maintain  redox 
8 balance  and  generate  further  energy  via  additional  pathways.  For  reviews  of  the 
parasites  metabolism  the  reader  is  directed  to  Müller,  1988  and  Coombs  and 
Müller,  1995. 
Of  particular  note  is  the  fate  of  pyruvate  produced  by  glycolysis  which  via 
oxidative  decarboxylation  is  catabolised  to  acetyl  Co-A  by  the  enzyme 
pyruvate:  ferredoxin  oxidoreductase  (PFOR)(Williams  et  al.,  1987).  This  enzyme 
utilises  ferredoxin  as  its  electron  acceptor  and  the  reduced  ferredoxin  is  then 
oxidised  by  hydrogenase.  All  three  central  proteins  in  T.  vaginalis  energy 
production  possess  iron:  sulphur  (Fe-S)  cores. 
1.6.3  Amino  Acid  Metabolism 
Although  it  is  assumed  that  T.  vaginalis  relies  heavily  upon  glycolysis  for  energy 
production,  there  is  evidence  that  it  can  utilise  other  substrates  and  in  particular 
amino  acids.  The  following  sections  of  this  introduction  considers  relevant 
aspects  of  amino  acid  metabolism  in  the  parasite  and  in  particular  sulphur 
containing  amino  acids,  the  main  consideration  for  this  study. 
1.6.3.1  Proteinases 
The  presence  of  high  levels  of  proteinase  activity  with  the  parasite,  both  intra-  and 
extracellularly,  has  been  well  documented  (for  review  see  North,  1991).  The 
enzymes  may  digest  extracellular  host  polypeptides,  generating  free  amino  acids, 
for  transport  into  the  cell  via  amino  acid  transporters  or  alternatively  act  upon 
phagocytosed  material.  However,  this  does  not  exclude  other  roles  for 
9 proteinases  in  disruption  of  the  host  immune  system  and  modulating 
cytoadherence 
1.6.3.2  Aminotransferase  Activities 
Aminotransferase  enzymes,  as  their  name  implies,  are  able  to  transfer  the  amino 
group  from  a  donor  molecule  to  an  acceptor.  This  process  is  intimately  linked  with 
the  synthesis  and  degradation  of  amino  acids  and  generally  constitutes  the  last 
and  first  steps  respectively.  There  are  a  considerable  number  of 
aminotransferase  activities  in  T.  vaginalis.  Those  active  towards  aspartate  and 
aromatic,  branched  chain  and  co-amino  acids  have  all  been  demonstrated  (Lowe 
and  Rowe,  1986). 
1.6.3.3  Amino  Acids  in  Energy  Production 
There  is  direct  evidence  that  the  degradation  of  arginine  can  be  utilised  to 
produce  ATP  at  a  ratio  of  1:  1.  Arginine  serves  as  a  rich  source  of  nitrogen  and 
medium  used  to  culture  trichomonads  is  considerably  depleted  of  this  amino  acid 
(Lockwood  and  Coombs,  1991  a).  The  excretion  of  large  amounts  of  alanine,  an 
end  product  of  glucose  metabolism,  may  account  for  this  need  for  nitrogen.  The 
breakdown  of  arginine  catalysed  by  arginine  deaminase  and  catabolic  ornithine 
transcarbamoylase  leads  to  the  production  of  ornithine  which  can  then  be  used  for 
polyamine  biosynthesis.  The  subsequent  action  of  carbamate  kinase  yields  ATP 
and  ammonia  and  C02  as  by-products  (Linstead  and  Cranshaw,  1983).  This 
pathway  is  summarised  in  figure  1.2  below. 
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Figure  1.2:  Pathway  leading  to  production  of  ATP  from  the  catabolism  of  arginine 
The  aminotransferase  activities  may  also  play  a  part  in  energy  metabolism.  It  has 
been  observed  that  PFOR  is  able  to  utilise  a  number  of  a-keto  acids  in  addition  to 
pyruvate  in  its  core  role  in  energy  production  (Williams  et  ä!.,  1987).  Thus  if 
glucose  levels  are  low  the  parasite  may  be  able  to  switch  energy  production  to  the 
use  of  amino  acids.  There  have  also  been  described  alternative  2-keto  acid 
oxidoreductases  able  to  utilise  these  deaminated  amino  acid  carbon  skeletons 
(Brown  et  al.,  1999). 
1.7  Sulphur  Amino  Acids 
The  enzymes  investigated  in  this  study  from  T.  vaginalis  act  upon  sulphur 
containing  amino  acids.  The  following  -part  of  this  chapter  considers  the  use  of 
11 sulphur  in  biological  systems  and  then  specifically  in  amino  acids.  Finally  specific 
enzymes  are  reviewed. 
1.7.1  Biological  Roles  of  Sulphur 
It  is  far  beyond  the  scope  of  this  work  to  review  properly  this  subject  but  it  is  worth 
mentioning  some  of  the  enormous  number  of  functions  that  sulphur-  containing 
compounds  are  involved  in  (for  a  comprehensivesummary  the  reader  should  see 
Mitchell,  1996). 
The"most  familiar  biologically  relevant  sulphur-containing  compounds  are 
methionine  and  cysteine,  two  amino  acids  that  commonly  occur  in  proteins. 
Cysteine  especially  plays  important  catalytic  roles  in  enzymes  and  because  of  its 
ability  to  dimerise  to  form  cystine  is  also  crucial  in  protein  and  tissue  stability.  N- 
Formylmethionine  is  encoded  as  the  first  amino  acid  in  polypeptide  chains 
although  often  subsequently  cleaved.  It  is  also  used  as  a  single  carbon  donor 
and  this  is  perhaps  its  most  important  role.  S-Adenosyl-L-methionine  (SAM)  is 
synthesised  with  ATP  and  can  then  be  used  in  methylation  reactions  or  in  the 
production  of  polyamines.  The  synthesis  of  glutathione'indicates  another  key  role 
of  sulphur,  that  of  a  reducing  agent  and  scavenger  of  toxic  radicals.  Other 
sulphur-containing  compounds  such  as  thioredoxin,  glutathione,  metallothionein 
also  play  varied  critical  roles  in  a  wide  range  of  processes.  Non-amino  acid 
sulphur  is  also  used  in  proteins  in  Fe-S  core  formation.  These  use  a  combination 
of  cysteine  residues  within  the  protein  and  also  sulphur  atoms  to  coordinate  iron 
atoms.  This  may  be  of  particular  interest  in  this  study  because  of  the  three 
proteins  with  Fe-S  cores  having  key  roles  in  T.  vaginalis  metabolism.  There  are  in 
12 addition  a  large  number  of  biologically  active  molecules  which  are  useful  because 
of  the  chemistry  of  sulphur,  these  include  Coenzyme  A  (CoA),  lipoic  acid  and 
thiamine  (vitamin  B1). 
1.7.2  Sulphur  Amino  Acid  Metabolism 
There  are  certain  features  of  sulphur  amino  acid  metabolism  shared  amongst  all 
organisms,  other  aspects  apply  to  only  a  few  species.  To  understand  the  roles  of 
enzymes  involved  in  both  synthesis  and  degradation  of  sulphur  containing  amino 
acids  in  T.  vaginalis  it  is  necessary  first  to  examine  the  available  data  for  other 
organisms. 
Methionine  and  cysteine,  the  two  sulphur  containing  amino  acids  found  in 
proteins,  are  synthesised  and  interconverted  predominantly  by  three  mechanisms. 
The  existence  and  relevance  of  any  individual  step  in  these  is  organism 
dependent  and  the  major  differences  will  be  highlighted  here.  The  three  pathways 
are:  sulphydrylation,  transsulphuration  and  the  methionine  cycle.  Suiphydrylation 
is  the  condensation  of  sulphide  and  a  carbon  backbone  to  produce  a  C-S 
compound.  Transsulphuration  is  the  two  step  conversion  of  cysteine  to 
homocysteine  via  cystathionine.  Reverse  transsulphuration  unsurprisingly 
converts  homocysteine  to  cysteine,  again  via  cystathionine.  The  enzymes  used  in 
each  direction  of  transsulphuration  are  related,  but  the  presence  of  those 
catalysing  one  direction  does  not  indicate  the  presence  (or  absence)  of  the  other. 
The  methionine  cycle  begins  with  the  methylation  of  homocysteine  and  then 
generally  incorporation  of  methionine  into  proteins  or  production  of  SAM.  SAM  is 
converted  in  two  steps  back  to  homocysteine. 
13 An  additional  point  worth  considering  is  the  origin  of  the  sulphur  atom.  The 
assimilation  of  inorganic  sulphur  is  commonly  used  to  provide  the  sulphide 
necessary  for  sulphydrylation  and  so  the  de  novo  synthesis  of  cysteine  and 
homocysteine.  Briefly,  inorganic  sulphate  is  usually  taken  up  from  the 
extracellular  environment,  phosphorylated  twice  using  ATP  and  then  reduced 
sequentially  to  sulphite  and  finally  sulphide.  This  then  provides  an  active  sulphur 
molecule  ready  to  be  used.  It  would  be  wrong  to  imply  that  this  is  the  only  source 
of  sulphur  for  incorporation  into  amino  acids.  However  in  many  microorganisms 
and  plants  this  may  provide  the  most  abundant  source  in  vivo. 
This  brief  overview  is  an  oversimplification  but  suffices  as  a  basic  introduction  to 
the  subject.  Figures  1.3,1.4  and  1.5  summarise  the  steps  referred  to  above  and 
indicate  the  key  enzymes.  Figure  1.6  shows  the  chemical  structures  of  the 
molecules  involved  for  reference.  The  function,  mechanism  and  existence  of 
these  enzymes  is  considered  in  detail  below. 
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Figure  1.3:  Mechanisms  of  suiphydrylation  to  produce  cysteine  and  homocysteine.  The  acyl  group 
attached  to  L-homoserine  for  the  production  of  homocysteine  varies  (details  are  given  in  the  following 
sections)  ,  the  production  of  cysteine  always  uses  acetate. 
TRANSSULPHURATION 
I 
REVERSE 
TRANSSULPHURATION 
O-Succinyl/Acetyl-L-homoserine  L-Cysteine 
L-Cysteine  1  NH4++  ac-ketobutyrate 
le*  Cystathionine 
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Cystathionine  CHZO 
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L-Serine 
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Figure  1.4:  The  interconversion  of  L-cysteine  to  L-homocysteine  in  both  directions.  The  left  side  of 
the  dashed  line  shows  transsulphuration.  Note  cysteine  is  shown  as  a  substrate  for  cystathionine  y- 
synthase  as  it  provides  the  thiol  group  for  homocysteine.  Reverse  transsulphuration  is  shown  on  the 
right  hand  side  of  the  dashed  line. 
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Figure  1.5:  The  methionine  cycle  showing  the  production  of  methionine  from  homocysteine, 
production  of  SAM  and  recycling  back  to  homocysteine. 
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Figure  1.6:  Structures  of  the  two  commonly  occurring  amino  acids  in  proteins  L-cysteine  and  L- 
methionine  and  their  intermediates  in  metabolism  L-homocysteine  and  L-cystathionine. 
1.7.2.1  Sulphydrylation 
Sulphydrylation  is  the  name  given  to  the  process  of  synthesising  cysteine  and 
homocysteine  from  sulphide  and  a  carbon  backbone.  The  enzymes  used  for  this 
16 are  0-acetyl-L-serine  sulphydrase  (OASS  or  cysteine  synthase)  and  an  0-acyl- 
homoserine  sulphydrase  (OAHSS  or  homocysteine  synthase),  respectively.  The 
acyl  group  of  the  0-  substituted  molecule  is  replaced  by  sulphide  in  both  cases. 
In  cysteine  synthesis  this  acyl  group  is  acetate  but  for  homocysteine  it  can  be 
acetate,  succinate  or  phosphate.  In  vitro  it  has  been  shown  that  both  enzymes 
are  able  to  utilise  other  sulphur  donors,  perhaps  most  notably  methanethiol 
(CH3SH)  (Flavin  and  Slaughter,  1967).  This  would  lead  to  the  direct  synthesis  of 
methionine  with  OAHSS  (a  process  not  shown  in  figure  1.3).  This  reaction  occurs 
much  more  slowly  than  that  with  H2S  and  its  relevance  in  vivo  is  unknown.  Both  of 
these  enzymes  are  PLP  (Pyridoxal  5'-Phosphate)-dependent  and  the  use  of  this 
cofactor  begins  a  common  theme  in  sulphur  amino  acid  metabolism. 
1.7.2.2  Transsulphuration 
The  two  step  conversion  between  cysteine  and  homocysteine,  in  either  direction, 
is  referred  to  as  the  transsulphuration  or  reverse  transsulphuration  pathway, 
respectively.  All  four  enzymes  associated  with  this  are  closely  related  PLP- 
dependent  enzymes. 
In  the  formation  of  homocysteine,  cysteine  acts  much  like  H2S  in  that  it  provides 
the  sulphur  moiety.  It  is  condensed  with  homoserine  by  the  action  of 
cystathionine  y-synthase  (CGS)  to  form  cystathionine.  The  molecule  then 
undergoes  cleavage  by  cystathionine  ß-lyase  (CBL)  to  release  homocysteine, 
pyruvate  and  ammonia.  The  reverse  transsulphuration  pathway  utilises  two  very 
similar  but  distinct  enzymes  to  those  used  in  the  opposite  direction.  Here 
homocysteine  acts  as  the  sulphur  donor  in  the  conversion  to  cysteine.  It  is 
17 condensed  with  serine,  catalysed  by  cystathionine  ß-synthase  (CBS),  to  produce 
cystathionine  prior  to  cleavage  by  cystathionine  y-Iyase  (CGL)  to  release  cysteine, 
a-ketobutyrate  and  ammonia.  CBS  has  been  referred  to  as  serine  sulphydrase 
and  has  been  shown  to  catalyse  the  production  of  cysteine  from  serine  and  H2S  in 
vitro.  This  activity  is  low  though  and  not  thought  to  be  relevant  in  vivo. 
The  reactions  catalysed  by  these  enzymes  are  very  similar  and  they  each  utilise 
PLP  as  a  cofactor.  Both  pairs  of  enzymes  (synthases  and  lyases)  are  sufficiently 
specific,  however,  that  they  are  able  to  carry  out  reactions  on  opposite  sides  of 
the  same  atom  without  appreciably  catalysing  the  other.  Although  in  vitro  it  is 
possible  to  demonstrate  these  "side  reactions",  they  are  at  very  low  rates  and 
thought  to  be  insignificant  in  vivo.  By  possessing  this  high  degree  of  specificity  a 
fruitless  cycle  of  synthesis  by  the  first  enzyme  and  cleavage  at  the  same  point  by 
the  other  is  avoided.  This  is  worth  commenting  on  here  both  because  of  the 
elegance  and  specificity  of  the  mechanism  which  will  be  discussed  later,  and  also 
because  of  the  large  number  of  reactions  that  these  enzymes  are  able  to  catalyse 
potentially  in  vivo. 
1.7.2.3  The  Methionine  Cycle 
Methionine  is  predominantly  synthesised  by  the  methylation  of  homocysteine  by 
methionine  synthase.  As  mentioned,  OAHSS  can  utilise  methanethiol  as  a 
sulphur  donor  in  sulphydrylation  to  produce  methionine  directly  but  this  is  unlikely 
to  be  significant.  The  synthesis  of  methionine  from  homocysteine  constitutes  the 
first  step  in  the  methionine  cycle.  A  critical  role  for  methionine  in  biology  is its  part 
in  the  formation  of  SAM  produced  from  methionine  and  ATP  by  SAM  synthase. 
18 Fulfilling  one  of  its  roles  as  a  single  carbon  donor  SAM  donates  its  methyl  group 
via  a  SAM  dependent  methyltransferase.  The  remaining  molecule  is  S-adenosyl 
homocysteine  (SAH).  This  is  hydrolysed  by  SAH  hydrolyase  to  adenosine  and 
homocysteine,  which  completes  the  cycle.  Homocysteine  can  then  either  be 
remethylated  to  again  produce  methionine  or  undergo  reverse  transsulphuration 
to  produce  cysteine.  Thus  homocysteine  sits  at  a  possible  branch  point  regulating 
the  levels  of  methionine  and  cysteine  in  the  cell. 
Not  shown  in  the  figures  above  to  avoid  confusion  is  the  action  of  MGL.  This 
enzyme  is  able  to  catabolise  methionine,  homocysteine  and  cysteine  to  varying 
degrees.  It  is  thus  able  to  deplete  the  cellular  pool  of  these  amino  acids. 
The  presence  or  absence  of  any  of  these  enzymes  and  processes  in  any 
parasites  has  not  been  addressed  fully  yet,  nor  are  there  specific  details  on  the 
enzymes  themselves  except  for  the  use  of  PLP  by  some.  In  the  following  sections 
their  distribution  will  be  considered  followed  by  a  detailed  examination  of 
published  data  on  cysteine  synthase  and  MGL. 
1.7.3  Sulphur  Amino  Acids  in  Bacteria 
Many  bacteria  have  the  ability  to  synthesise  both  cysteine  and  homocysteine 
through  sulphydrylation  and  can  assimilate  inorganic  sulphate  to  produce 
sulphide.  The  two  reduction  steps  used  to  convert  sulphate  to  sulphide  utilise 
thioredoxin  and  NADPH  (Siegel  et  a!.,  1973;  Tsang,  1983).  However  it  has  been 
shown  for  E.  coli  that  other  sulphur  containing  compounds  such  as  sulphite, 
19 thiosulphate,  taurine  and  glutathione  can  act  as  the  sole  sulphur  source  (Kredich, 
1996). 
The  synthesis  of  cysteine  via  suiphydrylation  by  cysteine  synthase  is  well 
characterised  in  bacteria.  The  enzyme  is  PLP-dependent  and  uses  OAS  as  the 
carbon  backbone,  synthesised  from  serine  and  acetylCoA  by  serine 
acetyltransferase  (SAT).  There  are  frequently  two  isoforms  of  cysteine  synthase 
present  and  one  in  particular  is  found  to  copurify  with  SAT,  a  complex  sometimes 
referred  to  as  cysteine  synthetase  (Kredich  et  al.,  1969).  The  structure  of  an 
uncomplexed  cysteine  synthase  from  S.  typhimurium  has  been  published 
(Burkhard  et  al.,  1998).  Synthesis  of  homocysteine  by  sulphydrylation  occurs  only 
in  non-enteric  bacteria.  The  identity  of  the  acyl  group  associated  with  the 
homoserine  carbon  backbone  varies.  It  is  a  succinate  group  in  P.  aeruginosa 
(Foglino  et  al.,  1995)  and  an  acetate  in  Brevibacterium  (Brush  and  Paulus,  1973), 
Bacillus  (Brush  and  Paulus,  1971),  Pseudomonas  syringae  (Andersen  et  al., 
1998).  There  is  evidence  that  homocysteine  synthase  can  utilise  thiols  other  than 
hydrogen  sulphide  to  produce  other  Cy-SS-R  compounds.  For  example 
methanethiol  (CH3SH),  which  leads  to  the  production  of  methionine  directly 
(Flavin  and  Slaughter,  1967).  This  direct  sulphydrylation  is  slow  and  the 
relevance  of  this  in  vivo  is  unknown  at  this  time. 
The  sequence  databases  contain  many  examples  of  the  four  enzymes  of 
transsulphuration  and  there  are  numerous  examples  of  purification  and 
characterisation  of  the  enzymes.  Also  the  structures  of  the  enzymes  responsible 
for  transsulphuration  in  E.  coli  have  been  solved  (Clausen  et  al.,  1996,  Clausen  et 
20 al.,  1998).  They  have  been  proposed  as  possible  drug  targets  because  the 
bacteria  lack  the  reverse  transsulphuration  pathway  and  the  enzymes  are  not 
present  in  mammals.  This  lack  of  the  reverse  pathway  occurs  in  all  enteric 
bacteria  but  others  such  as  P.  aeruginosa  possesses  both  the  forward  and 
reverse  pathway  and  thus  can  grow  equally  well  on  either  cysteine  or  methionine 
as  the  sole  source  of  sulphur  (Foglino  et  al.,  1995).  The  closely  related  bacteria 
P.  putida  lacks  the  key  enzymes  of  reverse  transsulphuration  and 
transsulphuration  is  not  very  active.  Perhaps  to  compensate  for  this  apparently 
poor  ability  to  interconvert  cysteine  and  homocysteine,  the  organism  is  able  to 
synthesise  both  of  these  through  sulphydrylation  (Vermeij  and  Kertesz,  1999). 
Interestingly  the  bacteria  is  one  of  the  few  organisms  identified  so  far  to  possess 
MGL.  It  has  been  proposed  that  it  may  provide  an  alternative  to  reverse 
transsulphuration  with  methanethiol  converted  to  a  suiphonate  and  then  sulphate 
before  being  reduced  in  he  normal  manner  to  provide  sulphide  (Vermeij  and 
Kertesz,  1999). 
The  differences  between  species  of  bacteria  alone  highlights  the  variations  that 
exist  in  sulphur  amino  acid  metabolism  and  the  difficulties  in  making  generalised 
statements. 
1.7.4  Plant  Sulphur  Amino'Acid  Metabolism 
Plants  are  also  able  to  assimilate  inorganic  sulphur  for  incorporation  into  amino 
acids  in  much  the  same  way  as  bacteria  (for  a  recent  review  see  Ravanel  et  al., 
1998).  The  ability  of  plants  to  accomplish  this  is  of  undoubted  importance  to  all 
mammals,  with  the  possible  exception  of  ruminants,  as  this  provides  the  essential 
21 source  of  dietary  sulphur  required  in  the  form  of  methionine.  One  difference  in 
this  mechanism  between  plants  and  bacteria  is  the  utilisation  of  glutathione  for 
sulphate  reduction  by  plants  (Tsang  and  Schiff,  1976a)  and  thioredoxin  in  bacteria 
(Tsang  and  Schiff,  1976b). 
In  plants,  as  in  bacteria,  the  synthesis  of  L-cysteine  is  achieved  by  condensation 
of  sulphide  and  OAS  by  OASS.  This  enzyme  has  been  studied  thoroughly  in 
plants  and  found  to  be  similar  to  the  enzyme  in  bacteria.  However,  whether  there 
exists  a  bienzyme  complex  of  SAT  and  OASS  in  all  plants  is  less  clear.  The 
published  evidence  seems  contrary  in  some  cases.  For  example,  purification  of 
cysteine  synthase  from  rape  leaves  (Masada  et  al.,  1975)  and  spinach  leaves 
(Warrilow  and  Hawkesford;  1998)  make  no  mention  of  co-purification  with  SAT. 
Others  have  shown  the  purification  of  both  enzymes  in  a  tight  complex,  for 
example  in  spinach  chioroplasts  (Droux  et  al.,  1992),  Allium  tuberosum 
(Nakamura  and  Tamura,  1990)  and  water  melon  (Saito  et  al.,  1995).  Analysis 
using  the  yeast  two-hybrid  system  has  proposed  association  of  the  enzymes  from 
Arabidopsis  thaliana  in  vivo  (Bogdanova  and  Hell,  1997)  but  later  work  using  A. 
thaliana  proteins  expressed  recombinantly  in  E.  coli  have  claimed  this  is  not  the 
case  (Droux  et  al.,  1998).  In  common  with  bacterial  cysteine  synthase,  multiple 
isoforms  are  found  in  plants.  These  can  be  classified  into  distinct  isoforms  which 
are  intercellularly  localised  into  plastids,  mitochondria  and  cytosol  (Lunn  et  al., 
1990;  Rolland  et  al.,  1992;  Yamaguchi  of  al.,  1998).  Four  species  have  been 
cloned  from  rice  (Nakamura  et  al.,  1999)  and  at  least  three  from  A.  thaliana  (Hell 
et  aL,  1994;  Barroso  et  al.,  1995;  Hesse  and  Altmann,  1995;  Nakamura  et  al., 
1997).  Although  there  are  obvious  organelle  distributions  for  the  enzymes  (i.  e. 
22 chloroplast,  )  in  plants  there  are  also  multiple  isoforms  present  in  a  single  cellular 
location. 
In  plants  cystathionine  is  produced  by  the  condensation  of  cysteine  with  0- 
phosphohomoserine  rather  than  an  acetate  or  succinate  substituted  molecule 
(Datko,  et  aL,  1974).  '  Homocysteine  is  generated  in  an  identical  fashion  to 
bacteria  with  the  a,  ß  elimination  of  cystathionine  by  CBL  (also  producing  pyruvate 
and  ammonia).  The  production  of  homocysteine  by  direct  suiphydrylation  in  vivo 
is  unlikely  in  plants.  CGS  has  been  shown  in  vitro  to  be  able  to  utilise  sodium 
sulphide  as  the  sulphur  donor  to  produce  homocysteine  (Ravanel  et  al.,  1995). 
However  it  has  been  calculated  that  this  would  be  only  able  to  provide  3%  of  the 
homocysteine  requirements  (MacNicol  et  al.,  1981).  There  is  thought  to  be  no 
reverse  transsulphuration  pathway  in  plants  as  no  CBS  or  CGL  genes  or  proteins 
have  been  identified. 
Plants  are  also  unusual  in  the  high  concentration  of  uncommonly  occurring 
sulphur  amino  acids  present.  These  substituted  cysteine  and  methionine 
compounds  such  as  S-methylcysteine,  homomethionine  and  various  suiphoxide 
derivatives  have  largely  unknown  functions. 
1.7.5  Yeast  and  Fungi  Sulphur  Amino  Acid  Metabolism 
It  had  been  thought  for  some  time  that  S.  cerevisiae  was  able  to  synthesise 
cysteine  by  two  distinct  pathways.  Either  via  reverse  transsulphuration  from 
homocysteine  and  also  by  a  dual  action  0-acetylserine  sulphydrylase/0- 
acetylhomoserine  sulphydrylase  (Yamagata  et  al.,  1974).  This  latter  mechanism 
23 is  now  thought  not  to  occur  for  the  production  of  cysteine  in  vivo  (Ono  et  al., 
1999).  Instead  only  the  sulphydrylation  of  O-acetyl-L-homoserine  is  of 
physiological  significance.  The  OAHSS  responsible  for  this  has  also  been 
characterised  in  S.  lipolytica  (Morzycka  and  Paszewski,  1979),  Aspergillus 
nidulans  (Paszewski  and  Grabski,  1974)  and  Neurosporra  crassa  (Piotrowska  et 
a1.,  1980;  Jacobson  and  Metzenburg,  1977).  Thus  it  would  appear  that  cysteine 
synthesis  does  not  occur  through  direct  suiphydrylation  but  from  reverse 
transsulphuration  only.  OAHSS  has  also  been  shown  in  vitro  to  produce 
methionine  and  ethionine  when  sulphide  was  substituted  for  the  appropriate  thiols 
(Yamagata,  1971).  However  the  relevance  of  the  abilities  of  this  enzyme  in  vivo  is 
unknown  at  this  time. 
The  enzymes  required  for  reverse  transsulphuration  have  been  found  in  these 
organisms.  CBS  from  S.  cerevisiae  has  been  purified  (Ono  et  al.,  1994)  and  CGL 
cloned  and  expressed  recombinantly  in  E.  coli  (Yamagata  et  al.,  1993).  This 
would  allow  for  the  production  of  cysteine  from  homocysteine.  Conversion  of 
cysteine  back  to  homocysteine  is  also  possible  as  CBL  and  CGS  have  also  been 
identified.  There  is  no  evidence  of  MGL  in  yeast  or  fungi.  For  a  comprehensive 
review  on  sulphur  amino  acid  metabolism  in  S.  cerevisiae  the  reader  is  directed  to 
Thomas  and  Surdin-Kerjan  (1997). 
1.7.6  Sulphur  Amino  Acids  in  Mammals 
The  most  obvious  and  key  difference  in  the  metabolism  of  sulphur  containing 
amino  acids  in  mammals  to  lower  organisms  is  the  absence  of  sulphydrylation. 
Methionine  but  not  cysteine  is  commonly  referred  to  as  an  essential  amino  acid  in 
24 mammalian  nutrition.  This  is  due  to  the  lack  of  transsulphuration  (conversion  of 
cysteine  to  homocysteine)  but  the  presence  of  the  reverse  transsulphuration 
pathway.  Thus  mammals  can  produce  sufficient  cysteine  for  requirements 
provided  the  dietary  source  of  methionine  is  adequate.  This  is  synthesised  in  the 
same  manner  as  described  for  bacteria  utilising  CBS  and  CGL.  For  a  summary 
see  Griffith,  1987. 
1.7.7  Parasite  Sulphur  Amino  Acid  Metabolism 
As  with  many  other  aspects  of  their  biology,  the  knowledge  of  the  processes  of 
sulphur  amino  acid  metabolism  in  parasites  is  much  scarcer  than  for  other 
organisms.  For  a  review  see  Walker  and  Barrett,  1997.  The  details  of  sulphur 
amino  acid  metabolism  in  parasites  other  than  T.  vaginalis  will  be  considered  in 
this  section. 
There  is  evidence  for  direct  sulphydrylation  in  Entamoeba.  Two  cysteine 
synthase  genes  have  been  cloned  and  partially  characterised  from  both  E. 
histolytica  (Nozaki  et  al.,  1998)  and  E.  dispar  (Nozaki  et  al.,  1999).  There  are  no 
other  published  accounts  of  the  purification  or  cloning  of  enzymes  capable  of 
sulphydrylation  in  parasites  although  data  on  activities  attributed  to  CBS  have 
been  published.  This  activity  termed  "activated  serine  sulphydrase"  has  been 
recorded  in  E.  histolytica  and  Leishmania  spp.  (Thong  and  Coombs,  1985b)  and 
also  species  of  nematodes  (Walker  and  Barrett,  1991).  The  enzyme  responsible 
for  the  "activated  serine  sulphydrase"  activity  has  also  been  partially 
characterised  from  a  free-living  nematode  source.  Described  as  a  novel  CBS 
enzyme  it  is  able  to  catalyse  the  production  of  cystathionine  from  homocysteine 
25 and  serine  or  cysteine  (Walker  et  al.,  1992;  Papadopolous  et  al.,  1996).  There  is 
also  evidence  of  an  additional  CBS  in  nematodes.  Cystathionine  synthesis  and 
catabolism  activity  has  also  been  detected  in  Hymenolepis  diminuta  (Gomez- 
Bautista  and  Barrett,  1988)  and  Fasciola  hepatica  (Bankov  et  al.,  1996).  The 
treatment  of  African  trypanosomes  with  metabolic  inhibitors  and  incubation  with 
excess  L-methionine  have  both  shown  increased  intracellular  levels  of  reverse 
transsulphuration  products  (cystathionine  and  cysteine)  (Bacchi,  et  al.,  1995; 
Goldberg  et  al.,  2000).  There  does  therefore  exist  part  of  the  transsulphuration 
pathway  in  some  parasites  but  the  complete  pathway  has  not  been  described. 
The  role  of  SAM  in  one  carbon  donor  reactions  is  likely  to  exist  in  a  number  of 
parasites.  Several  enzymes  involved  in  the  metabolism  of  SAM  have  been 
characterised.  This  includes  SAM  decarboxylase  from  Onchocerca  volvulus 
(Da'Darra  et  al.,  1996),  Trypanosoma  cruzi  (Persson  eta!.,  1998)  and  a 
bifunctional  SAM  decarboxylase/ornithine  decarboxylase  from  P.  falciparum 
(Rathaur  and  Walter,  1987;  Müller  et  al.,  2000).  Also  SAH  hydrolyase  has  been 
identified  in  both  Leishmania  donovani  (Henderson  et  al.,  1992)  and  Plasmodium 
falciparum  (Creedon  et  al.,  1994).  In  addition  to  this  part  of  the  methionine  cycle, 
methionine  y-lyase  has  also  been  shown  in  whole  parasite  lysates  of  E.  histolytica 
(Lockwood  and  Coombs,  1991b). 
1.7.8  Sulphur  Amino  Acid  Metabolism  in  T.  vaginalis 
The  synthesis  and  fate  of  sulphur  amino  acids  in  T.  vaginalis  is  the  central  area  of 
investigation  of  this  project.  Several  processes  and  enzymes  had  been 
26 characterised  from  the  parasite  prior  to  this  study  and  these  will  be  discussed 
here  in  detail. 
As  with  other,  organisms  methionine  is  required  for  the  synthesis  of  SAM  by  the 
parasite.  Radiolabelled  methionine  has  been  shown  to  be  incorporated  into  living 
trichomonads  (Thong,  1985)  The  radiolabelled  carbon  was  detected  in  SAM  and 
also  nucleic  acids  and  lipids  presumably  denoting  its  role  as  one  carbon  donor. 
The  parasite  has  been  shown  to  possess  methionine  adenosyl  transferase 
(Yarlett,  1988)  and  SAM  methyltransferases  (Thong  et  al.,  1987).  S-Adenosyl 
homocysteine  hydrolyase  activity  has  also  been  detected  (Thong  et  al.,  1985) 
and  the  gene  cloned  and  expressed  (Bagnara  et  al.,  1996;  Minotto  et  al.,  1998). 
Although  the  presence  of  methionine  synthase  has  not  been  confirmed  it  would 
complete  the  cycle  of  production  of  methionine  from  homocysteine  and  eventual 
conversion  back  to  homocysteine. 
No  method  of  direct  sulphydrylation  has  yet  been  published  for  T.  vaginalis  either 
for  the  production  of  cysteine  or  homocysteine.  The  presence  of  an  "activated" 
serine  suiphydrylase  in  species  of  trichomonads  has  been  shown  in  crude  lysates 
(Thong  and  Coombs,  1985b)  but  not  characterised.  The  production  of  hydrogen 
sulphide  from  this  enzyme  is  stimulated  by  the  presence  of  p-mercaptoethanol,  a 
situation  also  found  in  nematodes  (Walker  and  Barrett,  1991).  In  T.  vaginalis  this 
activity  has  been  shown  to  be  attributable  to  several  isoforms  (Thong  and 
Coombs,  1987). 
27 CGL  activity  has  been  reported  in  T.  vaginalis  lysates  (Thong,  1985).  This  was  at 
very  low  levels  however  in  a  crude  cell  preparation  and  has  since  not  been 
investigated.  Methionine  y-lyase  has  been  purified  and  cloned  from  the  parasite 
and  as  this  is  a  major  focus  of  this  study  it  will  be  covered  in  detail  in  the  next 
chapter. 
1.8  Pyridoxal  5'-Phosphate  (PLP)  Dependent  Enzymes 
PLP-dependent  enzymes  are  heavily  involved  in  amino  acid  metabolism  in 
general  and  that  of  sulphur  amino  acids  in  particular.  The  following  sections  of 
this  introduction  give  a  brief  overview  of  these  enzymes  followed  by  a  summary  of 
those  involved  in  this  study. 
Pyridoxal  5'-phosphate,  a  derivative  of  pyridoxal  or  vitamin  B6,  acts  as  a  cofactor 
in  a  very  large  number  of  enzymes.  These  PLP-dependent  enzymes  are 
ubiquitous  in  eukaryotes  and  prokaryotes  and  often  play  central  roles  in  amino 
acid  metabolism.  The  unique  chemistry  of  the  cofactor,  which  enables  it  to  act  as 
an  electron  "sink",  conveys  its  versatility.  The  most  commonly  utilised  substrates 
are  amino  acids  and  when  conjugated  to  PLP  by  their  amine  group  the  a-carbon 
is  labilised.  That  is,  there  is  the  potential  to  break  any  of  the  four  bonds  around 
the  Ca.  For  this  reason  PLP-dependent  enzymes  are  able  to  catalyse 
transamination,  decarboxylation,  racemisation,  elimination  and  replacement 
reactions.  Not  only  can  changes  take  place  at  the  Ca  but  also  along  the  amino 
acid  side  chain  as  well  at  the  ß  and  y  positions.  The  specific  architecture  of  the 
28 enzymes  active  site  dictates  the  catalytic  event  promoting  the  occurrence  of  the 
desired  reaction,  whilst  excluding  almost  entirely  all  others. 
There  are  a  very  large  number  of  sequences  available  for  PLP-dependent 
enzymes  in  the  databases,  a  situation  increased  dramatically  by  the  recent 
genome  sequencing  projects.  This  has  only  recently  been  complemented  with 
structural  information  on  these  enzymes.  Classification  has  been  difficult  up  until 
this  time  because  of  the  low  sequence  homology  even  between  related  enzymes. 
A  simple  and  largely  accurate  classification  has  been  suggested  in  which  these 
enzymes  can  be  broadly  subdivided  into  three  classes,  a,  ß  and  y  (Alexander  et 
al,  1994).  This  was  based  upon  the  chemical  characteristics  of  the  reaction, 
corresponding  to  the  position  at  which  they  act  upon  their  amino  acid  substrates 
side  chain,  and  correlated  with  sequence  data.  From  sequence  analysis  it  was 
predicted  that  the  a  and  y  families  were  more  closely  related  to  each  other  than 
the  0  family.  Some  PLP-dependent  enzymes  though  do  not  fit  this  classification 
and  it  is  thus  not  comprehensive  as  it  stands.  A  classification  based  upon 
structural  data  has  also  been  proposed  (Grishin  et  al.,  1995).  At  this  point  five 
different  folds  were  observed  and  through  sequence  analysis  it  was  predicted  that 
further  unknown  folds  existed.  A  recent  review  of  PLP-dependent  enzymes 
presents  the  most  current  attempt  to  summarise  the  available  data  and  classify 
the  enzymes  (Jansonius,  1998). 
29 1.8.1  Three  Dimensional  Structures  of  PLP-Dependent  Enzymes 
The  first  structure  of  a  PLP-dependent  enzyme  to  be  solved  was  that  of  aspartate 
aminotransferase  (AAT)  in  1980  (Ford  et  al.,  1980).  This  enzyme  has  since  been 
used  as  a  model  system  and  is  the  most  extensively  studied  of  all  such  enzymes. 
Currently,  a  search  of  the  structural  database  reveals  a  total  of  36  sets  of  atomic 
coordinates  for  AAT.  These  include  enzyme-complexes  with  various  compounds, 
enzymes  from  different  organisms  and  numerous  mutants.  The  total  number  of 
sets  of  coordinates  for  all  PLP-dependent  enzymes,  complexes,  mutants,  etc.  now 
exceeds  120.  This  is  an  even  more  remarkable  number  when  one  considers  that 
the  second  enzyme  structure  to  be  solved,  that  of  tryptophan  synthase  (TRPS), 
was  not  published  until  1988  (Hyde  et  al.,  1988).  Since  then  a  rapidly 
accelerating  number  of  new  structures  have  been  solved  (following  the  general 
trend  of  numbers  of  structures  being  solved)  and  with  this  the  opportunity  to 
assign  each  to  an  evolutionary  family.  Many  PLP-dependent  enzymes  are 
multimers  and  normally  active  as  dimers  of  at  least  80  kDa.  The  large  size  of 
these  molecules  have  undoubtedly  caused  many  problems  in  the  past  in  solving 
structures.  Table  1.1  lists  the  different  enzymes  for  which  the  three-dimensional 
structures  have  been  solved. 
30 Enzyme  Source  Reference 
Aspartate  aminotransferase  Chicken  mitochondria  Ford  eta!.,  1980 
Chicken  cytosol  Malashkevich  et  a!.,  1995 
Pig  cytosol  Malashkevich  at  a/.,  1995 
E.  coli  Okamoto  et  a!.,  1994 
S.  cerevisiae  Jeffrey  at  al.,  1998 
Thermus  thennophilus  Nakai,  eta!.,  1999 
Tryptophan  synthase  Salmonella  typhimurium  Hyde  at  al.,  1988 
co-Amino  acid:  pyruvate 
aminotransferase 
Pseudomonas  sp.  Watanabe  et  al.,  1989 
Glycogen  phosphorylase  Rabbit  cytosol  Martin  et  a/.,  1990 
Dialkylglycine  decarboxylase  Pseudomonas  capacia  Toney  at  al.,  1993 
Tyrosine  phenol-lyase  Citrobacter  freundii  Antson  et  al.,  1993 
Erwinia  herbicola  Pletnev  et  al.,  1997 
D-Amino  acid  aminotransferase  Bacillus  sp.  Sugio  et  al.,  1995 
Omithine  decarboxylase  Lactobacillus  30a  Momany  et  al.,  1995 
Trypanasoma  brucei  Grishin  at  al.,  1999 
Mouse  Kern  eta!.,  1999 
Cystathionine  p-Iyase  E.  coli  Clausen  et  al.,  1996 
Alanine  racemase  Bacillus  stearothermophilus  Shaw  at  a/.,  1997 
Glutamate-1-semialdehyde 
aminomutase 
Synechoccus  Hennig  at  al.,  1997 
O-Acetylserine  suiphydrylase  S.  typhimurium  Burkhard  et  al.,  1998 
8-Amino-7-oxononanoate 
synthase 
E.  coli  AJexeev  at  al.,  1998 
Aromatic  amino  acid  Paracoccus  denitrificans  Okamoto  et  aL,  1998 
aminotransferase  Trypanasoma  cruzi  Blankenfeldt  et  al.,  1999 
E.  coli  3TAT 
31 Cystathionine  7-synthase  E.  coli  Clausen  et  a!.,  1998 
Nicotiana  tabacum  Steegbom  et  a/.,  1999 
Omithine  aminotransferase  Homo  sapiens  Shen  of  a/.,  1998 
Senne  hydroxymethyltransferase  Homo  sapiens  Renwick  of  a!.,  1998 
Rabbit  cytosol  Scarsdale  eta!.,  1999 
E.  coli  Scarsdale  et  al.,  2000 
Threonine  deaminase  E.  coli  Gallagher  eta!.,  1998 
Tryptophan  indole-lyase  Proteus  vulgaris  Isupov  et  al.,  1998 
AHBA  synthase  Amycolatopsis  mediterrane!  Eads  et  al.,  1999 
1-Aminocyclopropane-1- 
carboxylate  synthase 
Apple  Capitani  et  al.,  1999 
Anthranilate  synthase  Su!  folobus  so!  fataricus  Knochel  et  a!.,  1999 
Diaminopelargonic  acid  synthase  E.  coli  Kack  of  a!.,  1999 
Phosphosenne  aminotransferase  E.  coli  Hester  et  a!.,  1999 
Bacillus  sp.  1  BT4 
CsdB  (SCL)  E.  coli  Fujii  et  al.,  2000 
Cystalysin  Treponema  denticola  Krupka  of  a!.,  2000 
Cystine  lyase  (C-DES)  Synechocystis  Clausen  et  al.,  2000a 
MaIY  E.  co!!  Clausen  of  al.,  2000b 
NifS  Thermotoga  maritima  Kaiser  et  al.,  2000 
Table  1.1:  List  of  structures  published  with  PLP  cofactor.  Only  the  first  example  of  any  structure 
reported  is  referenced.  Where  there  is  no  publication  available  on  a  deposited  set  of  coordinates  the 
PDB  accession  code  is  given. 
At  the  beginning  of  this  study  very  few  of  those  listed  above  were  in  the  database 
(though  not  necessarily  available).  CBL  was  the  only  representative  of  the 
proposed  y-family  and  since  that  time  only  two  other  examples  have  been 
published,  those  of  CGS  (Clausen  et  al.,  1998;  Steegborn  et  al.,  1999).  CBL  was 
32 also  the  only  example  of  a  PLP-dependent  enzyme  acting  upon  a  sulphur 
containing  amino  acid.  Since  that  time  though  four  structures  have  been 
published  that  act  upon  cysteine  (or  cystine),  CsdB  (Fuji  et  a!.,  2000),  cystalysin 
(Krupka  et  al.,  2000),  C-DES  (Clausen  et  al.,  2000)  and  NifS  (Kaiser  et  al.,  2000), 
in  addition  to  CGS. 
1.8.2  Methionine  y-Lyase  (MGL) 
In  T.  vaginalis  the  breakdown  of  L-methionine  into  ammonia,  a-ketobutyrate  and 
methanethiol  has  been  shown  to  be  catalysed  by  the  PLP-dependent  enzyme 
methionine  y-Iyase  (MGL)  (Thong  and  Coombs,  1987,  Lockwood  and  Coombs, 
1991  b):  The  same  enzyme  is  also  responsible  for  the  even  more  rapid 
breakdown  of  L-homocysteine  to  ammonia,  a-ketobutyrate  and  hydrogen 
sulphide,  formerly  described  as  homocysteine  desuiphurase  (Thong  and  Coombs, 
1985).  The  enzyme  has  been  purified  from  the  parasite  (Lockwood  and  Coombs, 
1991  b)  and  two  genes  cloned  and  expressed  in  a  prokaryotic  system  (McKie  et 
al.,  1998).  As  mentioned  previously  the  enzyme  is  also  present  in  P.  putida  and 
has  been  purified  from  the  bacteria  (Esaki  and  Soda,  1987)  and  two  genes  cloned 
in  an  analogous  fashion  to  T.  vaginalis  (Inoue  et  al.,  1995;  Hod  et  al.,  1996). 
Other  sources  from  which  the  enzyme  has  been  purified  include  Aeromonas  sp. 
(Nakayama  et  al.,  1984),  Brevibacterium  linens  (Dias  and  Weimer,  1998)  and 
Clostridium  sporogenes  (Kreis  and  Hession,  1973).  A  further  report  of  purification 
of  MGL  from  T.  vaginalis  has  incorrectly  claimed  isolation  of  a  further  enzyme  to 
the  two  already  published  (Han  et  al.,  1998).  The  differences  in  this  are  very 
minor  (two  amino  acid  changes)  and  presumably  strain  specific  or  PCR  based 
mutations.  Activities  for  MGL  have  also  been  reported  in  a  number  of  soil 
33 bacteria,  E.  histolytica  and  rumen  ciliates  (Lockwood  and  Coombs,  1991  b).  There 
is  no  mammalian  homologue  of  the  enzyme  and  it  is  apparently  absent  from  yeast 
and  other  eukaryotes  as  well.  Trace  levels  of  homocysteine  desuiphurase  activity 
in  mammals  have  been  attributed  to  the  action  of  cystathionine  y-lyase  and 
thought  to  be  of  little  significance  (Cooper,  1983). 
Characterisation  of  the  enzyme  has  revealed  it  to  be  active  as  a  multimer. 
Individual  subunits  have  an  Mr  of  40-44  000  and  the  active  enzyme  has  an 
estimated  M,  of  >150  000.  This  suggests  a  tetrameric  enzyme  and  the  activity  of 
recombinant  enzyme  from  P.  putida  and  T.  vaginalis  suggests  that  this  is  likely  to 
be  a  homotetramer.  Whether  this  is  the  case  in  vivo  has  not  been  shown.  PLP  is 
present  at  a  ratio  of  1  mole  per  mole  of  enzyme  subunit  in  each  case.  Relative 
levels  of  activity  differ  between  sources  but  the  enzyme  is  able  to  catalyse  a,  y- 
elimination  reactions  on  a  range  of  CY-S8  containing  amino  acids  such  as 
methionine,  ethionine  and  homocysteine.  To  a  lesser  extent,  similar  activities 
have  been  recorded  against'CO-Sr  substrates  such  as  cysteine  too. 
The  in  vivo  role  of  the  enzyme  is  unknown  at  present  although  there  is  evidence 
that  the  a-keto  acids  produced  may  be  utilised  as  an  alternate  energy  source 
(Lockwood  and  Coombs,  1991  b).  This  has  also  been  suggested  in  P.  putida 
because  of  its  gene  arrangement  within  an  operon  coding  for  part  of  an  a-keto 
acid  dehydrogenase  (Inoue  et  al.,  1997).  The  specific  role  of  the  large  amounts  of 
low  molecular  weight  thiols  produced  is  unknown  but  is  at  least  partly  responsible 
for  the  characteristic  odour  produced  by  T.  vaginalis  when  grown  in  vitro. 
34 1.8.3  Cysteine  Synthase 
As  already  mentioned  cysteine  synthase  or  OASS  is  present  in  many  bacterial 
species,  plants  and  also  recently  discovered  in  Entamoeba.  It  catalyses  the 
condensation  of  0-acetyl-L-serine  and  sulphide  to  produce  L-cysteine  and 
acetate  (for  a  recent  review  see  Tai  and  Cook,  2000).  The  enzyme  has  been 
purified  from  a  large  number  of  species  and  also  cloned  and  expressed 
recombinantly.  It  is  active  as  a  homodimer  and  the  structure  of  the  enzyme  from 
S.  typhimurium  has  been  solved  (Burkhard  et  al.,  1998).  As  with  MGL  and  the 
various  cysteine  desulphurase  enzymes,  it  is  a  PLP-dependent  enzyme.  Unlike 
these  others,  though,  it  belongs  to  the  ß-family  of  PLP-dependent  enzymes  with  a 
fold  similar  to  tryptophan  synthase  (Hyde  et  al.,  1988). 
For  both  plant  and  bacterial  enzymes  there  is  evidence  for  cysteine  synthase 
existing  as  a  complex  with  serine  acetyl  transferase  (SAT),  the  previous  enzyme 
in  the  cysteine  biosynthetic  pathway.  The  evidence  available  seems  to  suggest 
that  in  appropriate  circumstances  certain  isoforms  of  the  enzyme  associate  with 
SAT  to  form  the  "cysteine  synthetase"  complex.  In  vivo  the  association  of  the 
plant  enzyme  is  dependent  on  the  concentration  of  both  OAS  and  sulphide  (Droux 
et  a/.,  1998)  and  SAT  forms  high  molecular  weight  complexes  in  the  absence  of 
cysteine  synthase. 
1.8.4  Cysteine  Desulphurase 
Cysteine  desuiphurase  is  a  PLP-dependent  enzyme  that  catalyses  the  removal  of 
sulphur  from  cysteine  to  leave  alanine.  It  is  also  able  to  utilise  selenocysteine  as 
substrate  (Lacourciere  and  Stadtman,  1998).  Note  that  this  is  a  different  reaction 
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ammonia  in  the  lysis  of  cysteine.  The  enzyme  is  alternatively  referred  to  as  NifS 
in  reference  to  the  gene  product  from  Azotobacter  vinelandii  (Zheng  et  al.,  1993). 
Homologues  have  been  identified  in  E.  coli  (Mihara  et  al.,  1997),  S.  cerevisiae 
(Kolman  and  Söll,  1993),  Caenorhabditis  elegans  (Wilson  et  al.,  1994)  and  mice 
(Nakai  et  al.,  1998)  amongst  others.  There  does  also  exist  an  analogue  first 
identified  in  pigs  highly  specific  for  selenocysteine  termed  selenocysteine  lyase 
(SCL)(Esaki  et  a!.,  1982).  A  homologue  for  this  enzyme  has  been  identified  in  E. 
coli  termed  CsdB  (Mihara  eta!.,  1999).  NifS  has  been  shown  to  catalyse  the 
formation  of  FeS  clusters  in  nitrogenase  to  create  a  functional  enzyme  (Zheng  et 
A,  1993).  It  does  this  by  forming  an  internal  persulphide  complex  between  the 
released  substrate  sulphur  and  a  conserved  cysteine  residue  within  the  enzyme 
(Zheng  et  al.,  1994).  It  is  then  believed  that  this  would  then  be  passed  onto  an 
unknown  carrier  molecule  prior  to  use  in  FeS  cluster  formation  or  repair.  There  is, 
in  addition,  a  different  enzyme  that  can  direct  FeS  cluster  assembly.  This  enzyme 
isolated  from  Synechocystis  has  been  named  C-DES  and  has  a  different  substrate 
profile  and  proposed  mode  of  action  to  NifS  proteins.  Instead  of  forming  an 
internal  enzyme  persuiphide  complex,  C-DES  preferentially  utilises  cystine 
(dimerised  cysteine)  and  releases  pyruvate,  ammonia  and  cysteine  persulphide 
(Lang  and  Kessler,  1999).  This  cysteine  persulphide  is  then  presumed  to  be 
released  and  act  as  a  sulphur  atom  donor  in  an  analogous  fashion  to  the  enzyme 
bound  persulphide  of  NifS  enzymes.  Recently  the  structures  of  several  of  these 
enzymes  have  been  solved  and  published:  a  NifS-like  protein  from  Thermotoga 
maritima  (Kaiser  et  al.,  2000),  CsdB  (a  selenocysteine  Iyase)  from  E.  coli  (Fujii  et 
aL,  2000)  and  C-DES  from  Synechocystis  (Clausen  et  al.,  2000).  All  three 
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aspartate  aminotransferase. 
Another  different  cysteine  lyase  enzyme  from  Treponema  denticola  has  also  been 
characterised  (Chu  et  al.,  1997).  This  enzyme  is  more  similar  to  MGL  in  that  it 
also  catalyses  an  a,  p-elimination  reaction  catabolising  cysteine  to  pyruvate, 
ammonia  and  H2S.  Another  interesting  observation  is  that  it  is  proposed  to  be  at 
least  partly  responsible  for  the  haemolytic  properties  of  the  organism.  A  feature 
also  found  in  T.  vaginalis  pathology.  Recently  the  structure  of  this  enzyme  has 
been  reported  (Krupka  et  aL,  2000)  and  confirmed  its  structural  similarity  to  other 
PLP-dependent  aminotransferases.  The  active  site  is  more  structurally  similar  to 
CBL  and  CGS  reflecting  the  reaction  similarity. 
37 1.9  Aims  of  The  Project 
The  overall  aim  of  this  study  was  to  further  understand  sulphur  amino  acid 
metabolism  in  T.  vaginalis.  In  particular  the  roles  of  MGL  and  cysteine  synthase. 
To  do  this  three  practical  goals  were  set: 
1.  Crystallise  and  solve  the  structure  of  MGL 
2.  By  site-directed  mutagenesis  analyse  the  mechanism  of  MGL  and  relate  this  to 
potential  roles  in  vivo 
3.  Produce  and  purify  recombinant  cysteine  synthase  cloned  from  T.  vaginalis 
and  investigate  its  role  in  vivo 
38 CHAPTER  2.  MATERIALS  AND  METHODS 
2.1  Crystallisation  and  Structure  Solution  Materials  and  Methods 
2.1.1  MGL  Purification 
Enzyme  for  use  in  crystallisation  was  purified  as  published  (McKie  et  al.,  1998) 
with  minor  revisions  as  indicated  in  section  3.2.1. 
2.1.2  Enzyme  Sample  Preparation 
Freshly  prepared  MGL1  and  2  for  crystallisation  was  concentrated  using  a  10  kDa 
cut-off  MicrosepTm  centrifugal  concentrator  (Flowgen)  and  simultaneously  washed 
to  remove  glycerol  and  replace  the  buffers.  Firstly  the  enzyme  sample  was 
concentrated  to  a  volume  of  approximately  0.25  ml.  3  ml  of  100  mM  HEPES  pH 
7.5,250  µM  PLP,  1  mM  DTT  was  added  and  the  sample  concentrated  by 
centrifugation  until  the  volume  of  the  retained  sample  was  approximately  0.25  MI. 
This  process  was  repeated  three  times  to  ensure  removal  of  glycerol,  salts,  etc. 
After  concentration  of  the  sample  to  a  suitable  volume,  protein  concentration  was 
determined  and  the  sample  resuspended  in  the  same  buffer  to  6  mg/ml. 
2.1.3  Crystallisation  Solutions 
Sparse  matrix  screens  were  prepared  in  house  from  published  recipes,  e.  g.  Magic 
50  (Jancarik  and  Kim,  1991).  All  solutions  were  filtered  through  a  0.22  µm  syringe 
filter  to  reduce  microbial  contamination. 
39 2.1.4  Sitting  Drop  Crystallisation 
24  well  sifting  drop  plates  were  used  for  crystallisations  (NBS  biologicals,  UK).  1 
ml  of  the  appropriate  crystallisation  solution  was  added  to  the  reservoir.  For  each 
condition,  1.5  µI  enzyme  solution  was  added  to  1.5  µl  reservoir  solution  and  mixed 
by  pipetting.  Wells  were  sealed  using  transparent  adhesive  tape. 
2.1.5  Dynamic  Light  Scattering 
Monodispersity  of  the  concentrated  enzyme  solution  was  examined  by  dynamic 
light  scattering  using  a  Dynapro-801  (Protein  Solutions,  UK).  Enzyme  was 
concentrated  to  >10  mg/ml  in  25  mM  HEPES  pH  7.5  in  an  identical  fashion  to  that 
described  in  section  2.1.2.  Enzyme  was  then  resuspended  at  a  concentration  of  1 
mg/ml  in  the  desired  solution.  Samples  of  200  µl  were  loaded  into  the  instrument 
by  syringe  through  a  0.1  µm  filter. 
2.1.6  Data  Processing  and  Scaling 
All  data  were  processed  with  DENZO  and  scaled  using  SCALEPACK  (Otwinowski 
and  Minor,  1997). 
2.1.7  Molecular  Replacement 
Molecular  replacement  was  performed  using  the  programme  AMoRe 
(Navaza,  1994)  with  data  from  10  to  4.5  A  and  the  structure  of  CBL  (Clausen  et  al., 
1996)  used  as  a  search  model. 
40 2.1.8  Refinement 
Refinement  of  all  MGL1  structures  in  this  study  was  carried  out  using  REFMAC 
(Murshdov  et  al.,  1997)  using  the  Free  R-factor  (Branger,  1992)  to  monitor 
progress.  5%  of  randomly  assigned  reflections  were  selected  for  the  Free  R  set 
and  excluded  from  all  stages  of  refinement.  A  bulk-solvent  correction  (Kostrewa, 
1999)  was  used  in  later  stages  of  refinement.  Geometric  restraints  were 
calculated  using  PROTIN,  new  entries  for  PLP  and  the  PLP-propargylglycine 
complex  were  produced  using  MAKEDIC.  Maps  were  calculated  from  the  output 
of  REFMAC  using  the  CCP4  programme  FFT.  Waters  were  assigned  initially 
using  the  programme  ARP  (Lamzin  and  Wilson,  1993). 
2.1.9  Model  Building 
All  model  building  was  done  using  the  programme  QUANTA  (Molecular 
Simulations  Inc.,  UK).  Early  rounds  of  model  building  fitted  only  one  monomer 
and  advantage  was  taken  of  the  2-fold  NCS  in  the  asymmetric  unit.  The  maps 
produced  by  refinement  were  then  averaged  over  a  single  monomer  using  the 
CCP4  programme  MAPROT  and  the  process  repeated.  This  was  performed  until 
density  was  visible  for  all  main  chain  atoms  and  subsequently  monomers  were 
checked  individually. 
2.2  Molecular  Biology  Materials  and  Methods 
2.2.1  Bacterial  Maintenance,  Cultivation  and  Harvesting 
Escherichia  coli  strains  used  in  this  study  were  XL1-Blue  (Stratagene)  and  JM109 
(Promega)  for  cloning  and  M15pREP4  (Qiagen)  and  BL21  DE3  (Novagen)  for 
expression  of  recombinant  protein.  Stocks  of  bacterial  strains  were  maintained  by 
41 combining  an  overnight  culture  1:  1  with  a  40%  glycerol  and  2%  peptone  solution 
and  stored  at  -70  °C.  Overnight  bacterial  cultures  were  always  produced  by 
picking  a  single  discrete  colony  and  using  this  to  inoculate  an  aliquot  of  LB. 
Colonies  were  produced  by  streaking  out  a  sample  of  bacterial  stock  onto  a  solid 
LB-agar  plate  with  appropriate  antibiotics.  Bacteria  were  harvested  by 
centrifugation  for  5  minutes  at  13  000  rpm  in  a  benchtop  microfuge  or,  for  large 
scale  cultures,  15  minutes  at  4000  g.  Antibiotics  were  used  at  the  following 
concentrations:  ampicillin  100  µg/ml,  kanamycin  25  gg/mI. 
2.2.2  Plasmid  Purification 
Plasmid  DNA  was  routinely  isolated  from  a3  ml  overnight  culture  using  either 
WizardTM  mini  prep  kits  (Promega)  or  Qiaspin  columns  (Qiagen).  For  automated 
sequencing,  Qiaspin  columns  were  used  and  plasmid  resuspended  in  double 
distilled  deionised  water  (dddH2O). 
2.2.3  Polymerase  Chain  Reaction  (PCR)  Amplification 
PCR  amplifications  of  DNA  fragments  which  engineered  restriction  sites  onto  the 
ends  each  contained  5  ng  template  DNA,  oligonucleotide  primers  at  1  mM,  0.1 
mM  dNTPs,  0.75  mM  MgCI2,  reaction  buffer  as  supplied  by  the  manufacturer  and 
5U  of  DNA  polymerase.  VentTm  DNA  polymerase  (New  England  Biolabs)  was 
used  because  of  its  proof-reading  ability  to  minimise  mutations  inserted  during 
amplification.  Taq  DNA  polymerase  (Promega)  was  used  for  routine 
amplifications.  Pfu  polymerase  (Stratagene)  was  used  for  site-directed 
mutagenesis  experiments.  Individual  protocols  including  thermal  cycling 
parameters  will  be  referred  to  in  the  text  as  required.  All  PCR  was  carried  out  on 
a  Perkin  Elmer  GeneAmp  PCR  System  2400. 
42 2.2.4  Isolation  of  T.  vaginalis  Genomic  DNA 
Genomic  DNA  (gDNA)  was  purified  from  T.  vaginalis  using  a  phenol/chloroform 
extraction.  Parasites  in  log  phase  were  harvested  by  centrifugation  at  4000  g  for 
15  minutes  at  4  °C  and  washed  twice  in  pre-chilled  1x  PBS.  The  resulting  cell 
pellet  was  resuspended  in  extraction  buffer  (50  mM  TRIS-HCI  pH  8.0,50  mM 
EDTA,  100  mM  NaCI)  with  the  addition  of  1%  SDS  and  4  mg  proteinase  K  in  a 
final  volume  of  2  ml.  This  was  then  incubated  at  37  °C  for  2  hours  under  gentle 
agitation.  The  lysate  was  combined  1:  1  with  phenol  and  mixed  gently  for  5 
minutes  before  centrifugation  at  1500  g  for  15  minutes.  The  upper,  DNA 
containing  aqueous  phase,  was  carefully  removed  using  a  wide  bore  pipette  and 
the  remaining  organic  solvent  discarded.  The  aqueous  phase  was  then  mixed 
gently  with  a  phenol/chloroform  solution  (1:  1  v/v)  and  centrifuged  and  separated 
as  before.  Finally  the  aqueous  phase  was  combined  1:  1  with  chloroform  and 
mixed  gently  before  centrifugation  as  before.  High  molecular  weight  genomic 
DNA  was  then  precipitated  by  adding  0.1  volumes  of  3M  sodium  acetate  pH  5.2 
and  2.5  volumes  of  100%  ethanol.  The  visible  gDNA  was  spooled  using  a  pipette 
tip  to  obtain  the  largest  possible  fragments  and  avoid  co-purification  of  RNA.  The 
precipitated  gDNA  was  resuspended  in  TE  buffer  and  incubated  at  37  °C 
overnight  with  1  mg/ml  proteinase  K  before  repeating  the  phenol/chloroform 
extraction  procedure  and  ethanol  precipitation.  High  levels  of  EDTA  and 
proteinase  K  were  deliberately  used  in  the  extraction  buffer  to  minimise  nuclease 
degradation  of  gDNA.  The  second  proteinase  K  treatment  removed 
contaminating  proteins  to  aid  in  the  complete  enzymatic  digest  of  the  DNA  for 
Southern  analysis. 
43 2.2.5  Restriction  Endonuclease  Digest  of  DNA 
Plasmid  DNA  digests  were  routinely  done  using  an  excess  of  enzyme  to  ensure  a 
rapid  complete  digest.  Generally  up  to  200  ng  of  plasmid  DNA  was  digested  in  a 
total  volume  of  10  µl  using  5  to  10  units  of  restriction  enzyme  for  1  to  2  hours  at 
37  °C.  Restriction  enzymes  were  obtained  from  various  commercial  companies 
and  used  with  compatible  buffers  as  supplied.  T.  vaginalis  gDNA  was  digested  in 
a  total  volume  of  40  µl  with  40  units  of  restriction  enzyme.  30  units  were  added 
initially  and  incubated  for  3  hours  at  37  °C  before  the  addition  of  a  further  10  units 
and  continued  incubation  for  another  hour. 
2.2.6.  DNA  Ligations 
Ligation  of  PCR  products  into  pGEM-T  vector  (Promega)  were  performed 
according  to  the  manufacturers  instructions  with  ligase  and  buffer  as  supplied. 
PCR  products  were  purified  after  separation  on  I%  agarose  gel  and  DNA 
concentration  estimated  from  known  DNA  standards.  Sub-cloning  of  DNA 
fragments  into  restriction  digested  plasmid  was  performed  using  commercially 
obtained  T4  DNA  ligase  (New  England  Biolabs  or  Promega)  and  buffer  as 
supplied.  Ligations  were  performed  in  a  minimal  volume,  generally  10  µI,  with 
varying  ratios  of  insert  to  vector  at  either  16  °C  or  4  °C  overnight. 
2.2.7  Competent  Cells 
Chemical  competent  cells  were  commercially  supplied  XL-1  Blue  (Stratagene)  or 
JM109  (Promega),  efficiencies  were  1  x109  and  1x  107  respectively. 
Electrocompetent  cells  M15p(Rep4)  (Qiagen)  and  BL21  DE3  (Novagen)  were 
produced  by  the  method  of  Tung  and  Chow  (1995). 
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The  protocol  for  transformation  of  chemical  competent  cells  was  identical  for 
either  type  of  cells  with  one  small  exception.  For  both,  a  sample  of  the  ligation 
mix  (usually  1  or  2  µi  from  a  10  µl  sample)  was  added  to  the  competent  cells  in  a 
prechilled  eppendorf  tube  and  left  on  ice  for  30  minutes.  The  tubes  were  then 
transferred  rapidly  to  a  water  bath  at  42  °C  for  exactly  45  seconds  before 
replacing  on  ice  for  a  further  2  minutes.  1  ml  of  LB,  pre-warmed  to  37  °C,  was 
then  added  and  incubated  at  37  °C  for  1  hour  with  shaking  at  200  rpm.  100  µl  of 
this  was  then  spread  onto  an  LB-agar  plate  containing  the  appropriate  antibiotic. 
XL1-Blue  cells  followed  exactly  the  same  protocol  with  the  addition  of  ß- 
mercaptoethanol  with  the  ligation  mix  as  outlined  in  the  supplied  protocol.  Where 
colour  selection  of  positive  clones  was  required,  the  plates  were  also 
supplemented  with  60  µi  of  100  mM  IPTG  and  40  µl  of  20  mg/mi  X-gal 
immediately  prior  to  adding  the  cells.  For  routine  transformation  of  intact  circular 
plasmid,  high  efficiency  competent  cells  were  not  used.  Instead,  1  ml  of  an 
overnight  culture  of  XL1-Blue  cells  was  added  to  9  ml  LB  and  incubated  at  37  °C 
for  1  hour  with  shaking  at  200  rpm.  A1  ml  aliquot  was  removed,  the  cells 
harvested  by  centrifugation  in  a  bench  top  microfuge  at  6000  rpm  for  5  minutes 
and  washed  2  times  in  1x  PBS.  The  pellet  was  then  resuspended  in  100  µl  ice 
cold  20  mM  CaCI2.100  ng  of  plasmid  was  added  to  this  and  left  on  ice  for  30 
minutes  before  heat  shocking  at  42  °C.  To  this  400  µI  LB,  pre-warmed  to  37  °C, 
was  added  and  100  µl  immediately  spread  onto  LB-agar  plates  with  the 
appropriate  antibiotic. 
45 2.2.9  Agarose  Gels 
For  routine  analysis  of  DNA,  agarose  gels  were  prepared  by  melting  1% 
powdered  agarose  (w/v)  in  0.5  x  TBE.  The  solution  would  be  allowed  to  cool  to 
hand  hot  temperature  before  pouring.  If  the  DNA  was  to  be  excised  and  purified 
from  the  gel  then  an  identical  procedure  was  carried  out  but  1x  TAE  replaced  the 
TBE  buffer.  Samples  were  loaded  onto  the  gels  in  the  presence  of  gel  loading 
buffer  containing  glycerol  and  bromophenol  blue  dye.  To  visualise  DNA  after 
running  the  gels,  they  were  stained  in  a  solution  of  the  relevant  buffer  and  0.5 
µg/ml  ethidium  bromide.  Stained  gels  were  viewed  under  ultraviolet  illumination 
and  the  image  recorded  using  an  Appligene  Imager  (Appligene  Oncor).  Long 
wave  UV  was  used  if  the  DNA  was  to  be  excised  or  used  subsequently  for  transfer 
to  a  membrane  to  minimise  damage  to  the  DNA. 
2.2.10  DNA  Extraction  from  Agarose  Gels. 
DNA  fragments  were  excised  from  TAE/agarose  gels  with  a  clean  scalpel  blade 
and  isolated  using  a  Qiaquick  gel  extraction  kit  (Qiagen)  or  GenElute  column 
(Sigma).  Despite  manufacturer's  claims,  total  DNA  recovery  was  variable  and  it 
was  essential  that  subsequent  to  the  removal  of  contaminating  agarose  the  exact 
concentration  of  DNA  was  confirmed  by  running  a  sample  on  a  gel  with  a  DNA 
marker  of  known  quantities. 
2.2.11  Automated  DNA  Sequencing 
Purified  plasmid  for  sequencing  was  resuspended  and  sent  to  one  of  the  following 
commercial  laboratories  for  analysis:  PNACL  (Leicester,  UK),  MWG  (Milton 
Keynes,  UK),  MBSU  (Glasgow,  UK). 
46 2.2.12  Oligonucleotide  Primers  for  Cloning  and  Site  Directed  Mutagenesis 
Gene  specific  primers  were  obtained  from  commercial  suppliers.  All  were 
supplied  desalted  but  not  subject  to  further  purification.  The  sequence  of  the 
primers  used  in  this  study  are  indicated  in  Table  2.1. 
Oligonucleotide  Name  Oligonucleotide  Sequence 
OL281  5  -AGATCTGAGGACTAAGTCGAGAGCCT-3' 
O  L282  5'-CCATGGGTGGCCACGCTATCGACCCAACACATA-3' 
R58  Kf  5'-CCGGCTACATCTACACAAAGCTCGGCAACCCAACAG-3' 
R58  Kr  5'-CTGTTGGGTTGCCGAGCTTTGTGTAGATGTAGCCGG-3' 
R58Mf  5'-CCGGCTACATCTACACAATGCTCGGCAACCCAACAG-3' 
R58Mr  5'-CTGTTGGGTTGCCGAGCATTGTGTAGATGTAGCCGG-3' 
L59  Ff  5'-GGCTACATCTACACACGTTTCGGCAACCCAACAG-3' 
L59Fr  5'-CTGTTGGGTTGCCGAAACGTGTGTAGATGTAGCC-3' 
Y111  Ff  5'-CCGATGAGTGCCT7TTT  GGCTGCACACATGC-3' 
Y111  Fr  5'-GCATGTGTGCAGCCAAAAAGGCACTCATCGG-3' 
C113Pf  5'-CCGATGAGTGCCTTTATGGCCCCACACATGCTCTC-3' 
Cl  13Pr  5'-GAGAGCATGTGTGGGGCCATAAAGGCACTCATCGG-3' 
K209Sf  5'-GTCCACTCTGCAACAAGCTACATCAACGGCC-3' 
K209Sr  5'-GGCCGTTGATGTAGCTTGTTGCAGAGTGGAC-3' 
K238Af  5'-CGTATGGTTGGTATCGCGGATATCACAGGATCTG-3' 
K238Ar  5'-CAGATCCTGTGATATCCGCGATACCAACCATACG-3' 
M13  5'-GTAAAACGACGGCCAGT-3' 
T3  5'-AATTAACCCTCACTAAAGGG-3' 
OASS  1  5'-CATATGATCTACGACAACATCCTCGAGAC-3' 
OASS  2  5'-GAAGAAATCTGGGCCCAG-3' 
OASS  3  5'-GGTTCTTGCCAACACCCC-3' 
OASS  4  5'-CCGTGTCTACCGCGGTAGGCATTCC-3' 
OASS  5  5'-CTCACTCCCGCAAAGTTAGCTTGCGGC-3' 
OASS  7  5'-GCAGTGTCGACTTCTGTGTCGAAGAGCTTTG-3' 
Table  2.1  Oligonucleotides  used  for  sequencing  and  mutagenesis 
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DNA  probes  for  Southern  blot  hybridisations  were  radiolabelled  using  the  Prime 
ItTM'  kit  (Stratagene)  following  the  supplied  protocol.  Briefly,  25  ng  of  template 
DNA  was  incubated  in  the  presence  of  radioactively  labelled  dATP  (32P-3000 
mCi/mmol,  NEN  Dupont).  Random  hexamer  primers  and  Exo(-)Klenow  DNA 
polymerase  were  used  to  incorporate  the  radioactive  nucleotides  into  the  probe. 
Probes  were  denatured  by  boiling  for  10  minutes  prior  to  incubation  with  the 
membrane. 
2.2.14  Southern  Blotting 
T.  vaginalis  gDNA  was  digested  with  an  appropriate  restriction  enzyme  as  detailed 
in  section  2.2.5  and  resolved  on  a  0.7%  agarose  gel.  The  gel  was  stained  with 
ethidium  bromide  to  confirm  adequate  digestion  of  the  DNA  and  then 
photographed  before  further  treatment  prior  to  transfer  to  Hybond  N  membrane 
(Amersham  Pharmacia).  The  gel  underwent  depurination  in  0.25  M  HCI  for  10 
minutes  before  rinsing  briefly  in  dddH2O.  This  was  followed  by  denaturation  (1.5 
M  NaCl,  0.5  M  NaOH)  and  neutralisation  (1.5  M  NaCl,  0.5  M  TRIS-HCI  pH  7.5)  for 
30  minutes  each.  The  gel  was  rinsed  briefly  in  dddH2O  after  both  steps  before 
transfer  by  capillary  action  as  described  in  Sambrook  et  al.,  1989.  After  overnight 
transfer  in  20  x  SSC  the  gel  was  restained  with  ethidium  bromide  to  confirm 
complete  transfer  of  DNA.  The  transferred  DNA  was  cross-linked  using  a 
SpectrolinkerTM  XL-1000  crosslinker  (Stratagene)  before  the  filters  were  used  for 
hybridisation  with  radioactively  labelled  probes.  The  membranes  were 
prehybridised  for  4  hours  in  rotating  glass  tubes  with  sealed  ends  at  65  °C  with  10 
ml  hybridisation  solution  (0.5  M  sodium  phosphate  pH  7.2,7%  SDS,  1  mg 
denatured  and  sheared  herring  sperm  DNA).  Denatured  radioactively  labelled 
48 probe  was  then  added  directly  to  this  solution  and  incubated  at  65  °C  overnight 
with  continuous  rotation.  The  hybridisation  solution  was  then  decanted  and  the 
membrane  washed.  Increased  stringency  washes  were  performed  at  65  °C  with 
rotation  for  30  minutes.  Firstly  in  2x  SSC,  0.1%  SDS,  then  1x  SSC,  0.1%  SDS 
and  finally  0.1  x  SSC,  0.1  %  SDS.  The  blot  was  then  wrapped  in  saran  wrap  and 
exposed  to  autoradiographic  film  (Fuji  RX)  at  -70  °C  for  as  long  as  necessary 
(typically  12-36  hours).  Film  was  developed  automatically  using  a  Kodak  Xomat 
film  processor  or  manually  using  Kodak  reagents. 
2.2.15  Site  Directed  Mutagenesis  of  MGL1 
Mutagenesis  of  specific  residues  was  performed  using  mismatched 
oligonucleotide  primers  following  the  Quickchange  (Stratagene)  protocol.  Briefly, 
plasmid  g114  which  contains  the  mgll  ORF  in  expression  vector  pQE60  (Qiagen) 
was  used  as  a  template  and  complementary  oligonucleotides  were  used  to  mutate 
appropriate  nucleotides  changing  the  amino  acid  sequence.  The  remaining 
plasmid  sequence  was  then  synthesised  using  the  thermostable  DNA  polymerase 
pfu,  which  possesses  an  exonuclease  activity  and  has  a  reduced  likelihood  of 
incorporating  errors  into  the  DNA  strand.  After  25  cycles  of  DNA  synthesis  the 
original  plasmid  template  was  removed  from  the  mutated  DNA  by  digestion  with 
Dpn  I.  This  restriction  enzyme  is  a  methylated  DNA  specific  endonuclease  and  as 
such  only  digested  the  template  plasmid.  The  remaining  nicked  circular  mutated 
plasmid  was  then  transformed  into  competent  E.  coli  and  selected  on  LB  agar 
plates  containing  ampicillin.  Verification  of  the  mutant  was  by  automated  DNA 
sequencing  and  restriction  digest  analysis  where  appropriate. 
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Plasmid  gl15  encoding  mgi2  was  used  as  a  template  to  add  restriction  sites  to  the 
5'  and  3'  ends  by  PCR  using  primers  OL281  and  OL282  (Table2.1)  as  detailed  in 
section  2.2.3.  This  added  an  Ncol  site  to  the  5'  end  of  the  ORF  whilst  replacing 
the  missing  residues  and  a  BgfI  site  at  the  3'  end.  This  fragment  was  then 
excised  from  the  plasmid  and  ligated  into  precut  pQE60  as  described  for  mg/I 
(McKie,  1997).  To  produce  mutant  MGL2(c"6G),  a  SalUSphl  350  bp  fragment  was 
removed  from  the  original  construct  and  ligated  into  the  new  one.  This 
circumvented  the  need  to  repeat  the  site-directed  mutagenesis  previously 
required. 
2.2.17  Cysteine  Synthase  5'-RACE 
Isolation  of  the  5'  untranslated  region  (5'-UTR)  of  T.  vaginalis  cysteine  synthase 
was  attempted  using  a  5'-RACE  system  kit  (Life  Technologies).  Total  RNA 
isolated  from  the  parasite  was  used  as  the  template  for  the  reaction.  Experiments 
were  carried  out  according  to  the  manufacturers  instructions.  Briefly,  cDNA  was 
transcribed  from  mRNA  using  reverse  transcriptase  and  an  oligo  dT  primer.  A 
poly-dC  tail  was  added  to  the  isolated  cDNA  and  this  used  as  a  template  for  PCR 
with  a  supplied  anchor  primer  (complementary  to  the  dC  tail)  and  a  cysteine 
synthase  gene  specific  primer  (OASS  4).  Amplification  of  the  product  from  this 
reaction  was  attempted  with  another  gene  specific  primer  (OASS  5)  and  a 
supplied  anchor  primer. 
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2.3.1  Protein  Concentration  Estimation 
Protein  concentration  was  routinely  determined  with  the  Pierce  BCA  system  using 
the  supplied  microtitre  plate  protocol.  Bovine  Serum  Albumin  or  y-globulin  were 
used  as  protein  standards  over  a  range  of  0.1  to  2.0  mg/ml. 
2.3.2  Sodium  Dodecyl  Sulphate-Polyacrylamide  Gel  Electrophoresis  (SDS- 
PAGE) 
Protein  analysis  and  molecular  weight  estimation  was  done  using  discontinuous 
SDS-PAGE  as  described  by  Laemmli,  1971.  Acrylamide  resolving  gels  of 
between  7.5  and  12.5%  (w/v),  0.75  mm  thick  were  cast  and  run  using  a  Bio-Rad 
Mini  Protean  II  dual  slab  cell  as  per  manufacturer's  instructions.  Molecular  weight 
markers  (10  kDa  protein  ladder,  Gibco)  were  run  routinely  to  estimate  the 
apparent  molecular  weight  of  sample  proteins. 
Proteins  were  revealed  by  staining  with  Coomassie  blue  dye.  Gels  were 
immersed  for  30  minutes  or  more  in  staining  solution  (40%(v/v)  methanol,  7%(v/v) 
acetic  acid,  0.1%  (w/v)  Coomassie  Blue  R250)  and  then  destained  with  40%(v/v) 
methanol,  7%  (v/v)  acetic  acid  until  background  staining  was  at  a  minimum.  Gels 
were  either  photographed  or  stored  by  drying.  To  dry,  gels  were  soaked 
overnight  in  a  4%  glycerol  (v/v)  destain  solution  and  then  dried  overnight  between 
2  cellulose  sheets  pre-soaked  in  dddH2O. 
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Native  gels  were  cast  and  used  exactly  as  for  SDS-PAGE  but  with  the  omission  of 
SDS  from  gel  and  buffers.  Reducing  agents  such  as  DTT  or  p-mercaptoethanol 
were  also  omitted  from  loading  buffer. 
2.3.4  Western  Blotting 
Transfer  of  proteins  to  Hybond-ECL  membrane  (Amersham  Pharmacia)  from 
acrylamide  gels  was  achieved  as  described  by  Towbin  eta!.,  1979.  A  Bio-Rad 
mini  transblot  cell  was  used  following  the  manufacturer's  instructions. 
2.3.4.1  Membrane  Staining 
To  verify  successful  transfer  of  proteins  to  the  membrane  they  were  stained  with  a 
Ponceau  S  solution.  This  also  enabled  the  membrane  to  be  cut  accurately  if 
required  between  protein  lanes  and  molecular  weight  marker  positions  could  be 
marked  on  the  membrane.  The  membranes  were  immersed  in  the  Ponceau  stain 
for  a  few  minutes  and  rinsed  with  dddH2O  to  remove  background  staining. 
2.3.4.2  Prehybridisation  of  Membranes  -  Blocking 
Blocking  of  non-specific  binding  is  essential  in  Western  blotting  to  obtain  a  clear 
result  with  minimal  background.  The  blocking  procedure  prevents  binding  of 
immunoglobulins  (both  primary  and  secondary)  to  non-specific  areas  of  low 
affinity  on  the  membrane,  leaving  only  the  high  affinity  binding  sites  which  would 
be  preferentially  bound.  Before  adding  the  primary  antibody  the  membrane  was 
immersed  for  4  hours  at  room  temperature  with  gentle  agitation  in  blocking 
solution  (5%  (w/v)  skimmed  milk  powder,  0.2%  TWEEN  20,1  x  TRIS  buffered 
saline  (TBS)  (20  mM  TRIS-HCI,  150  mM  NaCl,  pH  7.6). 
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After  prehybridisation,  the  solution  was  removed  and  replaced  by  hybridisation 
solution  (1  %  (w/v)  skimmed  milk  powder,  0.1  %  TWEEN  20,1  x  TBS)  and  primary 
antibody  or  pre-immune  serum  added.  This  was  then  incubated  overnight  at  4  °C 
with  gentle  agitation.  Subsequent  to  incubation  with  the  primary  antibody, 
membranes  were  washed  3  times  for  30  minutes  with  1x  TBS  plus  1%  (w/v) 
skimmed  milk  powder  at  room  temperature. 
2.3.4.4  Secondary  Antibody  Binding 
The  secondary  antibody  used  for  detection  of  anti-cysteine  synthase  primary 
antibody  was  a  horseradish  peroxidase  (HRP)-conjugated  goat  anti-rabbit  IgG 
(Scottish  Antibody  Production  Unit,  SAPU).  After  washing  the  antibody  was 
hybridised  to  the  membrane  in  1x  TBS  plus  1%  (w/v)  skimmed  milk  powder  at 
room  temperature  for  2  hours.  After  incubation  the  membrane  was  washed  3 
times  for  30  minutes  in  1x  TBS  plus  1%  (w/v)  skimmed  milk  powder  at  room 
temperature  and  finally  in  1x  TBS  for  10  minutes. 
2.3.4.5  Western  Blot  Developing 
Detection  of  HRP  activity  was  by  enhanced  chemiluminescence  (ECL)  using  the 
ECL  kit  (Amersham  Pharmacia)  as  supplied.  Essentially  the  two  solutions 
provided  are  combined  1:  1  in  an  appropriate  volume  and  incubated  with  the 
membrane  with  agitation  for  2  minutes.  The  luminol  solution  in  the  kit  is  cleaved 
by  the  action  of  HRP  and  photons  of  light  are  emitted.  This  should  only  occur  at 
sites  of  secondary  antibody  binding  to  the  primary  antibody  and  thus  specific  for 
the  presence  of  the  protein  antigen  desired.  Film  was  developed  automatically 
using  a  Kodak  Xomat  film  processor  or  manually  using  Kodak  reagents. 
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Recombinant  MGL  for  biochemical  analysis  was  purified  as  previously  published 
(McKie  eta!.,  1998). 
2.3.6  Homocysteine  Desulphurase  Assays 
The  a'  elimination  of  homocysteine  and  subsequent  detection  of  1-12S  production 
was  by  the  published  method  of  Thong  and  Coombs  (1985a).  This  assay  was 
routinely  used  for  the  measurement  of  enzyme  activity  as  it  was  the  most  reliable, 
simple  and  sensitive  of  those  available. 
Other  MGL  assays  investigated  during  this  study  are  indicated  in  the  relevant 
chapters. 
2.3.7  Lysis  of  Small  Samples  of  E.  coli 
When  performing  test  expressions  in  E.  coli,  samples  removed  to  monitor  over- 
expression  of  recombinant  proteins  were  too  small  to  be  conveniently  lysed  by 
sonication:  Cells  were  instead  lysed  by  enzyme  and  detergent  action.  15  ml 
samples  of  cultured  bacteria  were  removed  as  appropriate  and  harvested  by 
centrifugation  at  3200  g  for  15  minutes  at  4  °C.  Pellets  were  washed  in  PBS  and 
placed  at  -20  °C  until  required.  Lysis  was  performed  by  resuspending  the  pellets 
in  0.5  ml  of  2  mg/ml  lysozyme,  0.1%  Triton  X-100,25  mM  TRIS  pH  8.5  and 
incubating  overnight  at  37  °C  with  agitation.  The  lysate  was  then  spun  at  13  000 
rpm  in  a  benchtop  microfuge  for  25  mins  to  remove  intact  cells  and  insoluble 
debris.  40  µl  of  the  supernatant  was  then  used  for  analysis  by  SDS-PAGE. 
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The  purification  of  cysteine  synthase  is  accomplished  in  a  very  similar  manner  to 
that  used  for  MGL.  The  development  of  the  method  used  for  expression  and 
purification  is  discussed  in  detail  in  section  5.2.3. 
2.3.9  Cysteine  Synthase  Assays 
Cysteine  synthase  activity  was  assayed  under  the  following  conditions.  Buffer 
and  dddH2O  were  deoxygenated  by  bubbling  with  N2  gas  for  15  minutes  prior  to 
use.  In  a  total  volume  of  0.5  ml,  enzyme  was  added  to  100  mM  sodium  phosphate 
buffer  pH  7.3,3  mM  sodium  sulphide,  10  mM  O-acetyl-L-serine,  1  mM  DTT  to 
initiate  the  reaction.  This  was  mixed  briefly  and  incubated  at  37  °C  for  5  minutes 
in  a  water  bath.  The  reaction  was  terminated  by  adding  150  µl  of  the  assay  mix  to 
350  µl  of  acidic  ninhydrin  solution  (1.3%  (w/v)  ninhydrin  in  1:  4  concentrated 
hydrochloric  acid:  glacial  acetic  acid)  (Gaitonde,  1967)  in  screw  capped  eppendorf 
tubes  and  mixed  thoroughly.  To  complete  the  colourimetric  reaction  eppendorf 
tubes  were  boiled  for  10  minutes  in  a  boiling  water  bath  before  cooling  on  ice  for 
30  minutes.  The  samples  were  then  diluted  by  adding  0.7  ml  100%  ethanol  and 
the  absorbance  measured  at  560  nm.  The  quantification  of  the  amount  of 
cysteine  produced  was  by  calibrating  against  a  standard  curve  of  known 
concentrations  of  L-cysteine.  " 
2.3.10  "Activated  Serine  Sulphydrase"  Assays 
These  assays  were  carried  out  essentially  as  described  previously  (Thong  and 
Coombs,  1985b).  Enzyme  was  added  to  a  total  volume  of  1  ml  100  mM  sodium 
phosphate  pH  7.3,330  µM  lead  acetate,  3.3  mM  p-mercaptoethanol  and  L- 
55 cysteine  to  initiate  the  reaction.  The  production  of  lead  sulphide  from  the  reaction 
of  H2S  with  lead  acetate  was  followed  at  360  nm. 
2.4  General  Materials  and  Methods 
2.4.1  Parasite  Line 
A  single  line  of  T.  vaginalis  was  used  in  this  study  throughout.  Clone  G3  is  a 
metronidazole  sensitive  line  used  for  many  years  in  this  laboratory  and  also  used 
for  the  random  cDNA  library  sequencing  project  carried  out  by  collaborators. 
2.4.2  Cultivation  of  T.  vaginalis  in  vitro 
The  parasite  was  cultured  axenically  in  Modified  Diamonds  Medium  (MDM) 
(Diamond,  1957),  supplemented  with  10%  (v/v)  heat  inactivated  horse  serum  (Life 
Technologies)(Complete  MDM),  at  37  °C.  MDM  is  comprised  predominantly  of 
peptone  (1  %  (w/v)),  yeast  extract  (0.5%  (w/v))  and  maltose  (0.5%  (w/v))  buffered 
with  potassium  salts  and  supplemented  with  ascorbic  acid  and  iron  sulphate. 
Cultures  were  checked  by  microscopical  examination  for  contamination  before 
use. 
To  produce  parasites  for  DNA  purification,  they  were  inoculated  into  fresh 
complete  MDM  and  grown  under  anaerobic  conditions  until  they  reached  late  log 
growth  phase,  producing  cells  at  a  density  of  1-2x106  cells/ml. 
Parasites  cultured  under  different  environmental  pressures  were  grown  in 
complete  MDM  supplemented  with  the  relevant  compound.  25  ml  cultures  were 
prepared  in  tightly  capped  universals,  except  for  those  exposed  to  aerobic  growth 
56 conditions  which  were  grown  in  500  ml  tissue  culture  flasks  in  a  normally 
aspirated  incubator.  For  growth  without  ascorbate,  complete  MDM  was  prepared 
identically  with  the  exception  of  the  omission  of  ascorbic  acid.  All  cultures  were 
initiated  with  1x105  parasites  per  ml  and  grown  for  18  hours  before  dividing  into  5 
ml  aliquots  and  harvesting. 
2.4.3  Cell  Counts 
Parasites  were  fixed  with  4%  paraformaldehyde  and  counted  under  phase 
contrast  microscopy  using  an  improved  Neubauer  hemocytometer. 
2.4.4  Harvesting  Parasites 
T.  vaginalis  were  harvested  by  centrifugation  at  2300  g  for  15  minutes  at  4  °C  and 
washed  twice  with  ice  cold  0.25  M  sucrose.  Cells  for  RNA  analysis  were 
resuspended  immediately  in  I  ml  Trizol  (Life  Technologies)  and  stored  at  -70  °C 
until  required.  Others  were  stored  as  pellets  at  -70  °C  until  required. 
2.4.5  Parasite  Lysis 
Crude  lysates  of  parasites  were  obtained  in  one  of  two  ways.  For  small  numbers 
of  cells  (less  than  5x107)  the  washed  cell  pellet  was  resuspended  in  0.25  M 
sucrose  plus  0.25  %  (v/v)  Triton  X-100.  Cell  debris  was  removed  by 
centrifugation  at  13  000  rpm  in  a  benchtop  microfuge  for  5  minutes.  For  larger 
numbers  of  cells  typically  resulting  from  a  500  ml  culture,  the  cells  were  lysed 
using  a  tissue  homogeniser.  Parasites  were  resuspended  at  approximately  2x108 
cells/ml  in  1x  PBS  or  0.25  M  sucrose.  Lysis  of  cells  was  checked  by 
microscopical  examination.  Cell  debris  was  removed  by  centrifugation  at  13  000 
57 g  for  30  minutes.  To  reduce  proteolytic  degradation  10  µM  leupeptin  and  10  µM 
E64,  both  cysteine  proteinase  inhibitors,  were  added  to  the  lysates. 
58 CHAPTER  3.  MGL1  STRUCTURE  -  HOLOENZYME  AND 
INHIBITOR  COMPLEX 
3.1  INTRODUCTION 
This  chapter  deals  with  the  result  of  completing  the  primary  aim  of  this  study, 
obtaining  the  3-dimensional  crystallographic  structure  of  MGL.  Results  of  the 
processes  carried  out  to  achieve  this  and  a  discussion  of  these  findings  are  given. 
The  first  step  to  accomplish  in  the  structural  determination  of  MGL  was  the  growth 
of  suitably  diffracting  crystals.  This  is  often  a  limiting  factor  in  the  structural 
studies  of  proteins.  The  situation  can  be  made  more  difficult  if  the  protein  is  post- 
translationally  modified  or  must  be  purified  from  a  native  source  if  not  available 
recombinantly.  This  was  not  the  case  for  MGL  and  the  production  of  large 
amounts  of  active,  highly  pure  recombinant  enzyme  meant  that  it  was  possible  to 
make  many  attempts  to  produce  crystals.  Preliminary  trials  were  conducted  at  the 
beginning  of  the  project  to  ascertain  the  likelihood  of  succeeding  in  this  and  the 
results  are  detailed  in  section  3.2.4  (this  work  was  carried  out  by  Dr.  AJ 
Lapthom). 
It  was  envisaged  that  the  large  number  of  PLP-dependent  enzyme  structures 
solved  and  published  would  aid  in  solving  the  structure  of  MGL  using  the 
technique  of  molecular  replacement.  Failing  this,  heavy  atom  derivatives  would 
allow  for  isomorphous  replacement.  It  was  briefly  considered  at  the  beginning  of 
the  project  to  produce  selenium  derivatives  of  the  enzyme  for  MAD  (Multiple 
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the  activity  of  the  enzyme  towards  both  of  these  compounds  prevented  this 
approach. 
At  the  beginning  of  this  project  only  a  single  structure  with  significant  sequence 
homology  and  predicted  to  be  in  the  same  family  as  MGL  (Alexander  et  al.,  1994) 
had  been  published,  that  of  cystathionine  ß-lyase  (CBL)  (Clausen  et  al.,  1996). 
The  coordinates  for  this  structure  were  unavailable  at  the  time  though  and  this 
prevented  detailed  analysis.  More  recently  there  have  been  two  further  structures 
published  of  the  closely  related  enzyme  cystathionine  y-synthase  (CGS)  (Clausen 
et  al.,  1998;  Steegborn  et  al.,  1999).  A  mechanism  of  action  has  been  proposed 
for  CBL  (Clausen  et  al.,  1997)  but  this  was  thought  likely  to  differ  significantly  from 
that  of  MGL  because  of  the  apparently  important  cysteine  residue  of  MGL  (McKie 
et  al.,  1998).  Differences  in  substrate  preference  between  the  enzymes,  MGL 
from'T.  vaginalis  is  unable  to  act  upon  cystathionine,  also  suggested  the  active 
site  would  be  dissimilar  and  thus  possibly  the  mechanism.  Solving  the  structure 
of  MGL  would  enable  us  to  propose  a  mechanism  and  assign  roles  to  specific 
residues  within  the  active  site. 
The  role  of  an  active  site  cysteine  in  MGL  was  difficult  to  define  without  structural 
information  as  the  enzymes  from  T.  vaginalis  and  Pseudomonas.  putida  were  not 
completely  inactivated  by  either  chemical  modification  or  mutagenesis  of  this 
residue  (Nakayama  1988a;  McKie  et  al.,  1998).  The  activity  though  was  severely 
curtailed  and  this  pointed  to  an  important  if  not  essential  function.  MGL  is 
inactivated  by  the  suicide  inhibitor  L-propargylglycine  and  this  has  been  shown  to 
60 target  either  a  cysteine  or  tyrosine  in  the  active  site  (Johnston  et  al.,  1979).  This 
also  implicated  the  cysteine  as  playing  a  role  in  catalysis.  The  crystal  structure 
would  hopefully  elucidate  the  role  of  this  residue  and  confirm  the  inhibition  by 
propargyiglycine. 
3.2  RESULTS 
3.2.1  MGL  purification 
MGL1  and  MGL2  were  purified  as  published  (McKie  et  al.,  1998)  with  some 
revisions.  As  enzyme  was  to  be  used  for  crystallisation,  it  was  considered  critical 
to  obtain  as  close  to  a  100%  homogenous  enzyme  preparation  as  possible. 
Elution  by  a  linear  gradient  of  0-500  mM  imidazole  produced  predominantly 
homogenous  enzyme,  but  some  contaminating  E.  coli  proteins  still  co-eluted.  A 
sample  of  each  of  the  fractions  collected  was  ran  on  7.5%  SDS-PAGE  and 
coomassie  blue  stained.  This  generally  revealed  low  level  but  detectable 
contamination  of  MGL  with  proteins  of  higher  and  lower  molecular  weights. 
In  an  attempt  to  avoid  this  contamination  and  produce  a  purer  preparation,  up  to 
50  mM  imidazole  was  included  in  the  sonication  and  wash  buffers  to  prevent  E. 
coli  proteins  with  low  affinity  from  binding  to  the  column.  This  was  less  successful 
than  had  been  expected,  giving  no  obvious  improvements  and  causing  the 
premature  elution  of  enzyme.  It  is  possible  that  this  was  due  to  low  levels  of 
imidazole  competing  for  Ni-NTA  binding  with  the  hexahistidine  tag  of  MGL. 
Although  these  concentrations  are  not  high  enough  to  elute  the  tagged  protein 
61 directly,  during  the  loading  of  the  crude  lysate  onto  the  column  a  proportion  of  the 
recombinant  enzyme  is  washed  away  as  it  is  continually  displaced  and  passes 
further  down  the  column  until  it  is  eventually  eluted  with  the  flow  through  buffer. 
In  support  of  this  suggestion  is  the  observation  that  subsequent  elution  of  the 
recombinant  enzyme  occurs  over  a  larger  volume.  Moreover  the  MGL  bound  to 
the  column  can  usually  be  seen  as  a  band  at  the  top  of  the  column  in  a  standard 
purification  (its  yellow  colour  visible  due  to  the  PLP  cofactor).  Adding  50  mM 
imidazole  to  the  buffers  results  in  the  yellow  band  of  enzyme  becoming  more 
diffuse  than  the  normal  tight  band. 
Therefore  in  a  different  attempt  to  remove  the  last  remaining  E.  coli  protein 
contaminants  effectively;  75  mM  imidazole  was  applied  to  the  column  prior  to 
elution  by  the  linear  imidazole  gradient.  This  caused  the  elution  of  a  number  of 
proteins  while  having  a  negligible  effect  upon  the  bound  MGL  and  proved  a  highly 
successful  method  for  removing  trace  contaminants  and  obtaining  a  high  yield  of 
very  pure  enzyme.  Figures  3.1  and  3.2  show  the  FPLC  purification  profile  of  the 
recombinant  enzyme  and  the  subsequent  analysis  on  coomassie  stained  SDS- 
PAGE,  respectively. 
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Figure  3.1:  FPLC  profile  of  MGL  purification.  The  blue  line  represents  the  eluted  sample 
absorbance  at  a  wavelength  of  280  nm.  The  upper  limit  of  detection  is  2.0  AU.  Fractions  collected 
are  indicated  on  the  figure  by  vertical  downward  strokes  of  the  blue  line.  Red  line  represents  the 
percentage  of  500  mM  imidazole  containing  buffer  applied  to  the  column. 
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Figure  3.2:  SDS-PAGE  of  a  typical  MGL1  purification.  10%  Polyacrylamide  gel  stained  with 
Coomassie  blue.  Lanes:  A-  10  kDa  protein  ladder;  B-  Crude  lysate;  C-  Column  loading/flow 
through;  D-  First  wash;  E-  75  mM  Imidazole  wash;  F  to  I-  Fractions  eluted  by  linear  155  to  185 
mM  imidazole  gradient. 
63 MGL1  can  be  clearly  identified  in  lane  B  as  a  band  at  43  kDa.  The  absence  of 
this  in  lanes  C,  D  and  E  indicated  it  was  still  bound  to  the  Ni-NTA  matrix.  The 
efficacy  of  the  75  mM  imidazole  wash  is  clearly  seen  by  the  large  number  of 
bands  visible  in  lane  E  and  the  sharp  rise  in  absorbance  at  280  nm.  1  ml  fractions 
corresponding  to  an  increase  in  imidazole  concentration  of  10  mM  were  collected 
across  the  linear  gradient.  Examples  of  those  containing  MGL1  are  shown  above. 
Displacement  of  the  enzyme  occured  at  imidazole  concentrations  of 
approximately  160  mM  and  higher  although  this  was  partially  obscured  by  the 
strong  absorbance  of  imidazole  at  280  nm.  The  gradient  was  not  halted  though 
when  this  occured  and  purified  enzyme  was  collected  in  a  number  of  fractions. 
Routinely,  the  MGL1  containing  fractions  from  the  column  were  identified  by  their 
yellow  colour  in  solution  and  checked  using  SDS-PAGE.  The  purest  fractions 
were  pooled  and  either  concentrated  ready  for  crystallisation,  or  dialysed  into 
sodium  phosphate  buffer  and  stored  as  published  (McKie  et  aL,  1998).  The 
enzyme  suffered  only  minor  losses  in  activity  when  stored  at  -20  °C  over  a  period 
of  several  weeks  in  either  condition.  Enzyme  for  crystallisation  was,  in  most 
cases,  prepared  fresh  with  2  or  3  days  required  in  total  for  purification, 
concentration  and  preparing  the  crystallisation  experiments. 
3.2.1.1  Identification  of  Two  Species  of  Recombinant  MGLI 
Initially  purification  of  MGL1  was  monitored  by  analysing  samples  using  7.5% 
polyacrylamide  SDS-PAGE.  In  order  to  detect  contaminants  more  easily  a 
significant  amount  of  highly  pure  MGL1  (>  5  µgs)  was  loaded  on  each  occasion. 
This  ran  as  a  large  43  kDa  band  with  only  a  single  species  visible.  However, 
64 running  the  same  samples  on  a  10%  gel  showed  two  very  close  but  distinct  bands 
differing  by  approximately  1  kDa  (Figure  3.3). 
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Figure  3.3:  Coomassie  blue-stained  10%  SDS-PAGE  of  purified  MGL1.  Lanes:  A-  protein 
molecular  weight  markers;  B  to  D-  Increasing  amounts  of  purified  MGL1. 
This  was  not  noticed  for  some  time  and  was  suspected  of  causing  the  failure  of 
some  of  the  crystallisation  trials.  As  can  be  seen  in  figure  3.3,  both  bands  stained 
to  a  very  similar  degree  and  were  estimated  to  be  present  in  an  approximately  1:  1 
ratio.  The  figure  shows  clearly  the  difficulty  in  identifying  two  bands  in  lane  D 
compared  with  lane  B.  The  large  amount  of  protein  loaded  in  lane  D,  though, 
does  confirm  the  very  high  purity  of  the  sample.  It  was  assumed  that  both  bands 
were  recombinant  MGL1  for  various  reasons  including  the  appearance  of  two 
bands  in  a  native  substrate-PAGE  gel  (not  shown).  In  an  attempt  to  avoid  the 
production  of  2  distinct  proteins,  the  levels  of  IPTG  used  to  induce  MGL1 
expression  were  reduced  from  the  very  high  concentration  used  of  2  mM  to  0.1 
mM.  This  had  a  positive  effect,  greatly  reducing  but  not  totally  eliminating  the 
smaller  of  the  two  bands  (the  second  MGL1  band  is  not  visible  in  figure  3.2  lanes 
F  to  I).  The  modification  did,  however,  coincide  with  successful  crystallisation  of 
65 the  enzyme.  Thus  no  further  attempts  were  made  to  eliminate  the  second  protein 
from  the  preparation.  The  cause  of  this  second  band  and  the  effect  of  reducing 
IPTG  levels  will  be  considered  in  the  discussion  section  of  this  chapter. 
3.2.2  Protein  Preparation 
MGL  was  prepared  for  crystallisation  as  described  in  section  2.1.2.  No  problems 
were  encountered  for  the  concentration  of  MGL1  samples  but  it  was  apparent  that 
there  was  some  protein  losses  when  concentrating  MGL2  and  this  was  attributed 
to  binding  to  the  MicrosepTM  membrane.  Concentrators  were  soaked  in  10% 
glycerol  overnight  at  4  °C  before  use  in  order  to  try  and  alleviate  this  problem  as 
much  as  possible.  Although  not  quantified  the  recovery  of  MGL2  after  this  was 
significantly  better. 
3.2.3  Analysis  of  MGL  Monodispersity  by  Dynamic  Light  Scattering  (DLS) 
It  has  been  proposed  that  that  the  monodispersity  of  a  crystallisation  sample  can 
be  correlated  to  the  likelihood  that  crystals  will  form  (Malkin  et  al.,  1994;  Veesler 
et  ai.,  1994).  Polydispersity  can  indicate  the  presence  of  impurities,  isoforms  or 
multiple  aggregation  states  in  the  protein  sample.  A  sample  which  is  composed  of 
a  single  species  is  theoretically  more  likely  to  produce  crystals. 
Monodispersity  of  MGL  was  measured  as  detailed  in  section  2.1.5.  Several 
factors  may  effect  the  monodispersity  of  a  solution,  the  most  straightforward  to 
examine  being  the  pH  or  the  presence  of  salts.  The  effect  of  pH  was  examined  by 
diluting  the  enzyme  sample  to  1  mg/ml  in  100  mM  of  relevant  buffer.  Buffers  were 
selected  to  cover  a  wide  range  from  pH  4.6  to  pH  10.0.  The  results  were 
66 equivalent  for  both  enzymes  showing  that  it  was  possible  to  obtain  a 
monodisperse  solution  by  altering  the  pH  to  below  6.5  or  above  8.0.  Both 
enzymes  aggregated  heavily  at  pH  7.5  as  was  immediately  evident  from  the 
difficulty  in  injecting  the  sample  through  a  0.1  µm  filter.  That  part  of  the  solution 
which  did  pass  through  the  filter  showed  species  of  estimated  molecular  weights 
of  greater  than  1000  kDa  confirming  a  large  aggregate  of  protein.  This  was  the 
case  for  both  MGL1  and  MGL2. 
In  combination  with  pH,  the  effect  of  DTT  and  additional  PLP  were  also  examined. 
However  these  had  no  apparent  effect  on  the  solution  regardless  of  the  buffer  and 
pH. 
3.2.4  Crystallisation  of  MGLI 
Initial  attempts  to  crystallise  MGL1  preceded  the  DLS  investigation  and  utilised  a 
number  of  "sparse-matrix"  screens  (Jancarik  and  Kim,  1991).  Here  the  enzyme 
had  been  stored  at  -20  °C  in  100  mM  HEPES  pH  7.5,40  µM  PLP,  30  µM  DTT, 
40%  glycerol  and  used  at  6  mg/ml  in  the  same  conditions  minus  the  glycerol.  The 
positive  results  are  summarised  in  the  table  below: 
67 Precipitant  Buffer  (0.1  M)  Salt  Result 
30%  PEG  4k  TRIS  pH  8.5  0.2  M  Li2SO4  Many  thin  rods 
30%  PEG  4k  TRIS  pH  8.5  0.2  M  NaCl  Many  tiny  rods 
3M  AmmSO4  Citrate  pH  5.6  0.2  M  Li2SO4  Thin  plate  like  crystals 
20%  PEG  8k  HEPES  pH  7.5  0.2  M  Li2SO4  Irregular  shapes 
20%  PEG  8k  TRIS  pH  8.5  0.2  M  NaKPO4  Very  fine  granular 
20%  PEG  8k  TRIS  pH  8.5  0.2  M  NaCl  Very  fine  granular 
30%  Me2k  PEG  Citrate  pH  5.6  Small  granular  crystals 
10%  PEG  4k  Citrate,  pH  5.6  0.1  M  Li2SO4  Feathered  needles 
20%  PEG  4k  Citrate  pH  5.6  0.2  M  AmmSO4  Long  needles 
30%  Me2k  PEG  MOPS  pH  6.5  Irregular  needles 
25%  PEG  4k  HEPES  pH  7.5  Small  rectangular 
30%  PEG  4k  TRIS  pH  8.5  Many  tiny  rods 
30%  PEG  4k  TRIS  pH  8.5  0.2  M  CaC12  Few  tiny  rods 
25%  PEG  4k  PIPES  pH  6.8  Small  rods 
Table  3.1:  Results  of  initial  crystallisation  trials  of  MGL1.  N.  B.  This  work  was  done  by  Dr.  AJ 
Lapthom. 
Thus  PEG  was  seemingly  the  precipitant  of  choice  with  a  range  of  suitable  buffers 
at  varying  pH  and  with  different  salts.  The  first  comprehensive  attempts  at 
crystallising  MGL1  encompassed  these  conditions.  After  a  number  of  trials  it  was 
evident  that  a  combination  of  PEG  4k,  0.1  M  citrate  pH  5.0  -  6.0  and  various  salts 
gave  the  most  consistent  and  promising  results.  The  crystals  resulting  from  these 
conditions  varied  from  small  cubic  shaped  (approx.  0.05  mm  x  0.05  mm)  and  small 
rods  (0.1  mm)  to  long  fine  needles  (up  to  0.5  mm).  However  none  of  these  were 
suitable  for  structural  analysis. 
68 At  this  time  the  data  on  the  monodispersity  of  the  solution  were  obtained  from  the 
DLS  analysis  and  the  buffer  was  changed  to  50  mM  imidazole  pH  6.5. 
Additionally,  because  of  reports  that  the  PLP  cofactor  can  be  unstable  in  some 
enzymes  giving  rise  to  a  population  of  apoenzyme  over  time,  the  concentration  of 
the  cofactor  was  increased  to  250  µM  and  the  DTT  concentration  raised  to  1  mM 
which  is  more  commonly  used  than  the  previous  30  µM.  These  new  conditions 
considerably  changed  the  morphology  of  the  resulting  crystals.  In  the  same 
conditions  as  had  previously  been  tried,  the  crystals  produced  were  much  larger 
(0.15  mm  x  0.075  mm)  but  were  hollow.  This  suggested  that  their  growth  rate  was 
too  rapid  and  so  the  same  conditions  were  repeated  at  4  °C  and  with  4%  glycerol 
in  the  solution  to  retard  growth.  Neither  of  these  alternatives  succeeded  in 
producing  large  crystals  without  a  hollow  centre. 
In  parallel  to  the  DLS  analysis,  duplicate  sparse-matrix  screens  had  been  set  up 
with  the  enzyme  inactivated  by  the  inhibitor  DL-propargylglycine  (5  mM).  L- 
propargylglycine  is  a  covalent,  suicide  inhibitor  of  several  PLP-dependent 
enzymes,  including  MGL  (Johnston  et  al.,  1979).  It  was  hoped  that  the  inclusion 
of  this  would  produce  a  more  rigid  structure  leading  to  larger  crystals. 
Crystallisations  were  set  up  identically  as  previously  described  but  with  the 
addition  of  5  mM  DL-propargylglycine  to  the  enzyme  solution.  The  screen  gave 
similar  results  as  previously  but  with  the  addition  of  large,  bipyramidal  crystals 
(0.3  x  0.2  mm)  in  conditions  of  3.0  M  AmmSO4,  OA  M  citrate  buffer  pH  5.6,0.2  M 
Li2SO4.  The  enzyme  at  this  time  was  concentrated  in  HEPES  buffer  indicating  the 
monodispersity  of  the  enzyme  was  not  critical  in  allowing  large  crystal  formation. 
After  optimisation  via  linear  screens  the  exact  concentration  of  ammonium 
69 sulphate  required  was  found  to  be  2.3  M.  The  process  of  optimisation  also 
highlighted  an  additional  point,  freezing  of  MGL1  reduced  its  ability  to  form 
crystals.  This  appears  to  be  a  relatively  common  problem  with  protein 
crystallisation  and  the  most  successful  trials  were  consistently  those  using  freshly 
purified  enzyme  no  more  than  2  or  3  days  old  and  stored  at  4  °C  prior  to  use.  The 
native  enzyme  also  crystallised  in  exactly  the  same  conditions  as  the  inhibitor 
complex,  once  all  of  the  important  factors  had  been  identified. 
Thus  in  summary:  crystals  were  grown  at  20  °C  by  combining  1.5  . tl  of  6  mg/ml 
MGL1  in  0.1  M  HEPES  pH  7.5,250  µM  PLP,  1  mM  DTT  with  1.5  µl  of  precipitant 
comprising  2.3  M  AmmSO4,0.2  M  Li2SO4  and  0.1  M  citrate  buffer  pH  5.6.  Single 
crystals  formed  over  6  weeks  and  achieved  approximate  dimensions  of  0.6  mm  x 
0.4  mm  x  0.4  mm  (See  figure  3.4).  The  gross  morphology  of  both  types  was 
identical  and  both  diffracted  anisotropically  to  1.6  A. 
Figure  3.4:  Single  orthorhombic  crystal  of  MGL1  in  complex  with  L-propargylglycine  grown  as 
detailed  above.  Crystal  shown  had  dimensions  of  approximately  0.6  x  0.4  x  0.4  mm. 
70 Smaller  crystals  were  obtained  with  ammonium  sulphate  concentrations  of  2.4  to 
2.5  M  but  these  had  rounded  edges  between  faces  rather  than  the  sharp  edges 
(as  shown  in  figure  3.4  above).  Note  also  the  yellow  colour  of  the  crystals  caused 
by  the  cofactor. 
3.2.5  Crystallisation  of  MGL2 
The  first  attempts  at  crystallising  MGL2  were  performed  identically  to  those  for 
MGLI.  The  protein  was  concentrated  to  6  mg/ml  and  resuspended  in  0.1  M 
HEPES  pH  7.5,40  µM  PLP,  30  IN  DTT  but  the  results  from  the  screens  gave  no 
promising  leads.  After  DLS  analysis  the  buffer  was  changed  to  20  mM  imidazole 
buffer  pH  6.5,250  µM  PLP,  1  mM  DTT.  Using  this  new  buffer  produced  some 
small  crystals,  the  best  results  are  listed  below: 
Precipitant  Buffer  (0.1  M)  Salt  (0.2  M)  Result 
15%  PEG  8k  MOPS  pH  6.5  NaKPO4  Heavy  crystalline  precipitate 
20%  PEG  8k  TRIS  pH  8.5  NaCl  Clusters  of  very  small  needles 
15%  Melk  PEG  MOPS  pH  6.5  MgCl2  Few  small  rods 
15%  Me2k  PEG  HEPES  pH  7.5  MgCl2  Few  feathered  rods 
20%  PEG  4k  HEPES  pH  7.5  AmmSO4  Heavy  crystalline  precipitate 
30%  PEG  400  HEPES  pH  7.5  MgCl2  Very  small  cubic  crystals 
8%  PEG  8k  TRIS  pH  8.5  Few  clusters  of  needles 
15%  PEG  4k  TRIS  pH  8.5  MgCl2  Few  small  rods 
Table  32:  irrst  successtui  results  of  attempts  to  crystallise  MGLZ 
71 It  was  not  possible  to  improve  upon  these  results  further  and  so  a  new  expression 
construct  of  MGL2  was  produced  in  an  attempt  to  improve  the  prospects  for 
producing  crystals.  The  previous  expression  construct  had  the  hexahistidine  tag 
at  the  N-terminus  and  also  5  residues  missing  from  the  original  sequence  which 
were  replaced  by  8  residues  from  the  cloning  vector  (McKie,  1997).  It  was 
considered  possible  that  the  incorrect  residues  and  N-terminal  tag  were 
preventing  crystallisation  in  some  manner  and  it  was  hoped  that  replacing  these 
would  lead  to  the  production  of  useful  crystals.  Therefore  the  new  construct  was 
designed  to  remove  the  incorrect  residues  and  replace  with  the  correct  sequence 
(see  section  2.2.16  for  method).  The  expression  vector  was  also  changed  to 
position  the  hexahistidine  tag  at  the  C-terminus  rather  than  the  N-terminus  as 
already  used  for  MGL1. 
This  new  MGL2  was  examined  for  the  retention  of  activity  in  various  buffers  at 
both  4  °C  and  20  °C.  It  was  decided  to  avoid  using  sodium  phosphate  buffer  in 
crystal  I  isations  because  of  the  likelihood  of  producing  phosphate  crystals.  Thus  a 
suitable  alternative  buffer  had  to  be  chosen.  The  previous  enzyme  had  been 
shown  to  be  most  stable  in  sodium  phosphate  buffer  at  pH  7.5  and  this  pH  was 
used  as  a  starting  point  for  the  selection  of  others  (McKie,  1997).  The  buffers 
chosen  to  be  examined  were:  BIS  TRIS  pH  6.5,  BTP  pH  7.5,  HEPES  pH  7.5, 
PIPES  pH  7.0  and  TES  pH  7.5.  All  were  used  at  0.1  M  with  80  µM  PLP  and  60 
µM  DTT  added.  Enzyme  was  expressed  and  purified  as  already  published. 
Pooled  enzyme  was  then  dialysed  overnight  at  4  °C  into  the  relevant  buffer  and 
stored  at  a  concentration  of  1  mg/ml  at  either  4  °C  or  20  °C.  The  enzyme  was 
then  assayed  with  DL-homocysteine  as  detailed  (section  2.3.6)  over  two  weeks. 
72 The  results  of  these  assays  are  shown  in  figure  3.5  and  3.6. 
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Figure  3.5:  ay-elimination  activities  of  MGL2  toward  DL-homocysteine  after  storage  in  different 
buffers  at  20  T. 
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Figure  3.6:  ay-elimination  activities  of  MGL2  toward  DL-homocysteine  after  storage  in  different 
buffers  at  4  °C 
The  results  clearly  showed  that  there  is  no  measurable  activity  after  2  weeks  when 
the  enzyme  is  kept  at  20  °C.  The  results  also  showed  that  the  enzyme  lost 
considerable  activity  when  stored  in  BTP  and  BIS-TRIS  buffers  regardless  of  the 
73 temperature.  Much  better  retention  of  activity  was  exhibited  in  PIPES,  HEPES 
and  TES.  The  highest  values  recorded  were  in  PIPES  and  so  this  buffer  was 
selected  for  use  in  crystallisation.  However,  despite  these  changes,  and  attempts 
at  co-crystallisation  with  propargylglycine,  it  was  not  possible  to  produce  suitably 
diffracting  crystals  of  MGL2  during  the  course  of  this  study.  However  the  attempts 
made  were  not  exhaustive  and  further  experimentation  may  yield  good  quality 
crystals. 
3.2.6  Structure  Solution 
This  section  of  the  chapter  describes  the  results  of  the  structure  solution  process 
for  native  and  inhibitor  complex  MGL1.  As  stated  in  the  aims  of  this  project  the 
intention  was  to  solve  the  structure  of  MGL  and  from  this  learn  something  of  its 
function  in  vivo.  It  was  envisaged  that  if  suitable  crystals  were  grown  then  the 
technique  of  molecular  replacement  would  be  used  to  facilitate  the  process  rapidly 
and  easily.  This  assumption  was  due  to  the  number  of  PLP-dependent  enzyme 
structures  already  deposited  in  the  PDB  (albeit  of  the  a-and  p-families)  and  the 
anticipation  of  the  release  of  the  coordinates  of  CBL  (Clausen  et  al.,  1996),  a 
member  of  the  y-family. 
3.2.6.1  Data  Collection  and  Processing 
Complete  2.18  A  datasets  were  collected  from  cryocooled  single  crystals  of  both 
the  holoenzyme  and  the  enzyme-inhibitor  complex  at  station  9.5  at  the  SRS, 
CLRC  Daresbury  Laboratory  at  a  wavelength  of  1.1  A  on  a  30  cm  MAR  image 
plate.  A  summary  of  the  statistics  for  each  is  presented  below: 
74 Structure  Holoenzyme  Inhibitor  Complex 
Resolution  Range  (A)  25.0-2.18  25.0-2.18 
Oscillation  Range  (°)  0.5  0.5 
Temperature  (K)  100  100 
Unique  Reflections  49696  48724 
Completeness  Overall  (25.0  -  2.18) 
Highest  (2.55  -  2.18) 
98.6 
97.2 
97.6 
77.4 
Redundancy  2.3  3.6 
Rmeme  4.5  6.7 
Table  3.3:  Data  collection  and  processing  statistics  for  MGL1  holoenzyme  and  inhibitor  complex 
As  mentioned  previously  these  crystals  exhibited  diffraction  to  1.6  A  but  with 
differing  levels  of  anisotropism.  This  was  seen  subsequent  to  collecting  complete 
2.18  A  datasets.  It  was  not  possible  to  collect  higher  resolution  data  because  of  a 
lack  of  time.  Decreasing  the  wavelength  of  the  X-ray  beam  away  from  its  optimum 
of  1.1  A  would  have  resulted  in  a  much  lower  intensity  beam  and  therefore  a 
significant  increase  in  the  time  required  for  each  frame. 
Both  holoenzyme  and  inhibitor  complex  crystals  contain  a  dimer  in  the  asymmetric 
unit  and  belong  to  the  same  spacegroup  and  possessed  identical  dimensions,  that 
is: 
Spacegroup  a  b  c  a  p  7 
P3,12  88.26  A  88.26  A  217.85  A  90°  90°  1200 
table  3.4:  Unit  cell  parameters  for  crystals  of  holoenzyme  and  inhibitor  complex  MGL1. 
75 Attempts  were  also  made  at  this  time  to  soak  crystals  in  solutions  containing 
heavy  metal  atoms.  The  lack  of  time  and  small  number  of  crystals  available 
allowed  only  a  few  attempts.  1  mM  mercury  acetate  and  1  mM  mercury  chloride 
were  used  and  crystals  were  soaked  for  between  I  and  30  minutes.  The 
diffraction  exhibited  by  these  crystals  after  exposure  to  both  compounds  was 
significantly  poorer  than  that  shown  for  untreated  crystals.  It  was  decided  not  to 
collect  data  from  these  crystals  and  whilst  waiting  for  the  growth  of  larger  crystals 
a  molecular  replacement  solution  was  sought. 
3.2.6.2  Structure  Solution  by  Molecular  Replacement 
It  was  envisaged  that  it  would  be  possible  to  find  a  Molecular  Replacement  (MR) 
solution  for  MGL1  using  one  of  the  numerous  PLP-dependent  enzyme  structures 
available.  No  y-family  enzyme  structure  was  initially  accessible  from  the  database 
and  so  attempts  were  made  using  members  of  the  a  and  0  families.  These  all 
proved  unsuccessful  whether  using  the  whole  polypeptide  chain  or  selected 
fragments.  After  the  eventual  release  of  the  coordinates  for  CBL  from  E.  coli  it 
was  possible  to  use  a  search  model  with  a  much  higher  degree  of  sequence 
similarity  and  presumed  structural  homology.  Comparing  the  sequence  of  MGL1 
with  those  used  to  find  a  MR  solution  shows  that  the  a-  and  y-families  of  PLP- 
dependent  enzymes  may  share  a  similar  fold  but  sequence  identity  is  quite  low 
(Table  3.5). 
76 Enzyme  Sequence 
Identity 
Sequence 
Similarity 
Cystathionine  ß-Iyase  (Clausen  et  al.,  1996)  28.8%  36.9% 
Tryptophanase  (Isupov  et  al.,  1998)  15.2%  41.4% 
Tyrosine  phenol  Iyase  (Antson  et  al.,  1993)  14.6%  36.9% 
Aspartate  aminotransferase  (Okamoto  et  al.,  1994)  11.4%  37.6% 
Ornithine  aminotransferase  (Shen  et  al.,  1998)  15.2%  32.3% 
D-amino  acid  transferase  (Sugio  et  al.,  1995)  9.4%  16.8% 
Table  3.5:  Sequence  comparison  of  enzymes  used  to  find  a  MR  solution  with  MGL1. 
The  first  attempts  at  MR  with  AMoRe  (Navaza,  1994)  using  inhibitor  data  from  25 
to  2.2  A  and  the  entire  CBL  molecule  as  a  search  model  gave  no  clear  solution. 
Subsequently  the  CBL  model  was  truncated  to  more  closely  resemble  MGL1. 
Insertions  in  the  primary  sequence  alignment  were  removed  and  where  individual 
residues  differed  they  were  changed  to  either  alanine  or  glycine.  See  figure  3.7 
for  an  alignment  of  the  two  sequences.  This  again  gave  no  single  solution  but  by 
using  data  to  only  4.5  A  and  the  truncated  CBL  model  a  best  solution  with  an  R- 
factor  and  correlation  coefficient  of  47.3%  and  36.0%,  respectively  was  obtained. 
The  packing  was  verified  visually  using  Setor  (Evans,  1993).  This  provided  a 
usable  map  with  which  to  start  modelling  the  structure  of  the  inhibitor  complex. 
The  solution  for  the  holoenzyme  structure  was  solved  rapidly  by  using  the  phases 
from  the  inhibitor  complex  model  directly  without  the  need  to  use  molecular 
replacement.  This  does  result  in  greater  model  bias  to  be  carried  over  from  the 
77 inhibitor  from  the  active  site  in  early  stages  of  refinement.  The  Free  R-factor  set 
of  reflections  set  aside  for  monitoring  the  progress  of  refinement  were  identical  for 
both  datasets. 
1  10  20  30  40  50  60  70  80 
T.  vaginalis_MGL1  MSHERMTPRTRCIHRNPQKDQFGHRIPPIYQTSTFVIUNCUQGGNRFRGQESGYI-YTRLGNPIVSNIIGKIRFItKTER 
E.  coli_CBL  MRDKKLDTQLVNRGRSKKYTLGRVNSVIQRRSSLVFDSVIRKKHRTRNRRNGELFYGRRGTLIHFSIIJQRMCEIIGGRG 
Consensus 
... 
# 
.............. 
K...  GR....  I...  S..  VFD..  tt...........  G...  Y.  R.  tl..  I...!  U.....  It 
.... 
81  90  100  110  120  130  140  150  160 
1--------+---------+---------+---------+---------+---------+---------+---------I 
T.  vaginalis_MGLI  ('VHTSSI;  MGII  I  HRTVI  TILKRGI)HLISDI  CLYGCTHRLFEHRI  TKFI  [QVDFINTR  I  Pill  '.  'KKHt1KPN  IKI  VYFI  11  BHP 
E.  coli_CBL  L':  LFPCI;  RHFI  ;  'FINS  II  RFIEQI,  IIIIVLMTNTRYEPSQDFCSKII  SKLI  VTTSUFUPL  1601)  I  VKHI  QPNT  KI  VI  LESPGSI 
Consensus  UV 
.... 
(;..  H!  H..!  I.....  GI1H....  a..  Y..........  I.  K.  (;!.....  a..  l..  tt!,  KHf.  FNIKIV%.  F"P... 
161  170  180  190  200  210  220  230  240 
I  --------+---------+---------+---------+---------+---------+---------+---------I 
T.  vaginalis_MGL1  IL  KIIDMERVCKDRHSQ-EGVLVIRDNIFCSPMITNPVDFGVDVVVHSRIKYINGHTLIVVRGLICGKIIDLLIIUIRMVGIK 
E.  coli_CBL  IMEVHDVPRIVRRVRSVVPDRIIMIDNIURRGVLFKRLDFGIDVSTQRHTKYLVGHSDRMII;  TRVCNIIRCHIULRENRY- 
Consensus  TE.!.  D.........  5......  !..  DNI..........  DFG!  DV.!..  R1KY..  GH.  II...  11.....  I1...  *U.  R..... 
241  250  260  270  280  290  300  310  320 
I--------+---------+---------+---------+---------+---------+---------+---------I 
T.  vaginalis_MGL1  DITGSVISPHDfNILITRGLSTLNIRtIKAESENRMKVRFYLKSHPRVEKVYYPGFEDHEGHDIRKKUMRMI;  GSNITFItKS 
E.  coli_CBL  -LMGQMVDRDTRYITSRGLRTLGVRLRQHHESSLKVHENLREHPQVRRVNHPRLPGSK(;  HEFNKRIFFTGSSGLFSFVIKK 
Consensus 
... 
G..!....  R....  RGL.  TL.!  RI....  F..  IKVHE.  I..  HP.  V..  V..  P......  GH#..  K.  tt...  S..  f..  I!  IK. 
321  330  340  350  360  370  380  390  400 
I  --------+---------+---------+---------+---------+---------+-----------------  I 
T.  vaginalis_MGL1  GF--I  GRKKLIIINLKLITLHVSLGGCIStIQHPRSMTHRVVPKEERERRGITDGIIIRISVGIEDRDELIHIIFKQGLDRLL 
E.  coli_CBL  KLNNIELRNYIDHFSI.  FSMRYSMGGYLSLIL--HNQPEHIRRIRPQGEIDFSGTIIRLHIGLEDVDDIIHULORGFRRIV 
Consensus 
....  i.....  LDN..  l..  tR.  S.  GG.  ESLI...  fl  .....!  .............. 
IIRL.!  G.  ED.  0#11HIl...  G..... 
Figure  IT  Sequence  alignment  of  T.  vaginalis  MGL1  and  CBL  from  E.  coli.  Conserved  residues 
and  similarities  are  highlighted  in  red.  The  consensus  sequence  is  given  in  the  third  line. 
3.2.6.3  Refinement  of  MGL1 
Refinement  of  MGL1  was  performed  as  outlined  in  section  2.1.8.  Table  3.6  and 
3.7  lists  the  improvements  in  the  R  and  Rfree  factors  for  the  native  and  inhibitor 
complex  structures  after  successive  rounds  of  refinement  using  all  data  from  40  to 
2.18  A. 
78 Round  of  Refinement  R-factor  Rt. 
1.  After  AMoRe  54.9  53.5 
2.  Main  chain  14%  incomplete  36.5  40.6 
3.  Main  chain  complete,  352  waters  added  29.7  34.4 
4.  Bulk  solvent  correction  added  20.8  25.5 
5.  Poor  waters  removed,  NCS  restraints  relaxed  18.9  24.3 
6.2  glycerols  identified  16.3  20.2 
7.  Final  round  14.7  19.0 
Table  3.6:  MGL1  inhibitor  complex  refinement  progression. 
Round  of  Refinement  R-factor  Rt. 
1.  Using  phases  direct  from  inhibitor  complex  22.0  27.0 
2.  Removed  poor  atoms  20.1  26.3 
3.456  waters,  cofactor  and  bulk  solvent 
correction  added 
16.3  21.2 
4.  Final  round  16.2  21.2 
Table  3.7:  MGL1  holoenzyme  refinement  progression. 
3.2.6.4  MGLI  Model  Building 
The  structure  of  CBL  itself  was  used  to  guide  placement  of  residues  using  the 
molecular  replacement  map  calculated  from  the  MGL1  inhibitor  complex  data. 
Areas  of  large  divergence  between  the  two  structures  lead  to  poor  electron 
density  and  there  were  several  breaks  in  the  main  chain  where  it  was  impossible 
to  assign  Ca  positions  as  well  as  numerous  incomplete  side  chains.  In  particular 
79 the  following  regions  were  not  visible  13-22,41-55,227-241,294-296,316-325 
and  348-370  (MGL1  numbering).  Advantage  was  taken  of  the  2-fold  NCS  in  the 
asymmetric  unit,  allowing  a  single  monomer  to  be  constructed  and  then 
transformed  into  a  dimer  to  complete  the  asymmetric  unit.  The  assumption  was 
that  during  early  stages  of  refinement,  differences  between  the  two  monomers 
would  be  insignificant  compared  to  any  errors  and  poor  quality  of  the  electron 
density  map.  Thus  the  maps  produced  by  refinement  were  averaged  over  a 
single  monomer  and  the  modelling  process  repeated.  Until  density  was  visible  for 
the  entire  main  chain  and  waters  added  this  was  repeated  and  then  subsequently 
each  atomic  position  checked  individually. 
3.2.7  MGLI  Structure 
The  following  part  of  this  chapter  describes  the  crystal  structure  of  MGL1  and  the 
inhibitor  complex  with  L-propargylglycine.  The  large  size  of  the  structure  prevents 
a  detailed  description  of  all  residues  and  their  apparent  roles,  instead  those  with 
key  roles  and/or  positions  will  be  mentioned  as  appropriate.  In  the  multimeric 
structure  of  the  enzyme,  residues  from  an  adjacent  monomer  involved  in  an 
interaction  will  be  marked  by  an  asterisk  (*). 
3.2.7.1  MGL1  Monomer 
The  MGL1  monomer  can  be  divided  into  three  domains:  1)  An  extended  loop  N- 
terminal  domain;  2)  a  PLP-binding  domain;  and  3)  a  C-terminal  domain  (Figure 
3.8).  The  enzyme  shares  the  same  overall  fold  as  the  other  published  y-family 
members  and  is  closely  related  to  the  a-family.  Both  families  possess  the  PLP- 
dependent  transferase  fold,  the  y-family  have  in  addition  an  N-terminal  domain. 
80 Figure  3.8:  Ribbon  diagram  of  the  MGL1  monomer.  a-helices  are  coloured  green,  ß-strands  are 
coloured  blue  and  numbered  individually.  The  PLP  cofactor  is  represented  as  a  ball  and  stick 
model  and  coloured  by  atom  type.  Figure  produced  using  the  programmes  RIBBONS  (Carson, 
1997)  and  THE  GIMP  (http:  //www.  gimp.  org). 
The  N-terminal  domain  of  MGL1  (residues  4-60),  comprises  helices  al  and  a2 
and  a  fairly  open  loop  structure.  Comparing  other  y-family  members  reveals  that 
this  is  the  most  varied  domain,  in  both  sequence  and  length.  CBL  differs  having  a 
short  a-helix  and  ß-strand  between  the  two  helices  (Clausen  et  al.,  1996)  and 
CGS  has  no  defined  secondary  structure  elements  and  a  more  open  conformation 
(Clausen  et  a!.,  1998;  Schoenbrook  et  a!.,  1999).  Helix  al  of  MGL1  packs  against 
helices  a9  and  a3  of  the  PLP-binding  domain.  Residues  22-35  interact  to  form 
81 part  of  the  tetramer  interface,  while  helix  a2  forms  part  of  the  opening  to  the  active 
site  and  is  critical  in  mediating  monomer-monomer  interactions. 
The  PLP-binding  domain  (residues  61-258)  is  the  largest  domain  with  a  core 
seven  stranded,  mainly  parallel,  ß-sheet  surrounded  by  seven  a-helices.  The 
strands  are  arranged  in  the  order  A,  G,  F,  E,  D,  B,  C,  with  G  in  an  antiparallel 
direction.  The  cofactor  is  bound  at  the  edge  of  the  monomer,  between  strands  ß 
E,  ßF  and  helices  a4,  a5,  where  it  would  be  accessible  to  solvent.  However,  the 
interactions  of  the  C-terminal  domain  and  the  N-terminal  domain  of  the  adjacent 
monomer  in  the  catalytic  dimer  bury  the  cofactor  and  form  the  active  site.  Figure 
3.8  shows  quite  clearly  the  distorted  helix.  a5.  The  regular  geometry  is  distorted 
by  His120  and  A1a121,  which  are  close  to  Lys238*  and  Asp239*.  These  residues 
are  implicated  in  the  enzyme  mechanism  and  shall  be  discussed  further  below. 
The  C-terminal  domain  (residues  259-396)  is  composed  of  a  five  strand  ß-sheet 
with  five  a-helices.  The  strands  are  in  a  mainly  anti-parallel  arrangement  in  the 
order  H,  I,  L;  K,  J.  The  domain  is  dominated  by  helix  a10.  This  has  a  large  kink 
induced  by  Thr259  which  connects  to  helix  a9  of  the  PLP-binding  domain. 
Together  helices  a9  and  al0  extend  for  almost  the  entire  length  of  the  monomer. 
Helix  al0  is  situated  on  the  outer  edge  of  the  domain,  between  helix  a14  and  the 
loops  at  the  ß-sheet  of  the  C-terminal  domain.  The  loop  between  strand  ßK  and 
helix  a13  (residues  348-357)  is  critical  in  sculpting  the  entrance  and  restricting 
access  to  the  active  site. 
82 3.2.7.2  Disulphide  Bridges  in  MGLI 
There  are  no  intact  disulphide  bridges  visible  within  the  structure  of  MGL1.  The 
enzyme  has  not  been  indicated  as  being  located  extracellularly  so  this  is  perhaps 
as  expected.  The  crystallisation  solution  also  contained  high  concentrations  of 
DII  (1  mM)  and  thus  may  also  be  expected  to  reduce  any  bonds.  Examination  of 
the  structure  reveals  two  cysteine  residues  with  the  potential  to  form  a  disulphide 
under  appropriate  conditions.  Cys80  and  Cys223  have  their  Sy  4.1  A  apart  in 
both  structures  but  would  be  able  to  move  closer  by  rotation  around  the  Cß. 
Figure  3.9  shows  the  relative  positions  to  each  other  and  the  position  of  Cys80  on 
strand  ßA  and  Cys223  on  ßG.  The  strands  are  positioned  in  an  antiparallel 
direction.  It  can  be  seen  from  an  alignment  of  MGL  sequences  (Figure  3.10)  that 
none  of  the  residues  shown  in  figure  3.9  are  conserved  including  the  cysteines 
except  for  MGL1  and  2  from  T.  vaginalis.  Neither  residue  is  involved  in 
intersubunit  interactions  or  catalysis  in  anyway  and  it  is  difficult  to  see  how  the 
formation  of  a  disulphide  bridge  would  change  this.  One  possibility  is  that 
disulphide  formation  may  shift  helix  a4  enough  to  disrupt  either  tetramer  binding 
or  cofactor  binding  via  GIy86  and  Met87. 
83 Figure  3.9:  Arrangement  of  Cys80  and  Cys223  in  MGL1.  Residues  are  coloured  according  to  atom 
type  and  labelled.  The  distance  between  Sy  atoms  is  4.1  A  in  both  holoenzyme  and  inhibitor 
complex  structures  and  identical  between  monomers. 
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Figure  3.10:  Alignment  of  MGL  sequences  from  T.  vaginalis  and  P.  putida.  100%  conserved 
residues  are  in  red  and  75%  conserved  in  blue.  Secondary  structure  elements  in  MGL1  as  denoted 
by  DSSP  (Kabsch  and  Sander,  1983)  are  indicated  above  the  sequences.  Residues  involved  in 
subunit  contacts  are  underlined  in  colour,  blue  for  monomer-monomer  interactions,  green  for 
dimer-dimer  and  red  if  involved  in  both.  The  alignment  was  carried  out  using  Multalin  (Corpet,  1988) 
3.2.7.3  cis-Prolines  in  MGLI 
There  are  two  cis-prolines  in  the  structure  of  MGL1,  Pro156  and  Pro159.  Both  are 
rigidly  conserved  in  MGL  sequences  identified  so  far  and  also  CGS  but  only 
Pro156  is  conserved  in  CBL.  Neither  residue  is  involved  in  intersubunit  contacts 
but  they  have  an  indirect  role  in  cofactor  binding.  Both  residues  are  positioned  in 
type  IV  ß-turns  (residues  154-157  and  158-161)  between  strand  ßD  and  helix  a7. 
85 This  positions  Asn158  in  the  optimal  site  for  making  hydrogen  bonds  with  03'  of 
the  cofactor  and  Arg373.  The  role  of  03'  is  important  in  the  catalytic  mechanism 
proposed  here  and  Arg373  is  conserved  in  all  PLP-dependent  enzymes  that 
utilise  amino  acids  as  substrates.  There  are  two  conserved  cis-prolines  in  AAT 
although  not  in  the  same  arrangement  as  MGL1.  The  two  residues  are  numbered 
138  and  195  for  the  E.  coli  enzyme  but  are  positioned  within  van  der  Waals 
contact  with  each  other.  Pro195  is  analogous  to  Pro159  of  MGL1,  coordinating 
the  adjacent  asparagine  residue  (Asn194  in  AAT).  However  mutagenesis  studies 
have  revealed  that  neither  of  these  residues  are  critical  for  structure  or  activity 
(Birolo  et  al.,  1999).  They  have  been  postulated  to  play  a  subtle  role  in  optimising 
catalysis  but  are  substitutable  for  alanine  with  very  little  deleterious  effect. 
3.2.7.4  Intersubunit  Interactions 
There  are  extensive  contacts  made  between  adjacent  monomers  in  the  catalytic 
dimer  with  residues  from  the  adjacent  subunit  being  essential  for  activity, 
throughout  the  text  residues  from  the  neighbouring  subunit  involved  in 
interactions  are  marked  with  an  asterisk  (*).  The  MGL1  homotetramer  is 
constructed  by  symmetric  association  of  two  catalytic  dimers.  Analysis  of  the 
subunit  interactions  was  performed  using  the  protein-protein  interaction  server 
(Jones  and  Thornton,  1995).  Residues  involved  in  intersubunit  interactions  are 
indicated  in  figure  3.10  in  an  alignment  with  other  MGL  sequences.  Those 
residues  at  the  monomer-monomer  interface  are  underlined  in  blue,  those  in  the 
tetramer  interface  green  and  those  involved  in  both  are  underlined  in  red.  The 
most  significant  are  mentioned  individually  below. 
86 3.2.7.4.1  Monomer-Monomer  in  the  Catalytic  Dimer 
The  association  of  the  two  monomers  in  the  asymmetric  unit  buries  approximately 
2600  A2  of  solvent  accessible  surface  in  an  area  of  approximately  67  A  by  39  A  in 
both  structures.  The  interface  formed  is  predominantly  non-polar  but  does  include 
36  intersubunit  hydrogen  bonds.  The  symmetry  between  the  two  dimers  can  be 
clearly  seen  in  figure  3.11.  The  dimer  is  formed  predominantly  by  close 
association  of  the  PLP-binding  domains,  which  comprises  51  %  of  the  interface. 
The  "clamp"  of  the  N-terminal  domain  contributes  31  %  of  the  interface  surface 
area,  interacting  with  both  the  PLP-binding  and  C-terminal  domains  of  the 
adjacent  monomer. 
Figure  3.11:  MGL1  dimer.  The  three  domains  are  highlighted  in  colour:  green  =  N-terminal;  gold  = 
PLP-binding;  purple  =  C-terminal.  The  PLP  cofactor  is  represented  as  a  spacefilling  model.  The 
figure  was  produced  using  RIBBONS. 
87 There  are  a  number  of  residues  playing  a  significant  role  in  dimer  formation; 
Gln31  forms  a  hydrogen  bond  between  its  amide  nitrogen  and  the  carbonyl 
oxygen  of  Thr215*  and  in  addition  also  hydrogen  bonds  via  waters  55,84  and  31 
to  the  amide  nitrogen  and  side  chain  hydroxyl  of  Thr215*.  In  this  region,  also 
close  to  the  dimer  surface  involved  in  tetramer  formation,  these  three  waters 
mediate  interactions  between  Ser33  and  residues  Thr208*,  Thr215`,  Ser338*  and 
Leu339.  Phe37  in  concert  with  Phe47,  I1e55,  Leu59,  Va1337*  and  Met352*  forms 
a  hydrophobic  patch  along  the  active  site  channel  leading  to  the  cofactor.  Phe37, 
Phe47,  Va1337  and  Met352  are  all  highly  conserved  in  MGL  enzymes  with  I1e55 
and  Leu59  being  substituted  only  for  hydrophobic  residues.  Another  hydrophobic 
patch  formed  by  the  two  monomer  interactions  involves  residues  Leu  117,  Leu122, 
Leu95,  IIe240  and  Leu95*  and  IIe240*  and  a  stacking  interaction  between  Phe125 
from  both  subunits. 
3.2.7.4.2  Tetramer  formation 
The  MGL1  tetramer  is  constructed  by  symmetric  association  of  two  catalytic 
dimers,  as  shown  in  figure  3.12.  The  approximate  dimensions  of  the  interface 
between  the  two  dimers  is  64  A  by  46  A  and  buries  around  4100  A2  of  solvent- 
accessible  surface,  which  is  comparable  to  other  y-family  enzymes.  The  tetramer 
is  formed  predominantly  by  hydrophobic  interactions  which  comprise  70%  of  the 
total  buried  surface  area  but  also  includes  33  intersubunit  hydrogen  bonds.  The 
N-terminal  region,  despite  being  the  smallest  domain  of  the  enzyme,  is 
responsible  for  55%  of  the  interface.  This  highlights  its  key  role  in  all  intersubunit 
interactions  as  well  as  active  site  formation.  The  PLP-binding  and  C-terminal 
domains  play  less  central  roles  and  form  20%  and  25%  of  the  interface, 
88 respectively.  Residues  25-33  form  one  ß-strand  (not  identified  by  DSSP)  in  a  two 
strand  antiparallel  ß-sheet  at  the  tetramer  interface.  The  second  strand  is 
comprised  of  the  same  residues  from  the  diagonally  opposite  subunit. 
Figure  3.12:  Ribbon  diagram  of  MGL1  tetramer.  Monomers  are  coloured  individually  in  red,  gold, 
blue  and  green.  The  cofactor  is  shown  as  a  spacefilling  model  coloured  according  to  atom  type. 
The  figure  was  produced  using  RIBBONS. 
For  the  most  part  residues  involved  in  tetramer  formation  are  not  conserved 
between  MGL,  CBL  and  CGS.  There  are  equivalent  regions  involved  but  few  of 
these  are  identical  at  the  primary  structure  level. 
89 A  crucial  interaction  that  is  conserved  is  the  intersubunit  salt  bridge  made  by 
Arg255  which  lies  antiparallel  to  its  symmetry  partner  in  the  adjacent  dimer  and  is 
coordinated  by  Asp216*  (Figure  3.13).  Alongside  this  is  His214  which  is  also 
conserved  and  with  His214*  coordinates  a  water  molecule.  Trp251  on  the  other 
side  of  the  salt  bridge  is  not  conserved.  The  sum  of  these  interactions  account  for 
approximately  17%  of  the  interface. 
T 
Figure  3.13:  Salt  bridge  interaction  between  catalytic  dimers.  Atoms  are  coloured  according  to 
type,  distances  between  key  interactions  are  marked  in  Angstroms  and  denoted  by  dashed  lines. 
Residues  from  adjacent  dimer  are  indicated  by  ".  Figure  produced  using  Setor. 
90 A  large  hydrophobic  patch  of  residues  from  the  N-terminal  domain  is  also  key  in 
MGL1  and  although  these  residues  are  not  conserved  in  CBL  and  CGS  there  are 
analogous  interactions.  In  MGL1,  Phe22  is  angled  roughly  perpendicular  to  the 
plane  of  Tyr30,  Phe35,  Tyr54  and  Pro62  in  an  area  which  makes  up 
approximately  12.5%  of  the  total  interface  area.  Tyr30  is  also  involved  in  an 
interaction  on  its  opposite  side  with  Pro28  and  I1e29  to  form  another  hydrophobic 
patch.  I1e29  is  conserved  between  CBL,  CGS  and  MGL  and  is  positioned 
adjacent  to  its  symmetry  partner  in  the  opposite  dimer. 
3.2.8  Comparison  of  Holoenzyme  and  Inhibitor  Complex  Structures 
There  are  no  major  conformational  differences  between  monomers  in  the  catalytic 
dimer  of  either  model  nor  between  the  structures  of  the  holoenzyme  and  inhibitor 
complex.  Superimposing  monomers  onto  each  other  gives  an  RMS  deviation  of 
0.360  A  and  0.326  A  for  main  chain  atoms  in  the  holoenzyme  and  inhibitor 
complex  respectively.  Superimposing  the  dimers  of  the  two  structures  gives  an 
RMS  deviation  for  main  chain  atoms  of  0.251  Ä. 
However,  a  comparison  of  main  chain  atom  B-factors  between  the  holoenzyme 
and  inhibitor  complex  models  does  reveal  higher  values  for  the  holoenzyme 
(Figure  3.14).  After  allowing  for  a  systematic  variation,  the  most  significant 
variation  occurs  for  the  residues  38-50  and  350-370.  Both  of  these  regions  are  in 
the  entrance  to  the  active  site.  Flexibility  for  this  part  of  the  structure  is  likely  to 
be  important  to  enable  the  active  site  to  accommodate  bulky  substrates  such  as 
S-adenosyl  methionine  (Lockwood  and  Coombs,  1991b). 
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Figure  3.14:  Comparison  of  atomic  B-factors  for  holoenzyme  and  inhibitor  complex.  The  native 
model  values  are  indicated  by  the  bold  solid  line,  the  inhibitor  complex  values  by  the  dashed  line. 
3.2.9  Active  Site  Structure  and  Implications  for  the  Catalytic  Mechanism 
The  following  description  of  the  structure  details  the  architecture  in  the  active  site 
around  the  cofactor  and  the  residues  implicated  in  the  enzyme  mechanism.  The 
presence  of  a  suicide  inhibitor  covalently  bound  allows  a  good  estimate  of  the 
likely  position  of  a  bound  substrate  especially  when  studied  in  conjunction  with  a 
native  enzyme  structure. 
3.2.9.1  Cofactor  Binding 
The  active  site  is  located  at  the  subunit  interface  in  the  catalytic  dimer  with  the 
cofactor  held  in  place  by  a  network  of  hydrogen  bonds  characteristic  of  PLP- 
dependent  enzymes.  All  of  the  close  contacts  between  the  protein  and  cofactor 
are  shown  schematically  in  figure  3.15,  including  those  involving  the  inhibitor  L- 
92 propargylglycine.  Differences  between  the  two  structures  are  minimal  as 
previously  stated.  In  addition,  Van  der  Waals  contacts  between  the  pyridine  ring, 
Tyrl  11  and  Ser206  also  exist,  restricting  any  vertical  movement  and  holding  the 
ring  approximately  parallel  to  the  plane  of  Tyrl  11.  As  described  for  aspartate 
aminotransferase  (Hayashi  et  a!.,  1990),  the  positioning  of  the  aromatic  side  chain 
should  increase  the  electron  sink  character  of  the  cofactor.  From  the  second 
monomer,  Arg58*  forms  a  salt  bridge  to  the  phosphate  group  of  the  cofactor  whilst 
also  being  close  (3.1  A)  to  the  OH  group  of  Tyrl  11.  In  addition  Tyr56*  hydrogen 
bonds  to  the  PLP  phosphate  and  Lys209  when  the  enzyme  is  in  the  external 
aldimine  form,  as  seen  in  the  inhibitor  complex.  In  the  holoenzyme  Lys209  is 
covalently  attached  to  the  cofactor  via  a  Schiff  base.  Also  in  the  holoenzyme 
structure  there  is  a  sulphate  ion  positioned  in  the  active  site  adjacent  to  Arg373 
instead  of  the  inhibitor  carboxylate  group. 
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Figure  3.15:  Schematic  representation  of  the  L-propargylglycine  inactivated  MGL1  active  site. 
Cofactor  atoms  are  coloured  red,  the  covalently  attached  inhibitor  molecule  is  shown  in  blue  and 
protein  atoms  and  water  molecules  are  labelled  in  black.  Non-covalently  attached  atoms  are 
indicated  by  dotted  lines  and  distances  are  shown  in  Angstroms. 
3.2.9.2  Substrate  Binding 
Substrate  binding  site  in  the  active  site  is  primarily  through  the  Schiff  base  link  to 
the  cofactor  and  also  the  coordination  of  the  carboxylate  group  by  Arg373.  This 
residue  is  conserved  in  all  PLP-dependent  enzymes  that  have  amino  acids  as 
substrate. 
94 3.2.9.3  Substrate  Access 
Entrance  to  the  active  site  is  via  a  channel  approximately  15  A  long  from  the 
position  of  the  substrate  Ca  to  the  solvent,  running  along  the  dimer  interface. 
Consequently  residues  from  both  monomers  are  involved.  The  cofactor  is  angled 
at  -90  °  to  the  channel  and  the  inhibitor  is  positioned  with  the  side  chain  pointing 
outwards  as  shown  in  figure  3.16.  It  can  be  seen  that  Phe47*  and  Leu59*, 
although  not  playing  an  active  part  in  catalysis,  are  in  this  channel  to  the  active 
site  and  form  a  hydrophobic  patch  along  with  Va1337  and  I1e55*  (not  shown).  Also 
crucial  are  Cys113  and  Lys238*  which  are  positioned  on  the  opposite  side  relative 
to  His354*.  These  two  residues  and  Asp239*  appear  to  be  functionally  important 
but  are  not  directly  involved  in  the  catalytic  mechanism  proposed. 
95 Figure  3.16:  Diagram  of  the  channel  leading  to  the  active  site  in  the  MGL1-inhibitor  complex  The 
solvent  accessible  area  is  shown  by  pink  lines.  Water  molecules  in  the  inhibitor  complex  are 
indicated  by  red  crosses.  Key  residues  involved  in  the  channel  formation  are  indicated,  with  residues 
involved  in  catalysis  also  marked.  Solvent  accessible  surface  was  calculated  by  the  programme 
SURFNET  using  the  inhibitor  structure  model  without  cofactor  and  inhibitor  atoms.  The  figure  was 
produced  using  QUANTA. 
3.2.9.4  Covalent  Attachment  of  L-Propargylglycine 
The  attachment  of  this  suicide  inhibitor  of  several  PLP-dependent  enzymes  is 
unambiguous  in  the  electron  density.  The  earliest  maps  in  the  inhibitor  complex 
model  showed  continuous  density  between  the  hydroxyl  group  of  Tyrl  11  and  the 
cofactor  consistent  with  the  binding  of  a  substrate/inhibitor  to  the  cofactor  and 
enzyme.  Fitting  a  putative  propargylglycine  molecule  was  simple  following  the 
predicted  mechanism  from  (Washtien  and  Abeles,  1977).  The  active  site 
nucleophile  was  thought  to  be  either  a  cysteine  or  tyrosine  residue,  and  although 
activity  data  from  mutagenesis  and  chemical  modifications  implicated  a  cysteine, 
the  model  showed  clearly  a  covalent  link  to  Tyr  111.  Thus  propargylglycine  is 
held  in  place  by  covalent  attachment  to  Tyrl  11  and  also  via  aldimine  linkage  to 
the  cofactor.  The  distance  from  the  Tyrl  11  side  chain  oxygen  atom  to  the 
inhibitor  Cß  in  the  final  model  is  1.8  A.  Arg373  plays  its  usual  role  in  coordinating 
the  carboxylate  group  of  the  substrate  and  in  this  case  the  inhibitor. 
3.2.9.5  Comparison  of  the  Holoenzyme  and  Inhibitor  Complex  Active  Site 
As  has  been  previously  stated  there  are  no  gross  structural  changes  between  the 
two  crystal  structures  and  this  allows  us  to  make  certain  assumptions  concerning 
96 binding  of  the  substrate  and  residues  involved  in  catalysis.  However  the  active 
sites  differ  subtly  and  this  provides  more  information  on  the  likely  mechanism. 
A  sulphate  ion  is  substituted  for  the  carboxylate  group  of  the  inhibitor  in  the 
holoenzyme  structure  and  the  Schiff  base  attachment  of  Lys209  to  the  cofactor 
replaces  the  attachment  of  the  inhibitor  amine  group.  Superimposing  the  two 
structures  shows  essentially  no  movement  of  the  cofactor  nor  changes  in  the 
pucker  of  the  ring.  The  position  of  Tyrl  11  shows  minimal  movement,  the  most 
significant  factor  is  the  poor  electron  density  for  this  residue  (Figure  3.17).  As 
mentioned  there  is  a  systematic  increase  in  B-factors  for  all  of  the  holoenzyme, 
however  the  electron  density  for  the  cofactors  in  each  model  is  similarly  clear. 
The  poor  density  exhibited  by  this  residue  adjacent  to  the  cofactor  can  be  taken  to 
be  because  of  mobility,  a  situation  prevented  in  the  inhibitor  complex  because  of  a 
covalent  bond. 
Figure  3.17:  Comparison  of  active  site  electron  density.  In  the  native  (A)  and  inhibitor  complex 
(B)  structures.  2  FO  -  Fc  electron  density  maps  contoured  at  1  and  2a  are  shown  in  orange  and 
pink  respectively.  Inhibitor  molecule  atoms  have  been  omitted  from  B  for  clarity.  The  continuous 
electron  density  for  the  covalent  bond  between  Tyrl  11  and  propargylglycine  is  clearly  visible.  The 
figure  was  produced  using  QUANTA  and  the  GIMP. 
97 3.2.9.6  The  Role  of  Cys113 
It  has  been  shown  previously  that  Cysl  13  is  very  important  for  MGL  activity.  The 
mutant  MGL1(c"3G)  was  shown  to  have  a  greatly  reduced  activity  towards  all 
substrates,  though  still  exhibiting  measurable  activity  (McKie  et  al.,  1998). 
Chemical  modification  studies  on  MGL  from  P.  putida  have  also  indicated  the 
importance  of  an  unidentified  cysteine  residue  in  catalysis,  but  confirmed  that  it  is 
not  essential  (Nakayama  et  al.,  1988a). 
In  the  inhibitor-complex  Cysl  13  has  an  obvious  dual  conformation  with  an  angle 
between  the  two  Sy  of  33.4  °.  This  places  the  Sy  3.5  A  from  the  C8  atom  of  L- 
propargylglycine  and  3.15  A  from  -OH  of  Tyrl  11  in  one  conformation  and  2.8  A 
from  the  Ne  of  Lys238*  which  is  2.8  A  from  the  08  of  Asp239*  in  the  other.  The 
same  residue  in  the  holoenzyme  model  does  not  appear  to  be  in  such  a  geometric 
arrangement  and  has  only  a  single  conformation  despite  appearing  similar  in  the 
figure  above.  Continually  through  refinement  any  attempts  at  arranging  Cys113 
as  a  dual  conformation  were  rejected  because  of  negative  density  in  the 
difference  maps.  It  is  probable  that  a  limited  range  of  movement  of  Cys113  exists 
in  the  native  structure  but  it  is  certainly  more  pronounced  in  the  inhibitor  complex. 
Perhaps  most  interestingly  in  the  holoenzyme  are  the  differences  in  the  active 
sites  in  which  the  distances  between  atoms  are  not  equal.  The  distance  between 
Cys113  Sy  and  Tyrl  11  -OH  is  3.66  A  and  4.17  A,  Sy  to  Lys238*  NE  is  3.71  A  and 
4.13  A  and  Lys238*  Ne  to  Asp239*  08  2.65  A  and  2.98  A.  Thus  one  active  site 
has  a  more  relaxed  arrangement  with  the  distances  between  all  atoms  larger  than 
the  other. 
98 The  distances  between  the  Sy  of  Cys113  and  the  CS  of  propargylglycine  and  S8  of 
homocysteine  are  likely  to  be  very  similar.  The  3.55  A  distance  seen  in  the 
inhibitor  complex  structure  suggests  that  this  is  too  great  for  a  direct  interaction 
between  Cys113  and  the  substrate  in  catalysis  unless  a  considerable 
conformational  change  occurs.  The  sequence  information  on  MGL  sequences 
(Figure  3.10)  indicates  that  both  Asp239  and  Lys238  are  conserved.  The 
distances  in  the  inhibitor  complex  suggest  that  a  charge  relay  between  the  three 
residues  would  result  in  the  Cysl  13  Sy  being  ionised.  The  influence  of  this 
charge  upon  other  atoms  in  the  active  site  and  therefore  activity  may  be  two-fold. 
The  distance  between  the  Sy  and  Tyr111  OH  is  close  enough  to  influence  the 
charge  upon  this  and  with  the  added  effect  of  Arg58*  could  conceivably  produce  a 
phenolate  ion.  This  will  be  discussed  further  in  the  proposed  catalytic 
mechanism.  The  other  effect  of  the  Sy  may  well  be  directly  upon  the  substrate. 
The  action  of  MGL  is  a  predominantly  Cy-S  and  to  a  lesser  extent  Cp-S  lyase. 
Homocysteine  is  the  preferred  substrate  for  the  enzyme  with  a  published  activity 
almost  40  times  more  than  that  for  methionine  (McKie  et  al.,  1998).  The  structure 
of  homocysteine  is  identical  to  methionine  but  lacks  the  terminal  methyl  group  of 
the  amino  acid  side  chain.  The  much  higher  activity  towards  homocysteine 
relative  to  methionine  may  be  due  to  the  "shielding"  effect  this  methyl  group  has 
upon  Cys113  Sy.  The  much  lower  activity  towards  cysteine  can  be  postulated  to 
reflect  the  greater  distance  between  Cysl  13  Sy  and  the  substrate  Sy.  That  is,  the 
nucleophilic  attack  by  Tyrl  11  is  not  aided  by  the  action  of  Cys113  Sy  to  anywhere 
near  the  same  degree.  This  idea  is  further  supported  by  the  substrate 
preferences  of  the  MGL1  C  3G  mutant.  It  shows  a  greater  relative  loss  of  activity 
99 for  ay-elimination  reactions,  i.  e.  9.3%  remaining  activity  toward  homocysteine  and 
39%  activity  toward  cysteine  compared  to  wild  type  enzyme  (McKie  et  al.,  1998). 
Another  possible  role  for  the  residue  is  suggested  by  the  action  of  a  related 
enzyme:  There  is  a  cysteine  analogous  to  Cysl  13  in  the  active  site  of  cysteine 
desuiphurase,  the  enzyme  encoded  by  the  nifS  gene  of  A.  vinelandii  (Zheng  et  al., 
1993),  and  its  homologues.  As  mentioned  in  section  1.8.4  these  enzymes  belong 
to  the  a-family  of  PLP-dependent  enzymes  and  catalyse  the  removal  of  sulphur 
from  cysteine'by  mechanisms  different  from  that  proposed  here.  However  the 
analogous  cysteine  residue  has  been  shown  to  form  an  internal  enzyme  bound 
persulphide  complex  after  cleavage  of  the  substrate  SH  group  (Zheng  et  al., 
1993).  The  sulphur  produced  is  then  ideally  placed  to  be  donated  for  Fe-S  cluster 
formation  in  the  case  of  NifS.  It  is  the  generation  of  a  persulphide  group  that  is 
key  here  and  the  controlled  delivery  of  sulphur.  A  comparison  of  MGL1  with  the 
structures  of  cysteine  desulphurase  enzymes  and  homologues  follows  in  this 
chapter. 
3.2.10  Predicted  Catalytic  Mechanism  for  MGL 
Although  MGL  is  classified  in  the  same  family  of  enzymes  as  CBL  and  CGS  and 
possesses  a  same  overall  fold,  it  has  considerably  different  substrate 
preferences.,  It  catalyses  the  breakdown  of  homocysteine  and  methionine  at  a 
much  more  rapid  rate  than  CBL  or  CGL  but  has  no  activity  towards  cystathionine. 
This  is  surprising  given  its  published  activity  toward  S-adenosyl  L-methionine 
(Lockwood  and  Coombs,  1991  b),  a  much  larger  substrate,  suggesting  that  this  is 
not  entirely  due  to  steric  restrictions  on  substrate  binding.  It  is  the  proposal  of  this 
100 study  that  MGL  has  a  different  catalytic  mechanism  (Figure  3.18)  from  that 
proposed  for  CBL  and  CGS  (Clausen  et  al.,  1996,1997,1998;  Steegborn  et  al., 
1999). 
In  PLP-dependent  enzymes,  a  lysine  residue  (Lys209  in  MGL1)  is  "essential"  for 
activity.  However,  it  has  been  observed  that  mutated  PLP-dependent  enzymes 
lacking  the  analogous  lysine  do  retain  trace  levels  of  activity  (Watabe  et  al., 
1999).  This  residual  activity  is  at  very  low  levels  though  and  for  most  PLP- 
dependent  enzymes  removal  of  this  residue  produces  an  inactive  enzyme.  In 
agreement  with  the  published  mechanisms  for  CBL  and  CGS  it  is  proposed  that  in 
MGL1  Lys209  catalyses  deprotonation  of  the  substrate  Ca  and  generation  of  the 
quinonoid  intermediate.  The  second  part  of  the  mechanism  involves  nucleophilic 
attack  at  the  ß  or  y  atom  of  the  substrate  but  in  MGL1  Lys209  does  not  appear  to 
be  optimally  positioned  to  perform  this  function.  There  are  few  other  residues  in 
the  active  site  as  suitable  alternatives  except  for  Tyrl  11.  The  phenol  side  chain 
of  this  residue  seems  to  be  in  precisely  the  correct  orientation  for  interaction  with 
the  substrate  at  this  point. 
Tyr111  has  been  suggested  to  exist  as  a  phenolate  ion  in  CGS  (Clausen  et  al., 
1998)  and  to  have  a  role  in  transaldimination  (Steegborn  et  al.,  1999),  i.  e.  the 
conversion  between  enzyme-cofactor  and  substrate-cofactor  complexes.  The 
residue  is  indeed  likely  to  be  in  a  deprotonated  form  under  the  influence  of 
Cys113  and  the  combined  action  of  Arg58*  and  the  phosphate  group  of  the 
cofactor.  If  this  is  accepted  as  the  case  upon  binding  of  the  substrate  then  the 
side  chain  must  be  protonated  prior  to  cleavage  of  the  substrate  y-S  bond.  This  is 
101 because  the  enamine  complex  generated  is highly  reactive  and  would  covalently 
bond  to  the  Tyrl  11  in  an  analogous  fashion  to  the  action  of  L-propargylglycine. 
Acting  as  the  active  site  nucleophile  upon  the  substrate  removes  this  problem  and 
the  hydroxyl  group  seems  optimally  positioned  for  this.  Addressing  the  proposal 
that  this  residue  is  instead  involved  in  transaldimination,  this  function  could  be 
carried  out  instead  by  the  cofactor  itself.  It  is  likely  that  the  03'  of  the  cofactor  is 
deprotonated  and  this  could  mediate  a  proton  transfer  between  the  amine  group 
of  the  incoming  substrate  and  the  Ns  of  Lys209  and  generation  of  the  external 
aldimine  (substrate-cofactor)  complex. 
Thus  we  are  able  to  postulate  an  enzyme  mechanism  based  upon  the  structure  of 
MGL1  and  the  known  biochemical  evidence  (figure  3.18): 
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Figure  3.18:  Postulated  mechanism  for  the  ay-elimination  reaction  catalysed  by  MGL.  (I) 
Deprotonation  of  the  substrate  Ca  by  Lys  209  and  formation  of  the  quinonoid  intermediate.  (II) 
Nucleophilic  attack  at  the  substrate  Cß  by  the  phenolic  Tyr111.  (III)  Elimination  at  the  Cy  of  SH 
influenced  by  the  ionised  Sy  of  Cys113.  (N)  Reprotonation  at  the  Cy  by  Tyrl  11  to  form  the  enamine 
intermediate.  (V)  Deprotonation  of  Lys209  by  the  cofactor  03.  (VI-VIII)  Regeneration  of  the  internal 
aldimine  and  displacement  of  the  enamine  which  via  hydrolysis  generates  a-ketobutyrate  and 
103 ammonia.  This  production  of  an  a-keto  acid  is  not  catalysed  by  the  enzyme  and  is  presumed  to 
occur  in  free  solution  away  from  the  active  site. 
3.2.11  Comparison  of  other  PLP-dependent  enzyme  structures 
It  is beyond  the  scope  of  this  study  to  perform  a  comprehensive  comparison  of 
MGL  with  published  structures  of  PLP-dependent  enzymes.  However  where 
specific  points  on  the  structure  of  MGL1  have  been  raised  and  other  structures 
show  analogous  situations  these  are  mentioned  here. 
The  structure  of  CBL  from  E.  coil  is  similar  enough  that  it  provides  a  molecular 
replacement  solution  and  this  reflects  the  overall  secondary  structure 
arrangement.  CGS  is  also  similar  and  yet  all  three  catalyse  different  reactions 
reflecting  their  different  active  site  arrangements.  It  is  apparent  as  well  that  the 
opening  to  the  active  site  is  different  to  MGL  for  both  of  these  enzymes.  The  size 
of  cystathionine  as  a  substrate  or  product  suggests  this  but  the  ability  of  MGL  to 
catabolise  SAM  does  not  fit  perfectly  with  this  argument. 
Despite  the  close  similarity  in  substrate  for  MGL  and  the  various  "cysteine 
desulphurase"  structures  published  there  is  little  homology  seemingly  beyond  that 
normally  seen  for  these  types  of  PLP-dependent  enzymes.  As  previously 
mentioned  there  are  now  three  published  structures  of  enzymes  able  to  catalyse 
the  removal  of  sulphur  from  L-cysteine  and  a  related  enzyme  whose  preferred 
substrate  is  L-cystine. 
104 The  structure  of  C-DES  from  Synechocystis  is  perhaps  unsurprisingly  the  least 
informative  (Clausen  et  al.,  2000).  It  does  not  possess  the  active  site  cysteine  so 
strongly  implicated  in  the  action  of  cysteine  desulphurase  and  has  a  binding  site 
specific  for  cystine,  a  situation  more  analogous  to  CBL. 
The  published  structure  of  a  NifS-like  protein  from  T.  maritima  (NifS)  is  similar  in 
structure  to  MGL,  being  a  member  of  the  a-family  of  PLP-dependent  enzymes 
(Kaiser  et  al.,  2000).  It  shows  more  similarity  overall  to  the  structure  of 
phosphoserine  aminotransferase  (Hester  et  al.,  1999)  than  CBL.  However,  the 
active  site  appears  to  be  more  analogous  to  the  situation  found  in  CBL.  Thus 
His99  in  NifS  is  in  an  analogous  position  to  Tyrl  11  in  MGL.  The  predicted  active 
site  cysteine  residue  in  NifS  (Cys324)  is  not  visible  in  the  structure,  being  located 
on  a  presumably  mobile  loop.  It  is  impossible  therefore  to  compare  the  positions 
of  this  and  Cys113  in  MGL.  The  mechanism  predicted  for  NifS  gives  Cys324  a 
direct  role  in  a  nucleophilic  attack  upon  the  substrate.  This  is  plainly  not  the  case 
in  MGL  as  already  mentioned  with  the  distance  being  too  great.  Further  evidence 
in  support  of  this  mechanism  in  NifS  is  provided  by  an  inhibitor  complex  structure 
utilising  allylglycine  (AG).  The  inhibition  of  NifS  by  AG  is  thought  to  be  by 
alkylation  of  the  active  site  cysteine  and  in  the  inhibitor  complex  neither  Cys324 
nor  AG  are  visible.  This  implies  that  AG  is  bound  to  Cys324  and  therefore  that 
Cys324  must  move  close  to  the  substrate  at  some  point.  Allylglycine  is  not  an 
irreversible  inhibitor  of  MGL  though,  again  suggesting  a  different  mechanism  of 
action.  It  must  also  be  remembered  that  unlike  MGL  the  products  of  the  reaction 
with  NifS  are  alanine  and  sulphide,  the  formation  of  a-keto  acid  and  ammonia  do 
not  occur. 
105 The  structure  of  CsdB  from  E.  coli  (Fujii  et  al.,  2000)  is  similar  to  NifS  from  T. 
maritima  and  therefore  to  a  degree  also  to  MGL.  The  active  site  arrangement  is 
much  more  like  that  already  mentioned  for  NifS.  In  CsdB,  His123  mimics  Tyr111 
in  MGL  in  much  the  same  way  as  His99  in  NifS  from  T.  maritima.  However  the 
putative  active  site  cysteine  (Cys364)  is  visible  in  CsdB.  The  lower  resolution  of 
the  structure  (2.8  A)  prevents  accurate  measurements  of  interatomic  distances  but 
the  Cys364  Sy  to  hypothetical  substrate  Sey  is  around  5  A,  clearly  too  far  to  make 
a  direct  interaction.  However  the  authors  still  speculate  on  the  ability  of  some 
residues  to  deprotonate  Cys364  enabling  it  to  perform  a  nucleophilic  attack  upon 
the  substrate.  Consideration  though  is  given  to  an  alternative  method  of  action  in 
which  the  cysteine  is  not  directly  involved  in  catalysis.  This  involves  a 
deprotonation  of  the  selenohydryl  group  and  subsequent  elimination  in  a  fashion 
similar  to  that  proposed  here  for  MGL.  The  residue  predicted  though  is  not 
His123  (analogous  to  Tyrl11  in  MGL1)  but  His55.  Additionally  there  has  been 
site-directed  mutagenesis  performed  upon  Cys364  (mutating  it  to  an  alanine) 
which  has  confirmed  a  role  for  the  residue  in  cysteine  but  not  selenocysteine 
degradation  (Fujii  et  al.,  2000).  Although  no  activity  data  has  been  shown  this 
seems  to  agree  with  the  loss  of  activity  toward  homocysteine  shown  in  MGL 
(McKie  et  a1.,  1998). 
The  crystal  structure  of  cystalysin  from  T.  denticola  (Krupka  et  al.,  2000)  is 
perhaps  the  most  promising  in  terms  of  hoping  to  learn  something  that  may  help  in 
the  analysis  of  the  mechanism  in  MGL.  It  catalyses  an  a,  ß-elimination  reaction, 
has  a  similar  overall  structure  and  an  analogous  residue  to  Tyrl  11  in  MGL 
(Tyr123  in  cystalysin).  Comparing  the  active  sites  though  reveals  no  analogous 
106 residue  to  Cys113  nor  Arg58,  both  of  which  are  implicated  in  the  action  of  MGL. 
A  very  similar  mechanism  to  that  of  CBL  and  MaIY  is  predicted  in  which  Lys238 
(analogous  to  Lys209  in  MGL)  first  deprotonates  the  Ca  and  then  protonates  the 
Sy  of  the  substrate  to  cause  y-elimination. 
3.3  DISCUSSION 
The  results  of  initial  crystallisation  screens  of  MGLI  were  promising  and  indicated 
that  it  was  likely  that  suitable  crystals  for  structure  determination  could  be  grown. 
Ultimately  however  these  results  proved  to  be  unhelpful  in  the  search  for  optimal 
growth  conditions.  The  results  of  DLS  although  indicating  a  polydisperse  solution 
of  enzyme  in  the  selected  buffer  also  proved  to  be  misleading  in  finally  growing 
large  crystals.  The  most  significant  factors  involved  in  growing  strongly 
diffracting,  large  crystals  was  the  preparation  of  enzyme  and  concentration  of 
AmmSO4  used  as  precipitate.  The  use  of  freshly  purified,  unfrozen,  recombinant 
enzyme  produced  crystals  but  this  ability  was  lost  if  the  enzyme  sample  was 
combined  with  glycerol  and  stored  at  -20  °C.  Although  no  apparent  loss  of  activity 
is  detectable  there  is  undoubtedly  a  detrimental  change,  a  feature  also  of  purified 
glutathione  S-transferases  in  this  laboratory  (R  Thom,  personal  communication). 
By  varying  the  AmmS04  concentration  by  100  mM  also  abolished  crystal 
formation,  2.4  M  produced  an  abundance  of  much  smaller  crystals  and  2.2  M 
failed  to  produce  any  crystals  at  all.  The  use  of  alternative  salts  to  Li2SO4  in 
crystallisation  was  not  investigated. 
107 After  apparent  optimisation  of  the  purification  to  prevent  even  the  minor 
contamination  that  previously  existed  it  was  highly  surprising  to  discover  a  second 
apparent  MGLI  species.  A  native  polyacrylamide  gel  stained  for  homocysteine 
desulphurase  activity  showed  two  bands  which  indicated  that  there  were  indeed 
two  MGLs.  The  fact  that  both  proteins  co-eluted  from  the  column  with  imidazole 
also  implied  that  they  were  both  histidine  tagged  MGL.  Contamination  of  the 
expression  culture  was  ruled  out  by  picking  a  single  colony  from  an  agar  plate  for 
use  in  each  expression  and  purification.  Proteolysis  was  unlikely  because  of  the 
presence  of  only  two  species  at  apparently  equal  concentrations  and  C-terminal 
degradation  could  be  ruled  out  because  of  both  proteins  ability  to  still  bind 
strongly  to  the  Ni-NTA  column.  What  seemed  most  likely  was  the  production  of 
two  forms  during  expression.  This  seemed  entirely  plausible  with  the  presence  of 
a  methionine  residue  at  position  6.  Why  lowering  the  concentration  of  IPTG 
added  to  the  cultures  should  reduce  the  amount  of  this  truncated  MGL1  is  not 
clear.  It  may  be  that  a  consequence  of  expressing  this  eukaryotic  gene  in  E.  coli 
is  the  recognition  of  the  2nd  methionine  as  a  transcriptional  start  codon  as  readily 
as  the  first:  -  The  cells  used  for  expression  of  MGL1  contain  an  additional  plasmid, 
pREP4,  which  encodes  additional  copies  of  the  lac  repressor  protein.  It  may  be 
that  high  concentrations  of  IPTG  are  enough  to  fully  dissociate  all  repressor 
proteins.,  --  Whereas  lower  concentrations  may  result  in  only  partial  derepression 
and,  for  an  unknown  reason,  produce  predominantly  the  full  length  transcript. 
Although  small  crystals  were  grown  of  MGL2  and  linear  screens  performed 
around  these  conditions,  with  and  without  the  use  of  propargyiglycine,  no 
substantial  improvements  could  be  made.  The  production  of  an  alternative 
108 expression  construct  was  also  unsuccessful  in  improving  upon  these  results.  At 
this  point  the  success  of  growing  large  well  diffracting  crystals  of  MGL1  and  the 
work  involved  in  solving  the  structure  lead  to  the  abandonment  of  any  further 
attempts  to  crystallise  MGL2. 
The  failure  to  crystallise  MGL2  was  mediated  by  the  success  with  MGL1  but  a 
good  deal  of  useful  information  could  have  been  gained  by  comparing  the  two 
structures:  Specifically,  in  examining  the  fine  detail  of  the  active  site  and 
correlating  this  with  the  small  but  measurable  differences  in  activity.  Given  more 
time  (and  less  success  in  crystallising  MGL1)  further  attempts  could  have  been 
made.  The  process  of  crystallisation  is  poorly  understood  at  least  in  terms  of 
being  able  to  predict  the  correct  conditions  required  or  the  reasons  for  success 
with  any  in  particular.  Searching  for  the  appropriate  recipe  in  a  largely  empirical 
manner  therefore  allows  for  an  almost  inexhaustible  number  of  variations.  For 
MGL2  the  next  logical  progression  could  have  been  temperature  variations,  a 
different  set  of  sparse-matrix  screens  (there  are  always  more  to  try)  and  variations 
in  protein  concentration  and  drop  size.  However,  using  the  small  crystals  already 
obtained  to  seed  other  drops  would  probably  be  the  first  course  to  follow.  The 
conclusion  is  clear  though,  although  it  is  impossible  to  predicted  how  to,  or  even 
whether  a  protein  will  crystallise,  there  remains  many  more  options  to  try  if 
required. 
The  results  of  refinement  confirm  the  observation  that  the  crystals  of  inhibitor 
complex  MGL1  diffracted  better  than  the  native  enzyme.  It  was  apparent  from 
comparing  the  diffraction  patterns  of  both  datasets  that  the  native  enzyme  crystals 
109 were  more  anisotropic  with  the  familiar  "rugby  ball"  pattern  of  reflections  much 
more  obvious.  The  maps  for  the  native  enzyme  were  always  inferior,  a  reflection 
of  the  lower  redundancy  in  the  data  despite  being  apparently  more  complete  in 
the  highest  resolution  shell.  It  is  possible  that  the  better  data  for  the  inhibitor 
complex  is  a  result  of  the  enzyme  being  held  in  a  fixed  conformation.  The 
variation  in  B-factors  for  the  two  structures  gives  further  support  to  this  theory. 
The  structure  of  MGL  confirms  its  relationship  to  CBL  and  CGS  in  the  postulated  y 
-family  of  PLP-dependent  enzymes  (Alexander  et  al.,  1994).  The  secondary 
structure  elements  in  the  two  largest  domains  are  very  similar  and  the  N-terminal 
domain  in  the  three  enzymes  plays  a  comparable  role  in  subunit  interactions. 
Despite  this,  although  residues  Tyr56  and  Arg58  are  conserved  in  these  enzymes 
the  short  N-terminal  region  shows  considerable  sequence  variability. 
The  attraction  of  finding  a  change  in  the  structure  resulting  from  disulphide 
formation  is  the  generation  of  a  negative  feedback  scenario.  It  is  possible  to 
imagine  a  situation  in  which  the  lack  of  products  from  the  enzyme  mechanism 
leads  to  inactive  enzyme  (via  the  disulphide  bridge).  This  is because  a  possible 
role  for  MGL  in  vivo  may  be  in  the  production  of  sulphide  for  cysteine  formation  by 
direct  sulphydration  or  as  an  alternative  to  the  reverse  transulphuration  pathway 
in  converting  methionine  and  homocysteine  to  cysteine.  Thus  inactivation  of  MGL 
leads  to  lower  cellular  cysteine  levels  because  of  insufficient  sulphide  which  in 
turn  leads  to  increased  transcription  and  translation  of  the  mgl  genes.  The 
possible  roles  that  MGL  may  play  in  vivo  will  be  discussed  in  the  final  chapter  of 
this  thesis. 
110 It  has  been  reported  that  there  is  an  asymmetry  of  the  B-factors  in  residues  in  the 
entrance  to  the  active  sites  of  CGS  (Clausen  et  al.,  1998).  This  is  said  to  show 
evidence  of  non-equivalency  in  the  active  sites  and  supports  the  evidence  from 
other  studies  on  mechanism-based  inactivators  (Abeles  and  Walsh,  1973; 
Silverman  and  Abeles,  1977;  Johnston  et  al.,  1979).  The  structure  of  MGLI  does 
not  exhibit  this  variation  in  B-factors  but  there  are  subtle  differences  between 
monomers  in  the  catalytic  dimer.  Although  small  the  differences  in  arrangements 
of  Tyrl  11,  Cys113,  Lys238  and  Asp239  in  the  holoenzyme  structure  point  to  the 
possible  existence  of  non-equivalent  active  sites. 
The  covalent  bond  between  Tyrl  11  and  propargyiglycine  confirms  the  previous 
biochemical  evidence,  that  inhibition  was  caused  by  binding  to  an  active  site 
cysteine  or  tyrosine  (Johnston  et  al.,  1979).  It  may  have  been  thought  however 
that  Cys113  was  the  probable  target  in  MGL1  based  on  the  mutagenesis 
evidence.  Even  without  the  inhibitor  complex  structure  it  would  be  easily  seen 
now  that  this  cannot  be  the  case  and  the  positioning  of  Cys113  precludes  any 
direct  interaction  with  either  mechanism-based  inhibitor  or  substrate. 
The  main  disagreement  between  the  mechanism  postulated  for  MGL  and  that  for 
CBL,  CGS  and  cystalysin  is  the  action  of  Lys209.  In  MGL1  we  believe  that  the 
residue  is  positioned  poorly  for  interaction  at  the  substrate  ß  or  y  position  and  that 
Tyrl  11  is  more  likely  to  fulfill  this  role.  Cys113  has  been  confirmed  as  playing  no 
direct  role  in  catalysis.  Both  Tyrl  11  and  Lys209  are  conserved  in  MGL,  CBL  and 
CGS  sequences  and  are  likely  to  have  essential  roles.  The  next  chapter  in  this 
111 thesis  details  the  investigation  into  the  catalytic  mechanism  of  MGL  and  attempts 
to  define  key  residues  and  their  roles. 
...,  . 
112 CHAPTER  4.  SITE-DIRECTED  MUTAGENESIS  OF  MGLI 
AND  SEQUENCE  ANALYSIS  OF MGL  ENZYMES 
4.1  INTRODUCTION 
The  structure  of  MGLI  presented  in  chapter  3  allows  us  to  postulate  roles  for 
individual  residues  both  in  the  physical  structure  of  the  enzyme  and  also  in 
catalysis.  Taking  into  account  this,  in  conjunction  with  published  data  on  PLP- 
dependent  enzymes  in  general  and  MGL  specifically,  facilitated  the  proposal  of  a 
catalytic  mechanism  for  MGL.  In  this,  we  have  putatively  identified  residues 
responsible  for  the  substrate  specificity  of  the  enzyme  and  involved  directly  in 
catalysis.  To  test  these  hypotheses,  site-directed  mutagenesis  (SDM)  was  carried 
out  to  obtain  modified  proteins  for  analysis.  The  results  are  presented  in  this 
chapter.  In  addition,  the  primary  amino  acid  sequences  of  MGLs  were  compared 
to  provide  more  information  on  apparent  key  residues  and  aid  in  the  identification 
of  the  enzyme  in  various  organisms. 
Site-directed  mutagenesis  had  been  used  previously  on  T.  vaginalis  MGL  to 
identify  a  role  in  catalysis  for  Cysl  13  (Cyst  16  in  MGL2)  (McKie  et  al.,  1998).  This 
showed  that  the  residue  was  important  for  activity,  but  not  essential.  Chemical 
modification,  and  random  mutagenesis  of  the  gene  were  techniques  that  could 
have  been  used  to  extend  this  study,  but  it  was  decided  that  a  targeted  approach 
was  more  appropriate.  Mutagenesis  is  a  powerful  tool  for  determining  the  role  of 
functional  groups  in  proteins  and  has  been  extensively  used  in  a  variety  of  PLP- 
dependent  enzymes.  For  example,  it  has  been  used  to  show  the  essential  role  of 
113 the  active  site  lysine  residue,  which  forms  the  Schiff  base  with  the  cofactor  and 
has  a  role  in  catalysis  (Rege  et  aL,  1996;  Hunter  and  Ferreira,  1999).  There  are 
also  a  large  number  of  mutants  for  which  the  structures  have  been  solved  and  are 
now  deposited  in  the  protein  structure  database.  The  structures  have  highlighted 
a  consideration  when  mutating  residues  within  a  protein,  what  effect  may  the 
change  have  upon  the  overall  structure?  It  would  therefore  be  ideal  to 
accompany  enzymatic  data  on  mutant  enzymes  with  structural  data.  Attempts  to 
obtain  the  structures  of  mutants  produced  in  this  study  are  also  detailed  here. 
4.1.1  Site-Directed  Mutagenesis  of  MGLI 
The  decision  on  which  residues  to  perform  mutagenesis  upon  was  based 
predominantly  on  the  structure  of  MGL1  presented  in  chapter  3.  It  had  been 
envisaged  that  if  the  structural  studies  had  been  delayed  that  these  decisions 
would  have  been  based  upon  sequence  analysis  and  comparisons  with  other 
related  enzymes.  This  would  have  been  less  desirable  not  only  because  of  the 
difficulty  in  identifying  key  targets  but  also  because  of  the  difficulty  in  interpreting 
results  based  solely  upon  in  vitro  assay  data.  The  proposed  roles  of  the  residues 
selected  were  discussed  in  chapter  3,  but  mutations  planned  are  listed  and 
explained  here  as  they  form  a  central  part  of  this  chapter. 
4.1.2  Residues  Selected  for  Mutagenesis 
The  residues  selected  for  mutagenesis  and  the  changes  introduced  are  listed  in 
Table  4.1: 
114 Original  Residue  Proposed  Role  Mutant 
Arg58  Cofactor  binding  and  catalysis  Met  &  Lys 
Leu59  Substrate  access  Phe 
Tyrl  11  Cofactor  binding  and  catalysis  Phe 
Cysl13  Indirectly  in  catalysis  Pro  &  Ser 
Lys209  Cofactor  binding  and  catalysis  Ser 
Lys238  Catalysis  Ala 
Table  4.1  Residues  selected  for  site-directed  mutagenesis  and  their  predicted  roles. 
4.1.2.1  Arginine  58 
A  primary  function  of  Arg58  appears  to  be  the  coordination  of  the  PLP  cofactor  in 
the  active  site.  Together  with  Tyr56  it  belongs  to  the  opposite  chain  of  the 
catalytic  dimer  when  compared  with  the  other  residues  that  directly  interact  with 
the  cofactor.  As  can  be  seen  in  figure  3.15  in  the  previous  chapter,  Arg58  is 
within  hydrogen  bond  distance  of  0P2  and  0P3  of  the  cofactor  and  also  3.1  A 
from  the  side  chain  hydroxyl  of  Tyr111  in  the  holoenzyme  and  inhibitor  complex. 
With  the  proposed  role  in  catalysis  of  Tyrl  11  reliant  upon  its  deprotonation,  Arg  58 
seemed  well  positioned  to  modify  the  pKa  of  Tyrl  11  together  with  a  role  in 
positioning  the  cofactor.  It  was  envisaged  that  substituting  methionine  would 
retain  the  architecture  of  the  active  site  because  of  its  similar  size,  but  would 
remove  the  charge  interactions.  Lysine  was  also  selected  as  a  means  of  partially 
removing  the  positive  charge.  It  was  hoped  that  this  would  bind  the  cofactor 
adequately  but  be  less  effective  in  deprotonating  the  Tyrl  11  hydroxyl  group. 
115 4.1.2.2  Leucine  59 
This  residue  is  not  implicated  in  the  catalytic  mechanism  at  all  but  it  is  in  the 
entrance  to  the  active  site.  It  was  envisaged  that  the  substrate  preference  of  the 
enzyme  could  be  altered  by  manipulating  the  size  of  this  entrance.  By 
substituting  a  bulkier  residue,  the  enzyme  activity  toward  larger  compounds  such 
as  S-adenosyl-L-methionine,  which  had  previously  been  reported  as  substrate 
(Lockwood  and  Coombs,  1991  b),  may  be  reduced.  The  decision  was  taken  to 
mutate  this  residue  to  a  phenylalanine,  a  substitution  that  would  place  the  large 
phenyl  ring  of  the  side  chain  directly  into  the  "channel". The  prediction  was  that 
the  smaller  molecules,  e.  g.  L-cysteine,  would  be  the  best  substrates. 
4.1.2.3  Tyrosine  111- 
The  catalytic  mechanism  for  MGL'proposed  in  this  study  predicts  a  critical  role  for 
this  residue.  After  a  proton  abstraction  by  Lys209  at  the  substrate  Ca,  the  ß  or  y- 
elimination  is  catalysed  by  the  nucleophilic  attack  from  Tyrl  11.  The  phenol  ring 
of  Tyrl  11  also  coordinates  the  pyridine  ring  of  the  cofactor,  holding  it 
approximately  parallel  by  van  der  Waals  interactions.  This  interaction  by  an 
aromatic  group,  alternatively  substituted  for  by  phenylalanine  or  histidine  in  other 
PLP-dependent  enzymes,  increases  the  electron  sink  character  of  the  cofactor 
(Hayashi  et  al.,  1990).  The  inhibitor  complex  structure  also  shows  that  the 
hydroxyl  group  of  this  residue  is  unequivocally  targeted  by  propargylglycine  in  its 
action  as  a  suicide  inhibitor.  Changing  this  residue  to  any  other  would  be 
expected  to  greatly  curtail  catalytic  activity,  or  remove  it  completely,  and  also 
prevent  covalent  attachment  of  propargylglycine  and  its  action  as  a  suicide 
inhibitor.  The  most  reasonable  change  would  be  to  histidine  or  phenylalanine, 
116 thereby  removing  the  active  hydroxyl  group  but  retaining  the  aromatic  ring. 
Another  possible  change  would  be  to  alanine  and  then  subsequently  attempting  to 
rescue  any  lost  activity  with  phenol.  Phenylalanine  was  selected  for  this  study  as 
the  residue  most  likely  to  retain  the  structure  of  the  enzyme  whilst  removing  the 
active  group  and  so  allowing  the  testing  of  our  hypothesis. 
4.1.2.4  Cysteine  113 
The  possible  role  of  Cys113  in  the  enzyme  mechanism  is  one  of  the  most 
interesting  features.  Previous  mutagenesis  and  chemical  modifications  have 
shown  that  the  thiol  group  is  important  and  its  loss  has  a  detrimental  affect  upon 
the  catalytic  activity  (Nakayama  et  al.,  1988a;  McKie  et  al.,  1998).  It  was 
something  of  a  surprise  therefore  to  find  in  the  MGL1  structure  that  the  residue 
was  too  distant  from  the  presumed  position  of  the  substrate  to  be  directly  involved 
in  catalysis.  Neither  does  the  cysteine  appear  to  coordinate  the  cofactor.  There 
are  several  possible  reasons  for  the  drop  in  activity  seen  upon  modification  of  this 
residue: 
1/  Chemical  modification  may  partially  block  access  to  the  catalytic  centre  of  the 
active  site; 
2/  A  cysteine  to  glycine  change  would  allow  Tyrl  11  (only  two  residues  away)  to 
move  a  significant  distance  from  the  optimal  position  for  its  proposed  role  in  a 
nucleophilic  attack  upon  the  substrate; 
3/  A  non-catalytic  interaction  between  the  thiol  group  of  Cysl  13  and  the  substrate 
is  lost. 
117 Through  mutagenesis  it  was  intended  to  substitute  a  serine  which  would  maintain 
all  steric  conditions  (with  the  exception  of  the  Sy  being  larger  than  the 
corresponding  Oy)  but  remove  the  thiol  group.  It  was  also  chosen  to  mutate 
Cys113  to  a  proline.  This  was  selected  to  mimic  the  active  site  structure  of  CBL. 
4.1.2.5  Lysine  209 
An  essential  lysine  residue  analogous  to  Lys209  in  MGL  is  present  in  all  PLP- 
dependent  enzymes  studied  so  far.  It  is  via  the  side  chain  amine  group  that  the 
Schiff  base  linkage  is  formed  between  cofactor  and  enzyme  (the  so  called 
"internal  aldimine"  (Christen  and  Metzler,  1985)).  The  binding  of  substrate, 
release  of  products  and  regeneration  of  the  starting  complex  is  catalysed  by  this 
residue.  Where  substrates  are  amino  acids,  it  catalyses  a  deprotonation  at  the 
Ca.  "  It  was  envisaged  that  a  mutant  MGLI  lacking  this  residue  would  be  inactive 
and  this  would  confirm  its  essential  role  in  catalysis.  More  importantly,  perhaps  it 
would  then  allow  enzyme  substrate-complexes  to  be  produced  and  their 
structures  determined.  This  would  allow  examination  of  the  binding  of  different 
substrates  and  identify  reasons  for  differences  in  specific  activities.  The 
substitution  chosen  was  serine,  although  it  could  have  equally  been  another  non- 
charged,  non-aromatic  residue  such  as  alanine  or  methionine. 
4.1.2.6  Lysine  238 
The  reason  for  mutating  this  amino  acid  was  related  to  the  desire  to  discover  the 
role  of  Cys113  in  the  enzyme  mechanism.  The  method  of  catalysis  postulated 
from  the  crystal  structures  implies  that  the  Sy  of  Cys113  is  ionised  and  Lys238*  in 
118  . combination  with  Asp239*  may  be  required  to  produce  this.  Thus  the  hope  was 
that  mutating  Lys238  may  prevent  this  ionisation  and  so  the  activity  would  fall  to  a 
level  reflecting  the  contribution  of  the  cysteine  alone.  This  possibly  being  similar 
to  that  measured  in  the  MGL1(c"3G)  mutant.  Lys238  is  also  located  in  the  channel 
leading  to  the  cofactor,  but  makes  no  direct  interactions  with  the  adjacent 
monomer.  Thus  any  change  would  not  be  predicted  to  interfere  with  subunit 
association  as  water  would  fill  any  spaces  left  by  the  missing  side  chain.  To  fulfill 
the  aims  for  this  mutation,  alanine  was  chosen  as  the  alternative  residue.  It  is 
small,  non-polar  and  would  allow  water  to  enter  into  any  empty  space  and  so  be 
unlikely  to  distort  the  structure. 
4.2  RESULTS 
4.2.1  Site-Directed  Mutagenesis  of  MGLI 
This  section  of  this  study  details  the  results  of  construction,  production  and 
analysis  of  mutant  recombinant  MGL1  enzymes. 
SDM  was  carried  out  using  the  QuickchangeTm  kit  (Stratagene)  as  detailed  in 
section  2.2.15.  An  overview  of  the  technique  is  shown  in  figure  4.1.  The  design 
of  complementary  mismatched  oligonucleotide  primers  followed  the  guidelines  in 
the  manufacturers  protocol  and  are  listed  in  section  2.2.12. 
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Figure  4.1:  Overview  of  site-directed  mutagenesis.  I-  Isolate  plasmid  with  gene  target  for 
mutagenesis;  II  -  Denature  plasmid  and  anneal  complementary  oligonucleotide  primers  containing 
the  desired  mutation;  III  -  Extend  both  DNA  strands  using  thermostable  proof-reading  DNA 
polymerase,  incorporating  mutagenic  oligonucleotide  primer.  Repeat  steps  II  and  III  for  20-25 
cycles.  IV  -  Incubate  amplification  products  with  Dpnl  restriction  enzyme  to  cleave  parental 
methylated  DNA  template.  Leaves  only  mutated,  circular  nicked  plasmid;  V-  Transform  mutated 
plasmid  into  E.  coli  where  cellular  machinery  repairs  nicks  and  produces  intact  circular  plasmid. 
Transformation  of  competent  E.  coli  with  the  products  from  the  mutagenesis 
reactions  gave  a  varied  number  of  colonies,  from  less  than  ten  to  more  than 
120 several  hundred.  In  the  first  instance  three  colonies  from  each  plate  were  picked 
and  grown  up  overnight  for  mini-prep  plasmid  purification.  Successful  production 
of  mutants  L59F,  R58K  and  R58M  was  selected  for  by  restriction  digest  and  then 
confirmed  by  DNA  sequencing.  For  all  other  mutants,  DNA  sequencing  alone  was 
used  to  identify  positive  mutations.  These  three  mutants  however,  resulted  in  the 
same  change  to  the  restriction  map  of  the  plasmid  by  destroying  a  BsmAI 
recognition  site.  The  changes  are  listed  in  Table  4.2. 
Mutant  Sequence 
Parental  Plasmid  TACACACGTCTCGGCAAC 
ATGTGTGCAGAGCCGTTG 
YTRLGN 
R58K  TACACAAAGCTCGGCAAC 
ATGTGTTTCGAGCCGTTG 
YTKLGN 
R58M  TACACAATGCTCGGCAAC 
ATGTGTTACGAGCCGTTG 
YTMLGN 
L59F  TACACACGTTTCGGCAAC 
ATGTGTGCAAAGCCGTTG 
YTRFGN 
Table  4.2:  Sites  of  mutagenesis  of  MGL1  R58K,  R58M  and  L59F  mutants.  The  BsmAl  restriction 
site  is  marked  in  bold  text  in  the  parental  plasmid  template  sequence.  Changes  made  to  nucleotide 
and  amino  acid  sequences  are  highlighted  in  red  in  the  mutants. 
Several  mutations  were  successfully  isolated  and  identified  rapidly  but, 
surprisingly,  sequencing  showed  a  number  of  unexpected  non-positive  mutation 
results.  These  were  in  addition  to  the  expected  levels  of  negative  clone 
background  which  results  from  template  plasmid  being  uncut  by  Dpnl  and 
transformed.  There  were  also  a  number  of  clones  which  were  mutated  but  did  not 
encode  the  specific  mutations  designed  into  the  oligonucleotide  primers.  The 
121 strategy  used  to  produce  the  mutants  ensures  that  the  site  of  mutagenesis  and 
the  upstream  and  downstream  flanking  sequence  is  defined  by  the  oligonucleotide 
primers.  Thus  it  was  very  surprising  to  have  a  number  of  mutants  which  encoded 
changes  within  these  areas  not  designed  into  the  primers.  This  problem  was  most 
evident  in  the  designed  Tyrl  11  to  Phe  and  Cys113  to  Ser  mutations.  A  positive 
MGL1  O'"'F)  mutant  was  isolated  only  after  sequencing  twelve  transformants. 
MGL1(c"3s)  was  difficult  to  synthesise  for  an  unknown  reason  and  resulted  in  the 
lowest  number  of  transformants.  After  repeating  the  mutagenesis  and 
transformation  step  and  obtaining  no  positive  clones,  this  mutant  was  abandoned 
as  there  had  by  then  been  success  in  producing  seven  other  mutants. 
4.2.2  Expression  and  Purification  of  Mutants 
Confirmed  mutants  were  transformed  into  E.  co/i  strain  M15  pREP4,  for 
expression  in  an  identical  fashion  to  the  parental  plasmid.  Successful 
transformants  were  selected  by  growing  on  LB,  ￿f,,  agar  plates.  Single  colonies 
were  used  to  prepare  an  overnight  starter  culture  and  expression  and  purification 
were  performed  identically  to  that  already  detailed  for  unmutated  MGL1.  All 
mutants  were  produced  as  soluble  enzyme  and  the  recombinant  proteins  were 
isolated  to  a  similar  purity  as  the  parent  MGL1. 
122 4.2.3  Enzyme  Assays 
This  section  of  the  thesis  describes  the  data  obtained  from  the  enzymatic  analysis 
of  the  site-directed  mutants  produced  of  MGL1.  There  are  three  previously  used 
and  published  assays  for  MGL: 
1/  a  stopped  assay  to  detect  a-keto  acid  production, 
2/  a  continuous,  coupled  assay  measuring  the  production  of  a-keto  acid, 
3/  a  continuous  assay  measuring  the  production  of  hydrogen  sulphide. 
The  results  and  problems  from  each  of  these  will  be  dealt  with  in  turn. 
4.2.3.1  Results  of  Stopped  Assay  Using  Methylbenzoylthiolhydrazone 
(MBTH)  to  Determine  a-Keto  Acid  Production 
This  detection  of  a-keto  acid  products  is  from  a  published  method  (Soda,  1968). 
It  relies  upon  the  reaction  of  MBTH  specifically  with  the  a-keto  acids  to  produce 
an  azine  which  has  a  measurable  absorbance  at  a  wavelength  of  320  nm.  The  in 
vitro  assay  is  thus  incubation  of  enzyme  with  substrate  followed  by  termination  of 
the  reaction  and  finally  reaction  of  the  products  with  MBTH.  Calibration  is  by  a 
standard  curve  produced  using  commercially  available  a-ketobutyrate. 
The  previously  used  conditions  were  a  total  reaction  volume  of  I  ml,  100  mM 
buffer  with  varying  levels  of  substrate  and  enzyme  maintained  at  37  °C  for  5 
minutes.  The  assay  was  stopped  by  the  addition  of  125  µl  of  12.5%  (w/v) 
trichloroacetic  acid  (TCA)  and  the  sample  centrifuged  to  remove  precipitates.  1  ml 
of  this  was  then  added  to  1  ml  of  1M  acetate  buffer  pH  5.0  and  0.4  ml  0.1  % 
123 MBTH  and  heated  at  65  °C  for  30  minutes  before  measuring  the  absorbance  at 
320  nm.  The  high  concentrations  of  acetate  buffer  were  used  to  neutralise  the 
effects  of  the  TCA  used  in  stopping  the  assay  and  maintaining  an  optimum  pH  for 
the  reaction  of  MBTH  with  a-keto  acids. 
It  was  observed  initially  that  the  results  from  the  assays  were  quite  variable 
between  replicates  and  also  on  any  given  date.  These  observations  also  included 
the  apparent  detection  of  activity  towards  compounds  not  shown  previously  to  be 
substrates  of  MGL1.  This  was  thought  to  be  highly  significant  at  first,  until  it 
became  apparent  that  the  results  were  not  repeatable  and  then  the  accuracy  of 
the  assay  came  under  question.  These  apparent  errors  and  uncertainties  were 
compounded  by  the  low  catalytic  activities  exhibited  by  the  MGL1  mutants. 
To  obtain  more  reliable  data,  the  components  of  the  assay  were  investigated 
further.  The  most  surprising  finding  was  that  the  MBTH  reagent  reacted  strongly 
with  the  acetate  buffer  giving  high  absorbance  readings  around  305-325  nm.  This 
caused  obvious  concerns  as  the  reaction  was  thought  to  be  specific  for  a-keto 
acids.  Evidently  acetate  (CH3COOH)  was  able  to  cross  react  strongly  and  there 
was  concern  that  the  TCA  used  to  halt  the  assay  and  even  the  carboxylate  group 
of  the  substrate  could  also  react.  Investigations  with  a  number  of  different  acids 
showed  varying  degrees  of  reactivity  and  whilst  the  absorbance  peaks  were  not 
precisely  at  320  nm  there  was  a  high  level  of  absorbance  at  this  wavelength. 
The  decision  was  therefore  taken  at  this  point  to  not  use  this  assay  system  further 
but  to  utilise  one  of  the  other  assays  available  to  us. 
124 4.2.3.2  Continuous  Coupled  Assays  Detecting  a-Keto  Acids 
An  alternative  assay  system  previously  used  to  study  MGL  has  used  lactate 
dehydrogenase  (LDH)  as  a  coupling  enzyme  to  monitor  the  production  of  pyruvate 
from  L-cysteine  and  0-acetyl-L-serine  (McKie,  1997).  The  conversion  of  NADH  to 
NAD+  by  the  enzyme  as  pyruvate  is  catabolised  is  measured  continuously  at  340 
nm.  Several  isoforms  of  LDH  are  expressed  in  cells  with  differing  substrate 
specificities.  The  enzymes  are  not  totally  specific  for  pyruvate  but  also  act  upon 
larger  a-keto  acids  including  a-ketobutyrate.  It  was  hoped  that  this  could  then  be 
used  to  detect  ay-  in  addition  to  aß-elimination  reactions  by  MGL. 
Assays  were  attempted  in  an  identical  manner  to  that  already  published  for  MGL. 
Unfortunately  it  was  not  possible  to  obtain  reliable  data  for  any  of  the  mutants  with 
this  assay.  In  control  reactions  using  pyruvate,  the  LDH  enzyme  was  shown  to  be 
active.  The  activity  of  mutant  MGL1  was  also  confirmed  using  the  1-12S  trapping 
assay  detailed  in  the  next  section  of  this  chapter.  However  the  activity  of  these 
enzymes  could  not  be  coupled  to  the  action  of  LDH.  Because  both  enzymes 
exhibited  activity  separately  it  is  assumed  that  the  lack  of  success  was  due  to  the 
very  low  levels  of  a-keto  acids  produced. 
The  decision  was  then  taken  not  to  pursue  the  reasons  for  the  failure  of  this 
assay  but  instead  to  use  the  H2S  trapping  assay. 
125 4.2.3.3  Hydrogen  Sulphide  Trapping  Assays 
These  assays  were  performed  as  previously  described  for  homocysteine 
desulphurase  (Thong  and  Coombs,  1985b).  This  continuous  assay  utilises  the 
reaction  of  hydrogen  sulphide  with  lead  acetate  which  forms  lead  sulphide.  The 
lead  sulphide  forms  a  brown  precipitate  which  in  the  timespan  of  the  assay 
remains  in  suspension  and  can  be  measured  at  a  wavelength  of  360  nm. 
Hydrogen  sulphide  is  one  of  the  products  of  the  ay-elimination  of  homocysteine 
and  ap-elimination  of  cysteine.  Thus  this  assay  was  used  for  measuring  activity 
of  MGL1  mutants  on  these  substrates.  It  is  also  used  in  detecting  activity  in 
native  PAGE  (Thong  and  Coombs,  1987).  Enzyme  resolved  on  a  gel  can  then  be 
visualised  by  incubating  in  a  solution  containing  cysteine  or  homocysteine  and 
lead  acetate.  The  action  of  the  enzyme  causes  the  lead  sulphide  precipitate  to 
accumulate  in  a  band  denoting  the  position  of  the  enzyme  in  the  gel. 
4.2.4  Analysis  of  Mutated  MGLI  Activities 
4.2.4.1  MGLI  Arg58  Mutants 
The  results  of  mutating  Arg58  to  lysine  or  methionine  could  not  be  predicted  with 
confidence.  The  residue  is  strictly  conserved  in  other  y-family  PLP-dependent 
enzymes  but  a  role  in  catalysis,  although  proposed  from  the  structure  of  MGLI, 
was  not  definitely  established. 
Both  mutants  (R58K  and  R58M)  were  overexpressed  successfully  in  E.  coli 
although  neither  were  yellow  in  solution  as  seen  for  MGL1.  This  presented  no 
126 problems  in  purification  though  and  highly  homogenous  preparations  were 
produced. 
Neither  mutant  exhibited  normal  Michaelis-Menten  behaviour  and,  in  fact,  it  was 
difficult  initially  to  detect  any  activity  at  all  for  either  enzyme.  Activity  was  finally 
only  seen  at  or  below  certain  concentrations  of  substrate.  These  values  were 
dependent  upon  the  amount  of  enzyme  being  used  and  indicated  likely  substrate 
inhibition.  When  detectable,  both  enzymes  exhibited  high  levels  of  activity  at  very 
low  levels  of  substrate.  By  increasing  the  substrate  concentration  whilst 
maintaining  the  same  amounts  of  enzyme,  the  linear  rate  observed  would 
increase  until  a  substrate  concentration  was  reached  when  no  activity  was 
detectable.  With  normal  substrate  inhibition  the  activity  would  be  expected  to 
decrease  more  gradually.  What  was  observed  however,  was  an  intermediate 
concentration  where  a  lag  phase  of  several  minutes  lasted  until  rapid  linear 
activity  was  measured  until  the  substrate  was  exhausted.  An  example  of  the 
differences  between  the  two  situations  is  given  below  in  figure  4.2. 
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Figure  42:  Spectrophotometer  traces  of  MGL1  (RmK)  assays.  I-  DL-homocysteine  concentration  of 
2.5  mM;  II  -  DL-homocysteine  concentration  of  5  mM.  X-A,  ds  denotes  time  of  reaction  in  minutes.  Y- 
Ads  denotes  change  in  absorbance  measured  at  360  nm  from  approximately  0  to  1.0  absorbance 
units.  Both  assays  gave  approximately  equal  upper  limits  of  absorbance,  no  scaling  has  been 
applied  to  the  outputs. 
The  narrow  "window"  of  substrate  concentrations  required  for  activity  made  it 
difficult  to  make  estimates  for  Km  and  Vmax  values.  This  was  also  compounded 
by  the  difficulty  to  accurately  measure  an  initial  rate  because  of  the  rapid 
depletion  of  substrate.  Neither  enzyme  appeared  to  be  exhibiting  Michaelis- 
Menten  kinetics  and  so  attempts  to  define  Km  and  Vmax  values  were  not 
attempted. 
Compounding  problems  in  assaying  MGL1  «  was  the  change  in  pH  profile  and 
buffer  preferences  of  the  mutant  enzyme.  Activity  was  measurable  between  pH 
128 4.3  and  5.6  with  acetate  buffer  and  similar  ones  such  as  formate  and  succinate. 
However  no  activity  was  seen  with  buffers  such  as  citrate,  pthalate  or  imidazole  at 
these  pHs.  The  concentration  of  acetate  buffers  also  had  a  critical  effect  on 
activity.  At  concentrations  of  50  mM  there  was  no  lag  in  absorbance  increase  but 
at  higher  concentrations  of  buffer  and  the  same  concentrations  of  substrate  and 
enzyme  there  was  a  distinct  lag.  This  lag  lengthened  as  the  buffer  concentration 
increased  until  no  activity  was  detected  at  all  at  concentrations  greater  than  200 
mM.  The  rates  measured  after  these  lags  were  also  lower  than  those  with  no  lag. 
It  therefore  seemed  possible  that  acetate  was  acting  as  an  activator  at  low 
concentrations  and  an  inhibitor  at  high  concentrations.  This  idea  had  to  be 
discarded  when  it  was  found  that  equally  high  activity  with  no  lag  phase  was 
measured  using  the  sulphonic  acid  buffer  MES.  Although  MGL1(R58M)  showed  a 
similar  substrate  inhibition  profile  as  MGL1(R58"),  it  did  not  exhibit  this  strange 
buffer  activation/inhibition  and  was  highly  active  at  pH  6.5  in  100  mM  imidazole. 
Due  to  the  difficulties  in  interpreting  data  from  these  mutants  further  investigations 
into  the  pH  profile  was  not  conducted. 
Estimations  of  specific  activity  for  both  mutants  with  DL-homocysteine  were  made. 
The  assay  conditions  are  probably  sub-optimal  though  and  the  true  values  may  be 
higher. 
129 Mutant  Specific  Activity 
(µmol/min/mg  protein) 
R58K  308  ±  28  (9) 
R58M  187  ±  22  (5) 
Table  4.3:  Estimated  specific  activities  for  MGL1(RSp  and  (R")  with  DL-homocysteine.  Activities 
given  are  means  :tS.  D.  with  the  number  of  experiments  given  in  parenthesis. 
4.2.4.2  MGLI  L59F  Mutant 
This  mutant  exhibited  the  typical  expression  and  purification  profile  seen  for 
parent  MGL1.  The  recombinant  enzyme  was  coloured  yellow,  clearly  seen 
binding  to  the  column  and  after  elution,  and  similar  quantities  of  enzyme  were 
purified  ('  10-15  mg  of  purified  enzyme  per  litre  of  culture). 
Unlike  MGL1  «  and  M),  there  was  no  immediate  problem  in  performing 
assays  for  this  mutant.  Firstly  the  enzyme  was  assayed  with  a  range  of  buffers  at 
varying  pH  values  to  find  optimal  conditions  for  calculating  activities.  A  broad 
screen  of  pH  values  showed  higher  activity  for  the  enzyme  at  pH  values  above 
that  optimal  for  MGL1.  The  enzyme  was  then  assayed  in  a  variety  of  buffers 
above  pH  7.0,  in  0.2  pH  unit  increments,  using  sodium  phosphate,  TRIS  and 
HEPES  (data  not  shown).  The  results  showed  an  optimum  activity  in  100  mM 
sodium  phosphate  pH  8.0  and  so  this  was  used  for  all  further  assays  with  this 
mutant.  This  determination  of  pH  and  buffer  optimums  was  carried  out  for  all 
mutants  prior  to  attempting  to  calculate  rate  constants  and  specific  activities. 
130 To  examine  the  kinetic  properties  of  the  mutant  enzyme,  a  fixed  amount  of 
enzyme  was  assayed  with  varying  concentrations  of  DL-homocysteine.  The 
results  of  these  assays  are  shown  in  figure  4.3. 
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Figure  4.3:  MGL1(L59F)  reaction  rate  with  DL-homocysteine.  Data  points  are  mean  values,  error  bars 
are  S.  D.  with  n=3. 
A  plot  such  as  this  typically  indicates  substrate  inhibition  at  high  concentrations 
but  can  also  be  caused  by  other  conditions  such  as  the  assay  conditions  being 
altered.  The  solution  was  checked  to  ensure  the  pH  of  the  assay  had  not 
changed  before  or  after  the  reaction.  There  was  no  evidence  that  this  had 
occurred.  Plotting  the  data  obtained  at  substrate  concentrations  up  to  25  mM 
shows  a  clear  hyperbolic  relationship  between  reaction  rate  and  substrate 
concentration  (figure  4.4). 
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Figure  4.4:  Saturation  curve  of  MGL1  (L59F)  with  DL-homocysteine  up  to  25  mM.  Data  points  are 
mean  values,  error  bars  are  S.  D.  with  n=3. 
A  Hanes  plot  was  then  constructed  to  calculate  Km  and  Vmax.  Unfortunately  this 
leaves  only  a  few  data  points  but  these  are  enough  to  produce  what  appears  to  be 
a  good  linear  plot  (figure  4.5). 
132 
0.0  5.0  10.0  15.0  20.0  25.0 14 
12 
lol 
C, 
C 
8 
06 
0 
4 
J 
0 
2i 
o 
0  2468  10  12  14 
[DL-homocysteine]  (mM) 
16  18  20 
Figure  4.5:  Hanes  plot  of  homocysteine  catabolism  by  MGL1(L59F) 
This  Hanes  plot  produces  a  plot  of  [s]/v  against  [s]  which  is  linear  with  a  slope  of 
1Nmax  and  an  x-axis  intercept  of  -Km.  Knowing  these  values  we  can  then  go  on 
to  calculate  the  specific  activity  of  the  enzyme  with  a  good  estimate  of  the  Km: 
Specific  Activity  (Etmol/min/mg  protein)  8.26  (±  1.18) 
Km  (mM)  3.7 
Vmax  (pmol/min/mg  protein)  2.0 
kcat  (S)  1.5 
kcat/Km  (M  S)  400 
Table  4.4:  Kinetic  data  for  MGL1(L59F)  with  DL-homocysteine  as  substrate.  Numbers  in  parenthesis 
are  S.  D.  with  n=5. 
133 An  identical  process  was  carried  out  with  L-cysteine  as  that  detailed  above  for  DL- 
homocysteine,  with  the  exception  of  determining  a  pH  optimum.  A  fixed  quantity 
of  enzyme  was  assayed  with  varying  concentrations  of  L-cysteine.  A  plot  of  the 
results  is  shown  below  in  figure  4.6. 
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Figure  4.6:  MGL1(L59F)  reaction  rate  with  L-cysteine.  Data  points  are  mean  values,  error  bars  are 
S.  D.  with  n=3. 
Unlike  the  situation  seen  for  DL-homocysteine,  with  this  mutant  there  is  no  clear 
hyperbolic  curve  even  at  low  substrate  concentrations.  It  seems  unlikely  that  a 
better  curve  could  have  been  produced  even  had  the  range  of  concentrations 
been  extended  lower.  Thus  for  some  unknown  reason  the  action  of  this  enzyme 
upon  L-cysteine  in  vitro  does  not  seem  to  adhere  to  the  Michaelis-Menten 
equation.  The  measured  specific  activity  for  the  enzyme  at  a  substrate 
concentration  of  40  mM  is  given  below. 
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[L-cysteine]  (mM) Specific  Activity  (µmol/min/mg  protein)  1.75  (±  0.34) 
Table  4.5:  Kinetic  data  for  MGL1(SF)  with  L-cysteine  as  substrate.  Numbers  in  parenthesis  are  S.  D. 
with  n=7. 
4.2.4.3  MGLI  Y111  F  Mutant 
Over-expression  of  this  mutant  in  E.  coli  produced  a  colourless  recombinant 
enzyme,  purified  in  an  identical  manner  as  parental  MGL1.  From  the  mechanism 
proposed  for  MGL  it  was  not  expected  that  this  mutant  would  possess  any  activity, 
or  at  best  only  very  low  levels.  This  was  apparent  immediately  because  of  the 
large  amounts  of  enzyme  required  before  any  activity  could  be  detected.  Once  it 
was  confirmed  that  the  enzyme  was  catalytically  active,  it  was  assayed  to  find  the 
pH  optimum  and  buffer  preferences.  Screening  a  range  of  buffers  and  pHs  gave 
highest  activity  with  100  mM  TRIS  at  pH  B.  B.  This  was  then  followed  up  by  trying 
to  calculate  kinetic  parameters  for  homocysteine  and  cysteine. 
Assays  were  carried  out  as  before  with  varying  substrate  concentrations  over  a 
broad  range  whilst  maintaining  the  same  amount  of  enzyme.  The  result  of  this  is 
shown  below  in  figure  4.7. 
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Figure  4.7:  MGL1(Y"1F)  reaction  rate  with  DL-homocysteine.  Data  points  are  mean  values,  error 
bars  are  S.  D.  with  n=3. 
Saturating  concentrations  of  substrate  were  reached  and  Michaelis-Menten 
conditions  apply  for  this  enzyme.  The  data  points  on  the  graph  conform  to  the 
hyperbolic  curve  expected  and  there  is  no  evidence  of  substrate  inhibition  at  high 
concentrations.  A  Hanes  plot  was  then  constructed  to  obtain  a  linear  relationship 
and  define  Km  and  Vmax  values  (Figure  4.8). 
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Figure  4.8:  Hanes  plot  of  DL-homocysteine  catabolism  by  MGL1(Y111F) 
Again  this  plot  shows  the  non-linearity  of  the  data,  largely  distorted  by  the  two 
lowest  substrate  points.  This  is  only  a  distortion,  however  from  the  perceived  ideal 
and  rather  than  discard  experimental  data  they  were  included  in  the  calculation  of 
kinetic  parameters.  If  these  values  were  omitted,  the  Km  and  Vmax  would  be 
lower  than  the  values  given  below  (Table  4.6). 
Specific  Activity  (µmol/min/mg  protein)  0.99  (±  0.31) 
Km  (mM)  15.7 
Vmax  (pmol/min/mg  protein)  1.0 
kcat  (s)  0.8 
kit/Km  (M  s)  50 
Table  4.6:  Kinetic  data  for  MGL1(Y"1F)  with  DL-homocysteine  as  substrate.  Numbers  in 
parenthesis  are  S.  D.  with  n=8. 
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DLfiomocysteine  (mM) No  activity  could  be  measured  using  L-cysteine  as  a  substrate  with  this  mutant.  It 
is  likely  that  any  trace  activity  remaining  is  below  the  limits  of  detection  for  this 
assay. 
Another  reason  for  constructing  this  mutant  was  to  confirm  the  action  of  L- 
propargylglycine.  In  the  inhibitor-complex  structure  presented  in  the  previous 
chapter  there  is  continuous  electron  density  between  the  hydroxyl  group  of  the 
Tyrl  11  side  chain  and  the  Cy  of  the  propargyiglycine.  Removing  the  hydroxyl 
group  was  postulated  to  abolish  activity  for  the  enzyme  and  prevent  suicide 
inhibition  by  the  inhibitor.  To  test  this,  purified  enzyme  was  incubated  with 
inhibitor  for  5  minutes  at  room  temperature  prior  to  assaying  and  also  added  to 
the  assays  immediately  before  the  enzyme.  Both  these  experiments  gave 
identical  results.  The  level  of  inhibition  exhibited  was  dependent  upon  the 
concentration  of  DL-propargylglycine  added.  Enzyme  preincubated  with  inhibitor 
had  the  same  levels  of  activity  as  that  with  inhibitor  added  at  the  beginning  of  the 
assay.  Assays  were  performed  with  increasing  concentrations  of  inhibitor  added 
immediately  prior  to  enzyme.  The  table  below  shows  the  loss  in  activity.  Each 
assay  contained  20  mM  DL-homocysteine  with  identical  amounts  of  enzyme  and 
was  carried  out  in  triplicate. 
138 DL-propargylglycine 
concentration  (mM) 
Rate 
(nmol/min/mI) 
Percentage  Inhibition 
0  3.73  (t  0.21)  0 
0.5  3.50  (t  0.52)  7% 
5.0  3.16  (t  0.27)  15% 
12.5  2.81  (t  0.26)  25% 
25.0  2.57  (t  0.14)  31% 
Table  4.7:  Inhibition  of  MGL1(Y"'F)  by  DL-propargylglycine.  Numbers  in  parenthesis  are  S.  D.  with 
n=3. 
As  a  control  the  same  amount  of  non-mutated  MGL1  was  assayed  and  inhibition 
was  100%  at  all  concentrations  of  propargyiglycine.  The  data  show  a  non-suicide 
inhibition  confirming  the  role  of  Tyr111. 
4.2.4.4  MGLI  Cl  13P  Mutant 
This  mutant  was  overexpressed  successfully  in  E.  coli  but  exhibited  no  yellow 
colour  in  solution  as  seen  for  parental  MGL1.  This  presented  no  problems  in 
purification  though  and  highly  homogenous  preparations  were  produced. 
After  screening  a  range  of  buffers  and  pH,  this  mutant  was  found  to  have  the 
highest  detectable  activity  in  100  mM  sodium  phosphate,  pH  7.0,  although  the 
activity  was  very  low.  All  further  assays  of  this  enzyme  were  performed  under 
these  conditions. 
139 The  saturation  curve  with  DL-homocysteine  is  similar  to  that  seen  for  MGL1111F)  . 
No  substrate  inhibition  is  seen  even  at  the  highest  concentrations,  but  the  data 
from  the  lowest  substrate  concentrations  did  not  produce  an  ideal  hyperbolic 
curve.  Again  it  is  impossible  to  say  what  the  cause  of  this  is,  due  to  the  very  low 
activity  exhibited. 
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Figure  4.9:  MGL1  (c"3p)  reaction  rate  with  DL-homocysteine.  Data  points  are  mean  values,  error 
bars  are  S.  D.  with  n=3. 
The  data  for  this  mutant  enzyme  appeared  to  adhere  well  to  standard  Michaelis- 
Menten  kinetics.  This  was  confirmed  by  producing  a  Hanes  plot  (Figure  4.10) 
where  the  only  points  not  accurately  fitting  a  linear  plot  were  those  at  low 
substrate  concentrations. 
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Figure  4.10:  Hanes  plot  of  DL-homocysteine  catabolism  by  MGL1(c1  13P) 
The  plot  above  was  used  to  calculate  values  for  Km  and  Vmax  values  (Table  4.8). 
Using  this  information  the  specific  activity  of  the  enzyme  was  then  measured  and 
kc,  at  values  calculated. 
Specific  Activity  (pmol/min/mg  protein)  0.88  (±  0.24) 
Km  (mM)  20.1 
Vmax  (µmol/min/mg  protein)  1.0 
ko  (s)  0.7 
,, 
/Km  (M  s")  k,  40 
Table  4.8:  Kinetic  data  for  MGL1(C  13P)  with  DL-homocysteine  as  substrate.  Numbers  in 
parenthesis  are  S.  D.  with  n=4. 
The  results  of  assaying  MGL1  (Cl  13P)  cysteine  catabolism  are  shown  below  in  figure 
4.11. 
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Figure  4.11:  MGL1  «"3P)  reaction  rate  with  L-cysteine.  Data  points  are  mean  values,  error  bars  are 
S.  D.  with  n=3. 
The  kinetics  exhibited  by  this  mutant  against  L-cysteine  are  very  similar  to  those 
seen  with  homocysteine.  No  evidence  of  substrate  inhibition  exists  and 
Michaelis-Menten  kinetics  are  apparently  observed.  As  previously  a  Hanes  plot 
was  constructed  to  calculate  estimates  of  Km  and  Vmax  (Figure  4.12). 
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Figure  4.12:  Hanes  plot  of  L-cysteine  catabolism  by  MGL1  (c"3P) 
40 
This  plot  was  also  very  similar  to  that  observed  against  homocysteine  with  least 
adherence  to  a  linear  relationship  seen  at  low  substrate  concentrations.  Values 
calculated  from  the  plot  are  given  below  (table  4.9). 
Specific  Activity  (pmol/min/mg  protein)  1.20  (±  0.17) 
Km  (mM)  16.2 
Vmax  (µmol/min/mg)  1.1 
kcat  (s)  0.9 
k/Km  (M  s)  50 
Table  4.9:  Kinetic  data  for  MGL1(C13P)  with  L-cysteine  as  substrate.  Numbers  in  parenthesis  are 
S.  D.  with  n=3. 
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[L-cysteine]  (mM) 4.2.4.5  MGLI  K209S  Mutant 
This  mutant  was  overexpressed  in  E.  coli  and  purified  successfully  as  a  colourless 
soluble  protein.  Despite  using  large  amounts  of  enzyme  with  either  homocysteine 
or  cysteine  as  substrate,  no  catalytic  activity  could  be  measured.  Although  this 
was  the  expected  outcome,  it  was  checked  thoroughly  to  ensure  the  inactivity  of 
the  enzyme  before  attempting  to  prepare  enzyme-substrate  complexes  for 
crystallographic  analysis. 
4.2.4.6  MGL1  K238A  Mutant 
Expression  and  purification  of  MGL1()  M)  was  carried  out  identically  as  for 
unmutated  MGL1.  It  was  noticeable  that  the  E.  coli  lysate  loaded  onto  the  Ni-NTA 
column  was  distinctly  orange  rather  than  the  yellow  colour  normally  seen.  This 
was  attributable  to  the  mutant  enzyme  which,  after  elution  from  the  column, 
retained  the  same  colour  in  solution.  The  preparation  retained  this  colour  in  the 
presence  or  absence  of  exogenous  PLP  or  DTT. 
The  enzyme  was  assayed  in  an  identical  manner  to  all  other  mutants.  It  was 
determined  first  that  activity  was  highest  in  100  mM  sodium  phosphate,  pH  8.0. 
Then  a  fixed  amount  of  the  enzyme  was  assayed  with  varying  concentrations  of 
substrate  (DL-homocysteine  and  L-cysteine). 
Figure  4.13  clearly  shows  a  relationship  between  activity  and  substrate 
concentration  consistent  with  Michaelis-Menten  kinetics. 
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Figure  4.13:  MGL1(  M)  reaction  rate  with  DL-homocysteine.  Data  points  are  mean  values,  error 
bars  are  S.  D.  with  n=3. 
The  curve  shown  in  the  figure  above  seems  to  correspond  to  Michaelis-Menten 
type  kinetics  well.  It  is  immediately  apparent  that  the  rates  at  low  substrate 
concentrations  are  very  rapid  and  saturating  levels  of  substrate  are  reached  at 
10  mM,  suggesting  a  low  Km  value.  The  data  were  expected  to  produce  a  good 
linear  plot  to  calculate  good  estimates  of  Km  and  Vmax  values  (Figure  4.14). 
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Figure  4.14:  Hanes  plot  of  DL-homocysteine  catabolism  by  MGL1("238 
As  thought,  the  data  from  these  experiments  produced  a  clear  linear  relationship. 
The  cluster  of  data  points  at  the  lowest  substrate  concentrations  did  not  show  the 
disagreement  with  the  line  of  best  fit  as  seen  for  MGL1(C13P)  seen  above.  They 
did  fix  the  y-axis  intersection  clearly  and  calculation  of  a  Km  did  produce  a  very 
low  figure  as  thought.  The  calculated  figures  for  Km  and  Vmax  from  this  graph 
and  specific  activity  from  other  experiments  are  shown  below  (Table  4.10). 
Specific  Activity  (µmol/min/mg  protein)  39.2  (±  2.7) 
Km  (mM)  1.1 
Vmax  (µmol/min/mg  protein)  21.4 
kit  (s)  16 
kcat/Km  (M  s)  15000 
Table  4.10:  Kinetic  data  for  MGL1(K238A)  with  DL-homocysteine  as  substrate.  Numbers  in 
parenthesis  are  S.  D.  with  n=8. 
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[DL-homocysteine]  (mM) The  process  was  repeated  with  L-cysteine  as  substrate  to  find  the  highest  activity 
toward  this  and  the  enzymes  kinetic  parameters.  The  results  are  shown  below  in 
figure  4.15. 
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Figure  4.15:  MGL1(  A)  reaction  rate  with  L-cysteine.  Data  points  are  mean  values,  error  bars  are 
S.  D.  with  n=3. 
The  data  points  suggested  that  there  may  have  been  some  substrate  inhibition  at 
high  concentrations.  However  this  apparent  non-adherence  to  a  hyperbolic  curve 
may  also  be  explained  by  the  errors  observed  in  the  rate  measurements.  Thus 
the  data  was  truncated  to  produce  a  Hanes  plot  to  calculate  Km  and  Vmax  values 
(Figure  4.16). 
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Figure  4.16:  Hanes  plot  of  L-cysteine  catabolism  by  MGL1(123eA) 
The  linear  plot  was  distorted  by  the  data  obtained  at  substrate  concentrations  of 
25  mM  and  higher.  The  low  number  of  data  points  used  to  plot  a  line  of  best  fit 
though  is  more  of  a  concern  in  terms  of  calculating  Km  and  Vmax  values  from  the 
graph.  Despite  this,  the  values  calculated  from  the  plot  are  given  below  (Table 
4.11). 
Specific  Activity  (µmol/min/mg)  3.27  (±  0.21) 
Km  (mM)  1.1 
Vmax  (µmol/min/mg)  2.9 
kcat  (s)  2.2 
kcat/Km  (M"  s)  2000 
Table  4.11:  Kinetic  data  for  MGL1lr""°")  With  L-cysteine  as  substrate.  Numbers  in  parenthesis  are 
S.  D.  with  n=6. 
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[L-cysteine]  (mM) 4.2.4.7  Summary  of  Assay  Results  for  MGLI  Mutants 
The  following  tables  summarise  the  results  from  the  previous  sections  of  the 
chapter  presenting  the  results  of  the  enzyme  assays  of  the  mutant  MGL1  s. 
Homocysteine 
Enzyme  Specific  Activity  Km  Vmax  kcat  kcaIKm 
MGL1  370  t  11  12.2  256  197  16100 
Cl  13G  34.5  t  3.2  (9.3)  15.2  42  32.3  2100 
R58K  308  ±  28  (83)  nd  nd  nd  nd 
R58M  187  ±  22  (51)  nd  nd  nd  nd 
L59F  8.26  t  1.2  (2.2)  3.7  2.0  1.5  400 
Y111  F  0.99  ±  0.31  (0.3)  15.7  1.0  0.8  50 
Cl  13P  0.88  ±  0.24  (0.2)  20.1  1.0  0.7  40 
K238A  39.2  ±  2.7  (11)  1.1  21.4  16.4  15000 
Cysteine 
Enzyme  Specific  Activity  Km  Vmax  k  k  /Km 
MGL1  6.02  t  0.63  8.5  14.9  11.5  1350 
Cl  13G  2.33i  0.35  (39)  9.7  4.6  3.5  360 
L59F  1.75  ±  0.34  (29)  nd  nd  nd  nd 
Cl  13P  1.20  ±  0.17  (20)  16.2  1.1  0.9  50 
K238A  3.27  ±  0.21  (54)  1.1  2.9  2.2  2000 
Table  4.12:  Summary  of  kinetic  parameters  for  MGLI  mutants.  Units:  specific  activity  = 
µmol/min/mg  protein,  Km  =  mM,  Vmax  =  µmol/min/mg,  kcat  =  s',  k,,  /Km  =  M'  s'.  The  numbers  in 
parenthesis  are  the  percentage  activities  compared  to  unmutated  MGL1  activity  for  the  same 
149 substrate.  Data  for  MGL1  and  mutant  Cl  13G  were  taken  from  McKie  et  a1.,  1998.  nd  =  not 
determined  for  reasons  explained  in  the  text. 
Enzyme  Buffer/pH  Optimum 
MGL1  Imidazole  pH  6.5 
Cl  13G  Imidazole  pH  6.5 
R58K  Acetate  or  MES  pH  5.0  to  5.5 
R58M  Imidazole  pH  6.5a 
L59F  Sodium  Phosphate  pH  8.0 
Y111  F  TRIS  pH  8.8 
Cl13P  Sodium  Phosphate  pH  7.0 
K238A  Sodium  Phosphate  pH  8.0 
Table  4.13:  Buffer  and  pH  optimum  of  MGLI  and  mutants.  a  this  enzyme  was  not  examined 
thoroughly  for  pH  optimum. 
4.2.5  Structural  Investigations  of  MGL1  Mutants 
The  effects  of  mutagenesis  may  be  simply  the  removal  of  an  active  group,  e.  g.  a 
thiol,  from  the  catalytic  centre  of  an  enzyme  or  they  may  be  more  subtle,  inferring 
a  conformational  change  of  some  degree  upon  the  enzyme.  This  effect  is 
obviously  more  pronounced  when  substituting  amino  acids  with  very  different 
properties,  especially  if  these  occur  deep  within  the  structure  rather  than  on  the 
surface.  Perhaps  the  best  way  of  interpreting  any  changes  of  activity  in  mutant 
enzymes  is  to  have  a  high  resolution  structure  to  accompany  enzymatic  data. 
This  is  an  ambitious  and  possibly  unrealistic  desire,  but  within  the  scope  of  this 
150 project  attempts  were  made  to  achieve  this.  The  results  are  detailed  in  the 
following  sections. 
4.2.5.1  Crystallisation  of  MGLI  Mutants 
Mutant  enzymes  were  purified  and  prepared  as  detailed  for  MGL1  in  chapter  2  of 
this  thesis.  In  all  cases  enzyme  for  crystallisation  was  concentrated  to  6mg/ml  in 
100  mM  HEPES  pH  7.5,250  µM  PLP,  1  mM  DTT.  Sitting  drop  vapour  diffusion 
crystal  Iisations  were  set  up  under  identical  conditions  as  for  MGL1,  i.  e.  2.3  M 
AmmSO4,0.1  M  NaCitrate  pH  5.6,0.2  M  Li2SO4.  The  results  of  these  experiments 
are  summarised  in  the  table  below: 
Mutant  Result 
R58K,  R58M,  No  crystals  produced 
L59F, 
Y111F, 
C113G 
C113P 
, 
Small  bipyramidal  crystals  (0.15  mm  x  0.05  mm  x  0.05  mm). 
Also  co-crystallised  with  5  mM  DL-allylglycine 
K209S  Large  colourless  bipyramidal  crystals 
(0.6  mm  x  0.4  mm  x  0.4  mm) 
K238A  Large  orange  bipyramidal  crystals  (0.6  mm  x  0.4  mm  x  0.4  mm) 
Table  4.14:  Results  of  crystallisations  of  MGL1  mutant  enzymes 
151 MGL1P"3c)  previously  produced  in  this  laboratory  was  available  at  the  beginning 
of  the  study.  Attempting  to  find  suitable  crystallisation  conditions  it  was  screened 
in  the  same  manner  as  MGL1  but  yielded  no  promising  results.  Similar  attempts 
were  not  performed  with  the  mutants  produced  in  this  study  due  to  time 
constraints. 
4.2.5.2  Data  Collection  and  Processing 
Crystals  of  MGL1  X38'",  MGL1  K20'S  and  MGL1  C1  13P  (holoenzyme  and  co-crystallised 
with  DL-allylglycine)  were  taken  to  the  ESRF  synchrotron  facility  Grenoble, 
France  for  data  collection.  A  summary  of  the  diffraction  exhibited  by  the  crystals 
is  given  below: 
Crystal  Highest  Resolution 
K238A  1.7  A 
K209S  1.6  A 
C1  13P  -  holoenzyme  5.0  A 
C1  13P  -  co-crystallised  5.0  A 
Table  4.15:  Summary  of  the  diffraction  limits  exhibited  by  mutant  MGL1  crystals. 
No  data  was  collected  for  MGL1(C13P)  because  of  the  low  resolution  diffraction 
exhibited.  Indexing  of  the  initial  frames  of  both  MGL1('209S)  and  MGL1(`2  ) 
indicated  the  same  space  group  as  unmutated  enzyme,  P  3112,  and  similar  unit 
cell  dimensions.  A  strategy  was  then  computed  to  collect  complete  datasets  for 
both  crystals. 
152 In  an  attempt  to  produce  enzyme-substrate  complexes,  crystals  of  MGL1  ("2°9S) 
were  soaked  with  homocysteine  and  cysteine.  Unfortunately  the  results  of  these 
soaks  was  a  total  loss  of  diffraction  by  the  crystals.  The  gross  morphology  of  the 
crystals  did  not  alter  during  the  soaking  and  they  remained  intact  for  several 
minutes.  The  loss  of  diffraction  was  concluded  to  be  due  to  a  conformational 
change.  No  further  attempts  were  made  to  produce  complexes  with  these 
crystals. 
Only  the  data  from  MGL1(  )  was  processed  and  analysed  further,  a  summary  of 
the  statistics  is  presented  below.  All  data  were  processed  with  DENZO  and 
scaled  using  SCALEPACK  (Otwinowski  and  Minor,  1997). 
Resolution  35  -  1.8  A 
Temperature  100K 
Oscillation  Range  0.5° 
Completeness  Overall  (40.0  -  1.82) 
Highest  (1.91  -  1.82) 
98.6% 
84.7% 
Unique  Reflections  90109 
Rmerge  5.6 
Table  4.16:  Data  collection  and  processing  statistics  for  MGL1(Y'm) 
4.2.5.3  Structure  Solution  of  MGL1  ý"M") 
The  solution  of  this  mutant  was  relatively  straightforward  due  to  the  similarity 
between  it  and  native  MGL1.  Phases  were  obtained  directly  from  the  refined 
153 holoenzyme  structure  and  the  same  subset  of  reflections  used  for  Free  R-factor 
determination  extended  to  include  the  higher  resolution  data. 
4.2.5.4  Model  Building  and  Refinement  of  MGL1I"238A) 
Model  building  of  the  mutant  was  carried  out  with  QUANTA  using  the  coordinates 
of  MGLI  holoenzyme  to  trace  the  first  maps.  These  maps  were  of  a  very  high 
quality  due  to  the  similarity  of  the  mutant  to  the  refined  holoenzyme  structure, 
from  which  the  phase  information  was  obtained.  No  breaks  in  the  electron  density 
for  main  chain  atoms  were  evident  and  there  was  no  need  for  averaging  of  the 
maps.  In  the  first  round  of  model  building  waters  were  included  from  the 
holoenzyme  structure  and  individually  checked.  Poorly  defined  atoms  were 
removed  and  extra  waters  added,  the  glycerol  molecule  and  sulphates  were 
clearly  visible  in  the  first  maps.  Refinement  was  subsequently  performed  with 
REFMAC  using  a  bulk  solvent  correction  and  maps  created  using  the  programme 
FFT  from  the  CCP4  suite.  Geometric  restraints  were  relaxed  after  the  second 
round  of  refinement.  A  summary  of  the  refinement  process  and  statistics  is  given 
below  (Table  4.17): 
Round  of  Refinement 
1.  Phases  taken  from  holoenzyme  model 
2.  Few  changes  necessary,  extra  waters  added 
3.  Poor  waters  removed,  minor  adjustments  only 
4.  Final  round 
R-factor  Rf 
22.1  1  26.6 
21.3  1  25.3 
20.2.1  23.4 
19.8  1  23.4 
Table  4.17:  Summary  of  refinement  of  MGL1(  &)  structure. 
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The  following  section  details  the  structure  of  the  mutant  MGL1  ('238'°')  at  1.7  A.  The 
crystallisation  and  indexing  of  data  from  the  crystals  implied  that  the  structure  was 
likely  to  be  very  similar  to  the  native  enzyme.  Purification  of  the  enzyme  revealed 
that  instead  of  the  yellow  colour  associated  with  the  parental  enzyme,  purified 
mutant  enzyme  was  orange  and  this  was  clearly  visible  in  the  crystals.  This 
phenomenon  was  not  attributable  to  a  change  in  pH  of  the  solution  as  conditions 
were  identical  in  each  case,  and  as  seen  in  the  native  structure,  Lys238  does  not 
make  a  direct  interaction  with  the  cofactor. 
4.2.5.5.1  Secondary  Structure 
The  secondary  structure  of  the  mutant  enzyme  is,  as  expected,  identical  to  the 
native  enzyme.  The  two  monomers  in  the  asymmetric  unit  do  not  differ 
appreciably  as  is  seen  in  the  holoenzyme  and  inhibitor  complex  structures.  An 
RMS  deviation  of  only  0.294  A  for  main  chain  atoms  was  seen  when 
superimposing  the  two  subunits.  Similarly,  superimposing  the  dimers  of  the 
mutant  structure  with  the  holoenzyme  and  inhibitor  complex  structures  gave  an 
RMS  deviation  of  only  0.235  A  and  0.262  A  respectively. 
4.2.5.5.2  Active  Site  Areas 
The  active  site  of  the  mutant  is  also  largely  similar  to  the  holoenzyme  structure. 
There  is  a  clear  difference  seen  at  the  site  of  the  lysine  to  alanine  change  at 
residue  238.  There  is  no  electron  density  past  the  position  of  the  Cß  and  the 
space  vacated  is  not  clearly  occupied  by  any  other  atoms.  Figure  4.17  shows  the 
electron  density  in  the  region  around  A1a238. 
155 Figure  4.17:  2F0  -  Fc  and  electron  density  maps  of  the  area  around  A1a238  in  the  MGL1(K238A) 
structure.  The  2F0  -  Fc  map  is  contoured  at  one  and  two  a  in  pink  and  orange,  respectively.  In  the 
F0  -  Fc  map  positive  density  is  indicated  in  green,  negative  density  in  red.  Only  Arg58,  Tyrl  11  *, 
C113`,  AIa238  and  Asp239  are  shown  in  the  figure  for  clarity. 
There  is  weak  density  nearby  to  the  Cß  of  A1a238  which  did  not  successfully  refine 
as  either  water  molecules  or  an  alternative  conformation  for  neighbouring  Asp239. 
Both  of  these  have  been  omitted  from  the  final  model,  although  it  is  possible  that 
both  may  actually  be  present  at  low  occupancy.  The  electron  density  for  the  side 
chain  of  Asp239  is  significantly  poorer  than  for  neighbouring  residues  and  is 
reflected  in  the  high  average  B-factor  of  38.2.  This  reinforces  the  idea  that  the 
side  chain  may  possess  a  dual  conformation. 
156 Also  evident  in  the  mutant  structure  is  the  change  in  the  electron  density  for 
Tyrl  11.  There  is  a  small  amount  of  positive  density  above  the  plane  of  the  phenol 
ring  between  the  side  chain  and  the  cofactor  pyridine  ring.  Although  not  clear  in 
figure  4.17,  this  density  is  consistent  with  the  ring  rotating  -900  to  position  itself 
parallel  with  the  cofactor.  Attempts  were  made  to  refine  a  dual  conformation  of 
Tyr111  but  were  unsuccessful.  A  change  such  as  this  would  force  a  movement  of 
the  cofactor  as  it  is  within  Van  der  Waals  distance  of  the  phenol  side  chain. 
The  most  intriguing  observation  in  the  active  site  though  is  the  density  around 
Cys113.  At  all  stages  of  refinement,  there  was  positive  density  adjacent  to  the  Sy. 
Unlike  the  maps  for  the  holoenzyme  and  inhibitor  complex  this  was  not 
attributable  to  a  dual  conformation.  Instead  the  unaccounted  for  density  in  the 
mutant  structure  extends  in  the  same  direction  from  the  Sy,  resulting  in  an  angle 
of  -120°  between  Cß-Sy-X,  where  Xis  the  unknown  atom.  The  distance  appears 
to  be  approximately  1.7  A  from  Sy  to  X  indicating  a  covalent  bond  between  the  two 
atoms. 
It  was  supposed  that  the  orange  colour  exhibited  by  this  mutant  was  due  to  a  shift 
in  the  position  of  the  cofactor  relative  to  the  residues  coordinating  it.  To  test  this 
monomers  of  the  mutant,  holoenzyme  and  inhibitor  complex  structures  were 
aligned  using  LSQKAB  and  the  models  superimposed.  Figure  4.18  shows  the 
three  cofactors  aligned  in  this  way. 
157 Figure  4.18:  Superposition  of  the  cofactors  from  the  three  MGL1  structures.  Green  -  PLP  + 
propargyiglycine,  Blue  -  holoenzyme  structure,  Red  -  K238A  mutant  structure.  The  figure  was 
produced  using  SETOR. 
There  is  very  little  movement  of  the  cofactor  in  the  MGL1  ('2')  structure  in 
comparison  with  the  others.  The  cofactors  were  aligned  through  their  position 
relative  to  the  polypeptide  chains  but  it  was  evident  that  there  were  no  significant 
movements  of  any  residue  directly  interacting  with  the  cofactor. 
158 4.2.6  MGL  From  Other  organisms 
MGL  activity  has  been  detected  in  a  number  of  organisms.  Much  of  these  data 
are  from  total  cell  extracts  and  are  therefore  a  little  unreliable  as  related  enzymes 
such  as  cystathionine  y-Iyase  (CGL)  are  able  to  catalyse  some  of  the  same 
reactions  as  MGL,  albeit  at  much  lower  levels.  At  present  there  are  only  four  mgl 
genes  in  the  database  that  have  been  confirmed  biochemically  to  encode  MGL 
enzymes,  two  each  from  T.  vaginalis  and  P.  putida  (Inoue  et  al.,  1995;  Hori  et  a!., 
1996;  McKie  et  al.,  1998).  These  show  a  high  degree  of  homology  to  other 
members  of  the  y-family  making  identification  of  putative  MGL's  difficult.  Indeed 
the  cloning  of  mgl  from  T.  vaginalis  was  carried  out  using  degenerate 
oligonucleotides  based  upon  CGL  sequences.  As  mentioned  previously,  in  both 
the  bacterial  and  protozoal  enzymes  studied  biochemically  so  far  a  cysteine 
residue  (Cys113,  T.  vaginalis  MGL1  numbering)  is  important  for  activity  and  100% 
conserved  (Nakayama  et  al.,  1988;  McKie  et  al.,  1998).  This  residue  is  not  found 
in  other  y-family  enzymes,  which  was  suggestive  that  the  MGL  mechanism 
differed  from  those  of  other  PLP-dependent  enzymes  such  as  cystathionine 
synthases  and  cystathionine  Iyases.  Moreover,  the  cysteine  residue  can  be  used 
as  a  marker  in  identifying  putative  MGL's.  Searching  the  available  data  released 
from  the  various  sequencing  projects  has  revealed  possible  MGL  enzymes  in  just 
a  few  organisms:  Porphyromonas  gingivalis,  Bacillus  anthracis,  Treponema 
denficola,  Caulobacter  crescentus  and  Shewanella  putrifaciens  (accessible  at 
http:  //www.  tigr.  org).  An  alignment  of  these  sequences  shows  their  extensive 
similarities  (Figure  4.19). 
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Figure  4.19:  Sequence  alignment  of  confirmed  and  putative  MGL  enzymes.  Secondary  structure 
elements  of  MGL1  are  indicated.  a-helices  are  represented  as  coils,  ß-strands  as  black  arrows, 
each  is  numbered  as  for  figure  3.6.  Conserved  residues  are  coloured  in  red  and  boxed.  Black 
triangles  indicate  those  residues  proposed  to  have  a  role  in  the  catalytic  mechanism.  Yellow 
triangles  indicate  residues  coordinating  the  cofactor.  The  figure  was  generated  by  ESPript.  All 
numbers  refer  to  MGL1. 
160 There  are  87  conserved  residues  amongst  all  9  sequences  and  the  level  of 
similarity  exhibited  to  MGL1  ranges  from  58%  against  the  B.  anthracis  sequence 
to  85%  against  MGL2.  With  the  exception  of  Met87,  all  residues  involved  in 
cofactor  and  substrate  binding  and  those  that  appear  to  be  involved  in  catalysis 
are  conserved.  Met87  is  alternatively  substituted  for  an  isoleucine  and  the  main 
chain  amine  group  of  the  residue  is  involved  in  the  interaction  and  so  the  side 
chain  is  less  crucial.  Significantly  Lys238  and  Asp239  are  also  conserved  in 
these  sequences  but  absent  from  other  PLP-dependent  enzymes.  Thus  in 
identifying  possible  MGL  enzymes  from  the  abundance  of  other  PLP-dependent 
enzymes  retrieved  in  a  BLAST  search  of  the  available  databases,  Cysl  13, 
Lys238  and  Asp239  are  critical.  Not  a  single  instance  was  found  of  any  one  of 
these  residues  being  present  without  the  other  two. 
4.3  DISCUSSION 
Results  have  been  presented  in  this  chapter  on  rationally  designed  site-directed 
mutagenesis  of  MGLI.  This  technique  has  been  applied  to  many  proteins  to 
investigate  roles  of  particular  residues.  It  has  also  been  successfully  used  on 
MGL  from  T.  vaginalis  to  investigate  the  contribution  of  an  active  site  cysteine  to 
catalysis  (McKie  et  al.,  1998).  For  this  study  mutations  were  selected  based  upon 
the  structure  of  MGLI  and  its  comparison  to  CBL  from  E.  coli  (Clausen  et  al., 
1996).  Eight  mutants  were  designed,  although  one  of  these  was  not  successfully 
produced,  targeting  a  total  of  six  different  residues.  Attempts  were  also  made  to 
solve  the  structures  of  these  seven  mutants,  crystals  were  grown  of  three  and  one 
structure  was  solved  to  a  resolution  of  1.7  A. 
161 When  searching  for  other  MGL  sequences  in  the  databases  the  homology  to 
other  members  of  the  y-family  of  PLP-dependent  enzymes  was  obvious. 
Identifying  any  of  these  positively  as  MGL  though  was  difficult.  To  attempt  to  do 
this,  we  used  information  from  the  structure  of  MGL1  and  the  results  of  SDM 
which  identified  key  residues  in  the  active  site.  Additionally  we  utilised  the 
structures  published  of  CBL  and  CGS  to  highlight  differences.  With  this 
information  it  allowed  us  to  putatively  identify  ORFs  from  the  genome  sequencing 
projects  that  encode  likely  MGLs.  In  the  active  site  of  y-family  PLP-dependent 
enzymes  Tyr58,  Arg58,  Tyrl  11  and  Lys209  (MGL1  numbering)  are  usually 
present.  However  key  residues  in  MGL1,  Cys113,  Lys238  and  Asp239,  are 
absent.  By  performing  BLAST  searches  with  MGL1  and  examining  those  hits  with 
high  homology  for  the  presence  of  these  seven  key  residues,  putative  MGLs  were 
identified.  Frequently  these  organisms  had  apparent  homologues  of  one  or  more 
cystathionine-utilising  enzymes,  but  in  each  case  these  other  enzymes  lacked 
Cysl13,  Lys238  and  Asp239.  Only  those  sequences  which  had  these  three 
residues  are  thought  to  be  MGL  enzymes.  Interestingly,  no  example  was  found  in 
any  of  these  organisms  of  two  isozymes  of  MGL  as  is  found  in  both  T.  vaginalis 
and  P.  putida. 
The  technique  employed  to  produce  mutants  utilises  oligonucleotide  primers  that 
flank  the  target  site  by  15  to  20  bases.  It  was  therefore  a  surprise  to  isolate  a 
large  number  of  putative  mutant  plasmids  whose  sequences  in  these  regions  was 
not  encoded  by  the  primer  or  original  clone.  The  number  of  these  varied  but  in 
the  case  of  the  C1  13S  mutant  no  correct  mutations  were  isolated.  The  production 
of  this  mutant  was  abandoned  because  of  the  work  involved  in  analysing  the  other 
162 seven.  It  can  only  be  concluded  that  the  cause  of  these  "random"  changes  were 
due  to  the  oligonucleotides  used.  Their  synthesis  may  not  have  been  entirely 
specific,  such  that  primer  populations  incorporating  errors  were  supplied. 
The  catalytic  mechanism  proposed  in  the  previous  chapter  gives  a  direct  role  for 
both  Tyrl  11  and  Lys209  in  catalysis,  with  the  activity  being  strongly  mediated  by 
the  action  of  Cys113.  Purified  MGL1("209S)  was  inactive  according  to  the  assays 
performed  which  is  in  agreement  with  this  mechanism.  However  crystals  of  the 
enzyme  no  longer  diffracted  X-rays  after  adding  substrate,  which  might  suggest 
the  retention  of  some  activity.  However,  this  may  equally  have  been  produced  by 
a  conformational  change  resulting  from  substrate  entering  the  active  site.  The 
published  structure  of  CGS  from  E.  coli  shows  an  asymmetry  in  the  B-factors  for 
residues  in  the  N-terminal  domain  which  is  postulated  to  reflect  a  conformational 
change.  This  may  be  necessary  for  the  active  site  of  CGS  which  has  to 
accommodate  two  substrates  (L-cysteine  and  0-acyl-L-homoserine)  but  there  is 
no  evidence  for  a  conformational  change  in  MGL1  when  the  holoenzyme  and 
inhibitor-complex  structures  are  compared. 
It  was  thought  that  the  mutation  MGL1"9)  would  produce  an  enzyme  with 
changes  in  substrate  specificity  and  a  probable  drop  in  activity.  The  calculated 
specific  activities  show  a  much  larger  fall  in  activity  than  expected,  although  this 
fall  is  much  larger  for  homocysteine  than  cysteine  (98%  and  71%  respectively), 
which  was  predicted.  The  k  and  k/Km  values  calculated  for  this  mutant  also 
agree  with  this,  showing  a  much  larger  fall  in  turnover  and  affinity  for 
homocysteine  than  cysteine.  Because  no  structural  data  is  available  to 
163 accompany  these  results  we  are  unable  to  say  exactly  what  is  responsible  for 
these  changes.  The  residue  is  adjacent  to  Arg58,  changes  in  which  we  have  seen 
in  this  chapter  result  in  significant  alterations  in  enzyme  activity.  Thus  the  activity 
of  the  MGL1«`59F)  mutant  may  be  due  to  both  a  change  in  the  active  site  and 
movement  of  Arg58. 
The  assay  results  of  both  MGL1('  and  ('")  are  difficult  to  explain.  Both  exhibit 
substrate  inhibition  but  only  the  lysine  mutant  shows  the  activation/inhibition  by 
acetate  and  similar  buffers.  The  reason  for  substrate  inhibition  is  unknown  but  it 
is  possible  to  give  some  explanation  for  the  lag  in  activity  seen  at  intermediate 
substrate  concentrations  ([s]).  With  a  low  level  of  residual  activity  remaining 
during  inhibition  by  high  [s],  as  the  substrate  is  depleted  it  eventually  drops  below 
inhibitory  levels.  This  accounts  for  the  activity  seen  after  a  few  minutes  delay. 
Previously  Cysl  13  has  been  shown  to  be  important  for  activity  and  mutation  to  a 
glycine  has  resulted  in  the  loss  of  -90%  of  homocysteine  catabolism.  The 
structure  of  MGL1  shows  that  the  distance  from  the  Sy  of  Cys113  to  the  substrate 
is  too  large  for  a  direct  interaction  occur.  The  position  of  the  cysteine  only  two 
residues  from  Tyr111  does  allow  for  the  possibility  that  the  change  in  activity  is 
due  to  movement  of  this  residue.  To  further  test  the  role  of  the  cysteine, 
mutations  to  serine  and  proline  were  designed  and  also  the  Lys238  to  alanine 
change  because  of  its  proposed  interaction  with  Cys113.  The  loss  in  activity  of 
MGL1  (CI  13P)  is  very  probably  due  to  a  change  in  the  active  site  geometry.  The 
glycine  mutation  at  this  position  would  allow  a  greater  freedom  of  movement  for 
the  polypeptide  chain  because  of  the  lack  of  steric  hindrances  caused  by  the 
164 absence  of  a  side  chain.  A  proline  mutation  though  would  restrict  the 
conformations  permissible  more  than  any  other  residue.  The  restricted  geometry 
of  the  proline  permits  only  certain  phi/psi  angles  and  these  may  well  distort  the 
neighbouring  structure,  displacing  Tyr111.  As  can  be  seen  in  figure  3.4,  an 
alignment  of  CBL  and  MGL1  shows  the  sequences  to  be  quite  different  in  a 
stretch  of  18  residues  (104  to  121)  with  only  Tyrl  11  being  conserved  and  one 
other  similarity.  Thus  where  a  proline  residue  is  optimal  in  CBL  it  has  a  severely 
detrimental  effect  in  MGL1.  The  fact  that  this  mutant  crystallised  in  identical 
conditions  to  MGLI  probably  indicates  the  overall  structural  changes  are  not  large 
or  at  least  do  not  affect  crystal  contacts.  It  is  interesting  to  note  however  that  this 
mutant  has  similar  levels  of  activity  toward  homocysteine  as  MGL1(y"'F),  but 
unlike  this  change,  MGL1  (Cl  13p)  exhibits  activity  toward  cysteine. 
The  role  of  Lys238  in  the  mechanism  of  MGL1  was  proposed  to  be  through  the 
combined  influence  of  it  and  Asp239  to  ionise,  Cys113.  The  fall  in  specific  activity 
of  this  mutant,  compared  to  the  parental  MGL1,  by  an  order  of  magnitude  is 
matched  by  the  drop  in  Km  and  kcat  values.  The  k/Km  value  however,  which  can 
be  taken  as  a  measure  of  the  specificity  of  the  enzyme  for  a  substrate,  is  similar  to 
the  values  for  parental  MGLI.  This  data  alone  would  indicate  the  possibility  of  a 
mutation  that  resulted  in  no  significant  structural  change  as  substrate  affinity  was 
not  substantially  affected.  The  fall  in  activity  though  points  to  the  loss  of  a 
functional  group  important  but  not  essential  for  catalysis.  These  conclusions  are 
confirmed  by  the  mutant  enzyme  structure.  The  only  significant  difference  is  the 
area  around  residue  238  and  the  side  chain  of  Cysl13.  The  electron  density 
around  the  Sy  suggests  the  side  chain  is  oxidised.  With  the  proposed  action  of 
165 Cys113  dependent  upon  its  ionisation  (by  Lys238  and  Asp239)  oxidisation  would 
prevent  this.  Thus  the  data  obtained  from  this  mutant  agrees  with  our  hypothesis 
on  the  role  of  Lys238  and  Cysl  13  and  the  importance  of  the  ionised  state  in  the 
mechanism. 
We  are  confident  that  the  action  of  Cysl  13  on  the  substrate  is  crucial  for  optimum 
activity,  but  it  is  still  difficult  to  explain.  The  distance  from  Cys113  Sy  to  substrate 
p  and  y  atoms  is  -  6.5  and  5.0  A  respectively.  The  agreed  mechanism  of  action 
for  ß-  or  y-elimination  requires  a  nucleophilic  attack  at  the  p  atom,  obviously  too 
distant  to  be  influenced  by  this  residue  directly.  Reconsidering  the  mechanism  we 
know  that  the  "quinonoid  intermediate"  is  formed  after  proton  abstraction  at  Ca. 
The  new  distribution  of  7t  molecular  orbitals  produces  a  "vinylogous  enamine". 
This  structure  produces  a  cofactor  which  is  electron  rich  and  basic  and  can  either 
be  protonated  or  push  out  a  leaving  group.  However  the  thiol  group  of 
homocysteine  (and  cysteine)  is  a  strong  nucleophile  and  it  is  presumably  the 
assistance  here  by  Cys113  that  produces  the  high  levels  of  activity  we  see. 
Cys113  and  its  proposed  oxidation  in  MGL1  (K  23"A)  is likely  to  be  responsible  for  the 
orange  colour  seen  in  the  enzyme  preparation,  as  the  structure  of  the  mutant 
reveals  there  is  no  movement  of  the  cofactor.  Although  there  appears  to  be  no 
close  contact  between  the  cofactor  and  the  side  chain  of  Cys113  it  is  noteworthy 
that  neither  of  the  mutants  MGL1(C13P)  and  MGL1(c"3G)  have  any  yellow  colour  in 
solution,  as  seen  in  unmutated  MGLI.  However  the  reason  for  this  colour  change 
has  yet  to  be  explained. 
166 It  is  tempting  to  look  for  answers  about  Cys113  in  the  mechanism  of  NifS  enzymes 
and  their  homologues.  These  enzymes  all  have  proposed  mechanisms  with  an 
essential  active  site  cysteine  forming  a  persulphide  after  catalysis  of  cysteine  or 
selenocysteine  (Zheng  et  al.,  1994).  However  they  all  also  predict  that  the  same 
residue  takes  part  in  a  nucleophilic  attack  upon  the  substrate.  Unless  a  large 
conformational  change  takes  place  in  MGL1,  for  which  there  is  no  evidence  in  the 
structure,  this  is highly  unlikely.  The  remaining  activity  in  the  MGL1(C130)  mutant 
also  totally  discounts  the  possibility  of  it  acting  as  an  essential  active  site 
nucleophile.  Thus  despite  some  outward  similarities  these  mechanisms  are 
fundamentally  different  from  MGLI. 
The  structure  of  cystalysin  from  Treponema  denticola  (Krupka  et  al.,  2000)  was 
also  examined  for  help  in  defining  the  mechanism  of  MGL.  This  enzyme 
catalyses  an  ap-elimination  reaction  on  cysteine  to  release  H2S,  pyruvate  and 
ammonia  rather  than  the  production  of  alanine  and  enzyme  bound  persulphide  by 
NifS-like  enzymes.  -  However  in  this  structure  there  is  no  analogous  active  site 
cysteine.  Catalysis  is  again  predicted  to  be  entirely  due  to  the  ubiquitous  active 
site  lysine  although  here  it  is  under  the  influence  of  the  PLP  phosphate  group,  a 
water  molecule  and  a  tyrosine  and  alanine  residue  in  the  active  site.  It  has  to  be 
concluded  then  that  after  a  search  of  the  available  literature  MGL  has  a  novel 
method  of  producing  a  good  leaving  group  from  a  strong  nucleophile. 
The  inability  to  detect  any  activity  with  MGL1('209S)  is  consistent  with  the  finding  in 
other  mutated  PLP-dependent  enzymes  where  the  residue  is  essential.  In  CBL 
and  CGS  it  has  been  proposed  that  the  analogous  lysine  to  this  is  the  sole 
167 residue  involved  in  catalysis  (Clausen  et  al.,  1997,1998).  This  has  been 
considered  for  MGL1,  but  thought  to  be  unlikely  because  of  the  distance  from  the 
amine  group  of  the  lysine  side  chain  to  the  proposed  position  of  the  substrate  Cß. 
Instead  it  is  proposed  that  Tyrl  11  would  fulfill  this  role.  MGL1(Y111F)  retains  0.3% 
of  its  activity  towards  homocysteine  compared  with  the  unmutated  enzyme  and  no 
measurable  activity  towards  cysteine.  -  Although  very  low,  this  is  not  predicted  for 
the  loss  of  an  essential  catalytic  residue.  Thus  the  question  to  be  answered  is 
can  the  very  low  levels  of  activity  still  exhibited  by  MGL1''1F)  be  explained  in 
terms  of  the  mechanism  proposed  here?  The  only  way  in  which  the  mutant 
activity  data  can  be  made  to  fit  our  hypothesis  is  if  there  is  an  additional 
mechanism  for  the  ay-elimination  of  homocysteine.  There  appear  to  be  only  two 
options  for  this:  the  action  of  Lys209,  or  the  action  of  Cys113.  Perhaps  it  is 
possible  that  the  trace  activity  retained  by  the  mutant  is  in  fact  due  to  Lys209,  as 
proposed  by  others.  The  unfavourable  position  seen  for  Lys209  in  MGL1  may  not 
be  totally  prohibitive  for  catalysis  and  may  be  able  to  deprotonate  the  substrate 
CO  albeit  at  very  low  levels.  The  action  of  Cys113  in  conjunction  with  the  cofactor 
may  also  be  enough  to  cleave  the  Cy-SS  bond.  It  is  feasible  that  the  action  of  the 
electron  rich  quinonoid  intermediate  and  the  ionised  Sy  of  Cys113  (approximately 
3.5  A  from  the  SS  of  homocysteine)  may  break  the  Cy-S8  bond.  If  neither  of  these 
possibilities  are  correct  then  an  alternative  role  for  Tyr111  must  be  given  which 
accounts  for  the  loss  of  activity. 
An  alternative  role  for  Tyrl  11  has  already  been  proposed  in  which  the  phenolate 
side  chain  is  critical  for  transaldimination  (Clausen  et  al.,  1998).  That  is,  the 
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aldimine)  complex.  This  is  the  primary  step  in  catalysis  and  involves  the  removal 
of  a  proton  from  the  incoming  substrate  amine  group  and  passing  this  to  the 
displaced  lysine  amine  (Lys209).  It  is  this  conjugate  form  of  PLP-substrate  that 
labilises  the  substrate  Ca  and  allows  the  reaction  to  proceed.  The  role  of  Tyrl  11 
in  this  still  relies  upon  the  negatively  charged  side  chain  hydroxyl  and  so  loss  of 
this  should  also  prevent  transaldimination.  In  MGL1  the  proposed  method  for 
transaldimination  is  controlled  by  the  cofactor  itself.  The  hydroxyl  group  on  C3  of 
the  cofactor  is  generally  accepted  to  be  negatively  charged.  This  should  then  be 
able  to  shuttle  protons  from  the  incoming  substrate,  four  atoms  along  to  the  lysine 
amine,  although  we  have  no  evidence  for  this. 
Alternatively  the  activity  data  of  the  mutant  can  be  explained  in  terms  of  the 
CBLICGS  mechanism  proposed.  That  is,  transaldimination  by  Tyrl  11  is 
abolished  in  the  phenylalanine  mutant  and  the  remaining  low  activity  levels  are  a 
result  of  sub-optimal  transaIdimination,  possibly  by  the  cofactor.  The  kinetic  data 
agrees  with  this,  producing  a  k/Km  much  lower  than  that  for  unmutated  MGL1 
which  indicates  a  much  lower  specificity  for  the  substrate:  Unfortunately  the  data 
we  have  does  not  allow  us  to  rule  out  either  hypothesis  and  so  further 
investigation  is  undoubtedly  needed  to  identify  the  true  function  (or  functions)  of 
Tyrl11. 
What  is  confirmed  by  the  data  is  not  only  the  importance  of  Tyrl  11  in  activity  but 
also  its  role  in  inhibition  by  propargylglycine.  The  action  of  the  inhibitor  on  MGL, 
CGS  and  CGL  has  been  studied  biochemically  and  confirmed  a  covalent  linkage 
169 to  the  enzymes  (Washtien  and  Abeles,  1977;  Johnston  eta!.,  1979).  Though 
clear  and  unambiguous  in  the  inhibitor  complex  structure  the  verification  of  no 
inactivation  of  MGL1(Y'11ý  by  the  compound  confirms  the  role  of  the  side  chain 
hydroxyl  group  as  the  site  for  covalent  attachment. 
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170 CHAPTER  5:  INVESTIGATION  INTO  T.  VAGINALIS 
CYSTEINE  SYNTHASE 
5.1  INTRODUCTION 
In  vitro  cultivation  of  T.  vaginalis  requires  reducing  agents  for  optimal  growth.  It 
has  been  shown  that  thiol  blocking  reagents  act  as  potent  anti-trichomonal 
compounds  with  cultured  parasites  (Gillin  et  al.,  1984).  Lacking  glutathione  or  an 
analogous  molecule  such  as  trypanothione  (Ellis  et  al.,  1994),  the  parasite  is 
thought  to  utilise  cysteine  as  the  primary  thiol  reductant.  Despite  this  there  is  no 
published  experimental  evidence  for  cysteine  synthesis  by  the  parasite,  either  by 
direct  sulphydration  (the  condensation  of  OAS  and  sulphide  by  cysteine 
synthase),  or  transuiphuration  (the  conversion  of  homocysteine  to  cysteine  by 
cystathionine  ß-synthase  (CBS)  and  cystathionine  y-lyase  (CGL)).  Very  low  levels 
of  CGL  activity  in  crude  lysates  has  been  detected  (Thong,  1985)  and  an 
"activated  serine  sulphydrase"  activity  described  that  has  similarities  to  CBS 
(Thong  and  Coombs,  1985b).  However  neither  of  these  have  been  shown  to 
produce  cysteine  from  homocysteine  either  in  vivo  or  in  vitro.  The  aim  of  this  part 
of  the  study  was  to  investigate  whether  the  parasite  has  the  ability  to  synthesise 
cysteine  by  direct  sulphydrylation. 
A  single  EST  clone  with  substantial  amino  acid  sequence  homology  to  cysteine 
synthase  was  identified  from  T.  vaginalis.  It  was  discovered  through  single  pass 
automated  DNA  sequencing  of  clones  from  a  cDNA  library  of  T.  vaginalis  strain 
G3.  The  library  was  produced  using  a  ZAP-cDNA®  synthesis  kit  (Stratagene) 
171 from  a  total  RNA  preparation  from  the  parasite.  A  large  number  of  clones  were 
randomly  chosen  and  sequenced.  A  tBLASTn  search  of  the  databases  was 
performed  with  the  nucleotide  sequences,  whereby  the  cDNA  sequence  was 
converted  into  all  6  possible  ORFs  (3  forward  and  3  reverse)  and  a  BLAST  search 
performed  to  find  homologues.  It  was  the  result  of  this  preliminary  search  which 
identified  the  clone  as  a  possible  cysteine  synthase  gene.  In  order  to  confirm  the 
identity  of  the  protein  encoded  by  this  gene  it  was  decided  first  to  verify  the 
nucleotide  sequence.  If  this  confirmed  that  the  gene  possessed  high  homology  to 
other  cysteine  synthasegenes,  then  it  was  to  be  cloned  into  a  prokaryotic 
expression  vector  to  produce  recombinant  protein  in  E.  coli  for  subsequent 
purification  and  characterisation.  The  expression  vector  selected  to  produce 
recombinant  enzyme  was  chosen  to  append  a  hexahistidine  tag  to  the  C-terminus 
of  the  mature  protein.  It  was  hoped  that  this  method  would  be  able  to  repeat  the 
success  in  expression  and  affinity  purification  of  recombinant  T.  vaginalis  MGL. 
When  deciding  upon  the  position  of  the  hexahistidine  tag,  the  published  structure 
of  0-acetyl  serine  sulfhydrylase  (cysteine  synthase)  from  S.  typhimurium  was 
examined.,  The  model  shows  a  disordered  C-terminal  end  in  the  crystal  structure 
(Burkhard  et  aL,  1998)  implying  that  changes  made  to  this  end  would  have 
minimal  effects  upon  the  overall  fold.  In  order  to  introduce  the  fewest  changes 
into  the  cysteine  synthase  ORF  and  to  position  the  hexahistidine  tag  at  the  C- 
terminus  of  the  protein,  the  vector  chosen  was  pET21  a+  (Novagen).  This  would 
then  allow  affinity  purification  of  the  recombinant  enzyme  in  an  analogous  fashion 
to  MGL  using  a  metal  chelate  chromatography  method  (McKie  et  al.,  1998).  Basic 
biochemical  characterisation  of  the  enzyme  could  then  be  carried  out  and  it  would 
172 be  examined  for  "activated  serine  sulphydrylase"  activity  as  previously  identified 
in  the  parasite  (Thong  and  Coombs,  1985b). 
There  are  commonly  multiple  isoforms  of  cysteine  synthase  present  in  micro- 
organisms  and  plants.  These  may  be  either  cytosolic  or  targeted  to  specific 
organelles.  However  only  a  single  clone  was  discovered  in  the  several  hundred 
clones  from  T.  vaginalis  sequenced.  It  was  envisaged  that  using  either  antibodies 
raised  against  the  recombinant  protein  or  nucleic  acid  hybridising  techniques,  any 
additional  gene  copies  or  homologues  would  be  identified.  Also  with  these 
specific  probes,  the  role  of  the  enzyme  in  the  parasite  could  be  investigated. 
5.2  RESULTS 
5.2.1  Sequencing  and  Genomic  Analysis  of  Cysteine  Synthase 
5.2.1.1  Verification  of  the  Putative  Cysteine  Synthase  Gene 
Clone  215  was  provided  by  Dr  R  Hirt  (Natural  History  Museum,  London)  and  the 
results  of  preliminary  sequencing  showed  homology  to  cysteine  synthase  genes  in 
the  databases.  A  BLAST  search  of  the  databases  showed  high  levels  of 
homology  to  identified  cysteine  synthase  genes  and  low  homology  to 
cystathionine  ß-synthase  and  threonine  deaminase,  other  members  of  the  ß-family 
of  PLP-dependent  enzymes.  To  confirm  the  sequence'of  the  cDNA  clone  the 
plasmid  insert  was  fully  sequenced  in  both*  sense  and  antisense  directions  using 
automated  DNA  sequencing.  -  Oligonucleotide  primers  designed  against  the 
173 flanking  plasmid  sequence  (M13  and  T3)  and  internal  gene  specific  primers 
(OASS2  and  OASS3)  were  used  as  detailed  in  section  2.2.12.  The  sequence  of 
the  gene  is  given  in  figure  5.6. 
The  sequence  of  clone  215  showed  the  presence  of  the  poly-A  tail  from  the 
reverse  transcribed  mRNA.  This  confirmed  the  3'  end  of  the  ORF  was  complete. 
After  fully  sequencing  the  gene  in  both  directions  an  ORF  of  897  nucleotides  was 
evident.  Comparison  of  the  amino  acid  sequence  with  other  cysteine  synthase 
enzymes  showed  that  the  predicted  length  of  299  residues  was  consistent  with 
that  generally  found  in  other  organisms.  A  TAA  stop  codon  was  confirmed  by 
repeated  sequencing  of  the  clone  and  assumed  to  be  correct.  Upstream  of  the 
putative  start  codon  were  an  additional  15  nucleotides.  These  bases,  shown 
below,  were  then  taken  to  be  the  5'  untranslated  region  (5'-UTR)  of  the  mRNA: 
5'  -  CGAGTCGGCACGAGC  -  3' 
This  very  short  UTR  is  consistent  with  the  findings  with  other  genes  isolated  from 
T.  vaginalis  (Quon  et  al.,  1994).  However  to  properly  identify  the  correct  start 
codon  and  ensure  a  full  length  cDNA  had  been  isolated,  5'-RACE  was  attempted. 
Experimental  details  are  given  in  section  2.2.17.  This  was  carried  out  in  parallel 
to  the  production  of  an  expression  construct  as  specified  in  section  5.2.1.1. 
Attempts  to  isolate  the  5'-UTR  by  5'-RACE  were  unsuccessful  though. 
Repeatedly,  the  final  products  of  the  reactions  were  a  faint  smear  visible  on  an 
agarose  gel.  This  corresponded  to  dsDNA  products  of  various  sizes  up  to 
approximately  1  kbp.  An  example  of  the  results  obtained  is  shown  in  figure  5.1. 
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Figure  5.1.5'-RACE  products  of  cysteine  synthase.  Ethidium  bromide  stained  1%  agarose  gel 
showing  the  final  DNA  products.  Lane  A-  DNA  standards;  Lanes  B&C-  Final  PCR  products  of 
two  separate  reactions.  DNA  from  100  to  400  bp  is  partially  obscured  by  the  bromophenol  blue 
dye  present  in  the  DNA  loading  buffer. 
From  the  design  of  the  gene  specific  oligonucleotide  primers  (OASS  4  and  OASS 
5),  the  expected  size  of  the  fragments  produced  was  >_  350  bp.  Control  reactions 
indicated  that  the  conversion  of  mRNA  to  cDNA  and  poly-dC  tailing  were 
successful  and  that  failure  was  therefore  due  to  PCR  amplification. 
5.2.1.2  Identification  of  the  Copy  Number  of  T.  vaginalis  Cysteine  Synthase 
Gene 
Southern  blot  analysis  of  gDNA  with  the  cysteine  synthase  ORF  was  performed  to 
identify  the  copy  number  of  the  gene,  to  determine  if  any  homologues  are  present 
within  the  parasite  genome  and  also  to  confirm  the  presence  of  the  gene  and  rule 
out  contamination  by  other  organisms  in  the  original  cDNA  synthesis  step. 
175 As  mentioned  previously  there  are  often  multiple  isoforms  of  cysteine  synthase 
present  in  an  organism.  Often  one  isoform  is  specifically  associated  with  an 
organelle  such  as  chloroplasts  or  mitochondria,  with  the  possibility  of  multiple 
isoforms  in  the  cytosol.  It  was  therefore  of  some  interest  to  examine  the 
possibility  that  this  may  be  the  case  in  the  parasite.  It  was  hoped  that  there  would 
be  sufficient  homology  between  any  isoforms  to  allow  a  probe  synthesised  against 
the  known  cysteine  synthase  gene  to  be  used  to  investigate  this. 
Initially  restriction  digests  of  T.  vaginalis  gDNA  showed  a  number  of  distinct  bands 
of  various  sizes  when  separated  on  an  agarose  gel.  This  was  thought  to  be  due 
to  highly  repetitive  nucleotide  sequences  within  the  parasite  genome  (Wang  and 
Wang,  1985).  This  banding  had  also  been  seen  in  the  analysis  of  mgl  (McKie, 
1997).  However  by  performing  a  second  proteinase  K  treatment  of  the  gDNA  with 
the  intention  of  removing  bound  proteins  (for  method  see  2.2.4),  subsequent 
digests  produced  a  heterogeneous  smear  of  DNA  when  separated  on  an  agarose 
gel.  This  does  not  exclude  the  presence  of  highly  repetitive  sequences  but 
suggests  that  incomplete  digestion  of  the  gDNA  may  have  been  at  least  partly 
responsible  for  the  bands  visible  previously.  When  isolating  gDNA,  it  was 
collected  by  spooling  out  the  precipitated  DNA  with  a  pasteur  pipette  tip  rather 
than  by  centrifugation.  This  reduced  the  amount  of  small  fragments  of  sheared 
gDNA  recovered  which  could  potentially  lead  to  spurious  results. 
Thus  complete  digests  of  10  µg  of  gDNA  were  resolved  by  0.7%  agarose  gel 
electrophoresis  and  transferred  to  Hybond  N  filters  (Amersham)  using  the 
supplied  protocol  adapted  from  the  method  of  Southern  (1975).  The  transferred 
176 DNA  was  UV  cross-linked  before  the  filters  were  used  for  hybridisation  with 
radioactively  labelled  probes.  The  probe  was  synthesised  and  radioactively 
labelled  by  a  random  primer  method  using  the  Prime  ItTm  kit  (Stratagene) 
incorporating  50  . tCi  32P-dATP  using  a  partial  ORF  of  EST215  as  the  probe.  This 
fragment  was  produced  by  performing  an  Xhol  digest  on  the  plasmid  and  gel 
purifying  the  resulting  900  bp  fragment  to  be  used.  Only  20  bp  of  the  gene 
sequence  is  omitted  in  this  template  and  should  not  reduce  the  specificity  of  the 
probe.  Hybridisation  of  the  probe  and  subsequent  washing  of  the  filters  was 
performed  under  high  stringency  conditions  of  0.1  x  SSC  with  0.1%  SDS  at  65  °C. 
Figure  5.2  illustrates  the  result  of  Southern  blot  analysis  of  T.  vaginalis  gDNA 
digested  with  four  different  restriction  enzymes. 
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Figure  5.2:  Southern  blot  of  T.  vaginalis  genomic  DNA  hybridised  with  the  900  bp  cysteine 
synthase  specific  probe.  Lane  A-  Hind  III  digest;  B-  EcoRV  digest;  C-  EcoRl  digest;  D-  Clal 
digest;  E-  DNA  standards.  Film  was  exposed  for  72  hours  at  -70  °C. 
Multiple  bands  are  visible  for  each  digest  with  a  single  band  in  each  lane 
producing  a  stronger  signal  compared  with  the  others.  The  digest  by  Hindill 
produces  a  strong  signal  corresponding  to  -700  bp  which  would  be  obtained  if  the 
cDNA  sequence  was  digested  with  the  same  enzyme.  To  identify  if  any  of  the 
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0.65 bands  were  non-specific  or  had  arisen  through  incomplete  digest  of  gDNA,  the 
work  was  repeated.  The  result  was  identical  banding  as  seen  in  the  figure  above. 
5.2.1.3  Sequence  Analysis 
In  order  to  identify  the  cDNA  clone  isolated  from  the  parasite,  the  translated 
amino  acid  sequence  was  examined  more  closely  for  homology  to  other 
sequences  in  the  database.  The  results  of  blast  searches  consistently  indicated 
that  the  sequence  was  indeed  a  cysteine  synthase.  When  aligned  against  a 
number  of  these  the  homology  was  clear  (Figure  5.3).  Table  5.1  gives  the 
sequence  identities  and  similarities  of  selected  cysteine  synthases  to  the  T. 
vaginalis  enzyme. 
Organism  Identities  (%)  Similarities  (%) 
Aquifex  aoelicus  49  67 
E.  histolytica  Type  I  47  65 
S.  typhimurium  Type  B  45  64 
Capsicum  annuum  43  62 
Spinicia  oleracea  42  60 
S.  typhimurium  Type  A  42  57 
Table  5.1:  Sequence  homologies  of  selected  cysteine  synthase  enzymes  with  putative  T.  vaginalis 
cysteine  synthase. 
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T.  vaginalis  MIYDNILEIIGNII'IVRINHLIPNP----KVQMYRVLIGFHI'TGSVKDRIRLKMIEl1IIERE 
R.  aeolicus  MSLKSCLMUVLGEHDEPYRKRRETILKLVGNII'IVRVKKCLPED-IPEDVEIIIHKLFSFHPGGSVKDRPRLSMFLIIHLKR 
E.  coli_B  MSTLEQTIGNIPIVKLQRMGPDN----  GSEVIILKLFGNNPRGSVKDRRRLSMIVIIIEKR 
S.  typhinuriun_B  MNTLEQTIGNII'I  VKLQRLGPDN----  GSEIIIVKLI  GNNI'RG  5VKDRRRLSMIVI  IIEKR 
E.  Coli_R  SKIFEDNSLTIGHII'IVRLNRIGNG-------RILHfVISRNI'SFSVKCRIGRNMINDHEKR 
S.  typhinuriun_R  SKIYEDNSLTIGHII  I  VRLNRIGNG------RILHkVI  SRNI'SP;  VKCNIGRNMIUI  IIFKR 
Z.  nays_R  MGERSPSIRKDVTELIGNII'IVYLNKVTDGCV----GRSRHKIISMIPCSSVIDxIGYSMITUHEEK 
S.  oleracea_R  MVEEKRFIRKDVTELIGKIPI  VYLNTVRDGCV----RRVRHKI  I  Gill  I'CS  '.  lIJPIGFSMITIIII[KS 
E.  histolytica  MEQISISSPRKRIYHNILETIGGTPIVELHGVTEHPRIKKGTRILVKLIYFNI'MSSVKURVGFNIVYl1HIKD 
E.  dispar  MEQISINSPRKRIYHNILETIGGTPFVELHRVTEHPTIKKGTRILVKLIYFNF'MSSVKURVGFNIVYUHIKN 
Consensus 
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GKLHPG-STIIERTSGNTGIGLRMIGRVKGYNVIIVMSEGVSIIRRKMIKRFGHEIIITDKKLGTDGIIIRKVRELVKENP 
H.  aeolicus  GLIKEG-KVVIDRTSGNTGIRIRMVGRRLGVPVELRMPHNVtiEIRKKIIKHFGHKLYIIDPLEITDGHILFVRFLVQKYP 
E.  coli_B  GEIKPG-DVLIEHTSGNTGIRLRMIRRLKGYRMKLLFiPDNm,  QlPRRRMRHYGRELIIVTKEQI;  MEGHRDLRLFMRNRGE 
S.  typhinuriun_B  GEIKPG-DVLIERTSGNTGIRLRHIRRLKGYRNKLLFIPDNMSQI  F'RRRMRIIY!;  IIELII  VTKEQ(,  ￿E!  IIIRDLRLRMSERGE 
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Figure  5.3:  Alignment  of  cysteine  synthase  amino  acid  sequences.  Produced  using  MULTALIN. 
Residues  printed  in  red  are  >90%  conserved  and  those  in  blue  are  >50%  conserved.  Sequences 
are:  T.  vaginalis  -  putative  T.  vaginalis  enzyme;  A.  aeolicus  -  type  B  enzyme  from  Aquifex  aeolicus; 
E.  coli_B  -  type  B  from  E.  coli;  S.  typhimurium_B  -  type  B  from  S.  typhimurium;  E.  coli  A-  type  A  from 
E.  coli;  S.  typhimurium  A-  type  A  from  S.  typhimurium;  Z.  mays_A  -  cytosolic  type  from  Zea  mays 
180 (maize);  S.  oleracea_A  -  cytosolic  type  from  S.  oleracea  (spinach);  E.  histolytica  -  type  1  from  E. 
histolytica;  E,  dispar  -  type  1  from  Entamoeba  dispar. 
The  high  degree  of  similarity  and  identity  between  the  sequences  is  evident  from 
the  figure,  despite  the  diversity  of  the  organisms.  The  large  number  of  identities 
would  prevent  the  prediction  of  essential  or  important  residues  by  sequence 
analysis  alone.  However  the  crystal  structure  of  the  type  A  enzyme  from  S. 
typhimurium  is  available  for  us  to  study  (Burkhard  et  al.,  1998).  As  with  all  PLP- 
dependent  enzymes,  the  cofactor  is  bound  to  the  enzyme  through  the  side  chain 
amine  group  of  a  lysine  residue.  This  is  Lys4l  in  S.  typhimurium  and  is 
unsurprisingly  100%  conserved.  Also  100%  conserved  are  a  number  of  residues 
involved  in  cofactor  binding:  Asn7l,  Thr177,  Thrl80  and  Ser272  (S.  typhimurium 
numbering).  Although  no  substrate  or  inhibitor  complex  structures  were  produced 
the  authors  postulated  a  model  for  O-acetyl-L-serine  binding.  Of  the  residues 
predicted  to  interact  with  the  substrate  during  the  first  part  of  the  reaction  five  are 
conserved  amongst  cysteine  synthase  enzymes:  Thr68,  Thr72,  Gin  142,  Phe143 
and  His152  (S.  typhimurium  numbering).  This  limited  comparison  with  the 
structure  would  indicate  that  the  same  functional  groups  are  present  in  the  active 
site  of  the  T.  vaginalis  enzyme. 
In  order  to  further  analyse  the  sequence  of  the  cysteine  synthase  from  T. 
vaginalis,  it  was  decided  to  produce  a  graphic  comparison  of  a  large  number  of 
cysteine  synthase  sequences.  It  was  hoped  that  the  results  of  this  would  provide 
more  information  on  the  relative  relationships  between  enzymes.  Such 
information  may  be  helpful  in  postulating  an  evolutionary  lineage  for  the  enzyme, 
or  more  likely  and  helpful  in  this  case,  identify  functional  homology.  A  number  of 
181 cysteine  synthase  sequences  were  first  obtained  from  the  databases.  The 
programme  MULTALIN  was  then  used  first  to  produce  a  sequence  alignment  and 
then  a  plot  of  the  relative  similarities  (Figure  5.4). 
The  plot  produced  by  this  alignment  programme  is  a  display  of  the  "hierarchical 
clustering"  used  to  produce  the  final  alignment  (Corpet,  1988).  The  programme 
uses  this  technique  to  produce  accurate  pairwise  alignments  of  multiple 
sequences  which  cannot  be  achieved  directly.  Thus  the  plot  gives  an  accurate 
representation  of  the  similarities  between  sequences  but  there  is  no  consideration 
given  to  the  codon  changes  necessary  for  a  specific  residue  change.  Therefore 
the  final  product  does  not  represent  a  phylogenetic  analysis  of  the  T.  vaginalis 
enzyme  but  a  more  direct  comparison  of  the  amino  acid  sequences. 
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Figure  5.4:  Hierarchical  clustering  of  cysteine  synthase  amino  acid  sequences.  Figure  plotted 
using  MULTALIN.  Cys  K-  plant  cytosolic  or  type  A,  Cys  L-  plant  organelle  localised,  Cys  M-  type 
B  (cytosolic).  Enzyme  nomenclature  is  taken  from  database  submissions.  The  position  of  the  T. 
vaginalis  sequence  is  highlighted  in  bold  text.  All  plant  sequences  are  shown  in  red. 
The  simple  analysis  of  a  reasonable,  but  not  exhaustive,  sample  of  cysteine 
synthase  enzymes  from  a  number  of  organisms  shows  that  despite  the  obvious 
sequence  homology  overall,  the  trichomonad  enzyme  does  differ  significantly  from 
183 most  other  eukaryotic  and  prokaryotic  examples.  Figure  5.4  shows  the  clear 
subdivision  of  plant  sequences  from  all  others.  Bacterial  sequences  are  more 
obviously  divisible  into  subspecies,  type  A  and  B.  The  sequences  from  both 
Entamoeba  species  are  distinguishable  from  each  other.  However  the  two 
enzymes  from  both  species  do  not  differ  significantly  and  so  are  not  separated  in 
the  figure.  The  T.  vaginalis  sequence  shows  the  least  divergence  from  a  type  B 
enzyme  from  A.  aeolicus,  a  hyperthermophilic  bacteria  (Deckert  et  al,  1998).  It 
also  seems  to  be  more  similar  to  type  B  rather  than  type  A  enzymes  from  E.  coli 
and  S.  typhimurium  among  others.  This  is  an  interesting  observation  as  the  type 
B  bacterial  enzymes  are  proposed  to  be  preferentially  expressed  under  anaerobic 
conditions  in  these  organisms. 
5.2.1.4  Cysteine  Synthase  Subcloning  into  a  Prokaryotic  Expression  Vector 
To  confirm  that  the  enzyme  encoded  by  the  nucleotide  sequence  was  a  functional 
cysteine  synthase  enzyme,  it  was  decided  to  clone  the  gene  into  a  plasmid  vector 
for  expression  in  E.  coli.  Due  to  the  low  homology  seen  at  the  N-terminus  of 
cysteine  synthase  sequences,  it  was  not  possible  to  align  sequences  sufficiently 
to  be  sure  that  the  correct  start  codon  was  being  used.  However  whilst  5'-RACE 
experiments  were  being  conducted  to  confirm  this,  it  was  decided  to  continue  with 
production  of  an  expression  construct. 
A  PCR  based  strategy  was  adopted  to  facilitate  rapid  and  easy  cloning  of  the 
gene  into  the  pET21  a+  expression  vector.  This  involved  adding  appropriate 
restriction  sites  to  the  5'  and  3'  end  of  the  cysteine  synthase  ORF  via  specific 
oligonucleotide  primers.  After  subcloning  of  this  PCR  product  into  a  plasmid 
184 vector,  the  ORF  could  then  be  excised  by  restriction  endonuclease  digest  and  the 
fragment  re-ligated  into  the  precut  expression  vector.  Figure  5.5  summarises  the 
procedure. 
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NdeI  Sail Figure  5.5:  Construction  of  recombinant  cysteine  synthase  expression  vector.  I-  PCR  amplification 
of  cDNA  clone  EST  215;  II  -  Ligation  of  PCR  product  into  plasmid  vector  pGEM-T  and  construction  of 
plasmid  CSpG;  III  -  NdelISall  double  digest  of  plasmid  CSpG  to  excise  cysteine  synthase  ORF;  IV  - 
Ligation  of  fragment  into  pET21  a+  vector  predigested  with  Ndel  and  Xhol  to  produce  expression 
plasmid  CSpET;  V-  Transform  plasmid  CSpET  into  E.  coli  BL21  DE3  for  recombinant  enzyme 
expression.  Primers  used  and  restriction  sites  are  indicated.  Z  represents  the  chimeric  SaNXhol 
restriction  site,  the  location  of  the  hexahistidine  tag  is  marked  in  blue. 
The  supplied  EST  clone  215  was  used  as  the  template  for  PCR  with  Taq  DNA 
polymerase  using  the  oligonucleotide  primers  OASS1  and  OASS7  as  listed  in 
section  2.2.12.  Non-proof-reading  polymerases  such  as  Taq  add  an  adenine 
base  at  the  Vend  of  the  DNA  product.  The  use  of  a  T-tailed  cloning  vector 
makes  the  ligation  of  these  PCR  products  easier  because  of  a  5'  complementary 
thymine  overhang.  However  there  is  a  higher  likelihood  of  incorporating  errors 
into  the  amplified  fragment  using  Taq  compared  with  thermostable  polymerases 
which  have  a  proof-reading  ability.  Therefore  replicates  were  performed  to 
ensure  a  copy  without  mutations  incorporated  was  synthesised. 
Four  separate  reactions  were  carried  out  and  each  was  ligated  into  pGEM-T 
(Promega).  Positive  clones  were  selected  after  transformation  into  commercially 
supplied  chemical  competent  XL1-Blue  cells  (Stratagene)  by  blue-white  selection 
with  X-GAL.  Selected  positives  were  confirmed  by  MOW  double  restriction 
digest  and  automated  DNA  sequencing.  The  cloned  PCR  fragment  was  excised 
from  purified  plasmid  by  digestion  with  Ndel  and  Sall  restriction  enzymes  and 
separated  on  a1%  agarose  gel  prior  to  gel  extraction.  This  fragment  was  then 
ligated  into  Ndel/Xhol  restricted  pET2la+,  to  produce  plasmid  CSpET, 
186 transformed  into  E.  co/iXLI-Blue  cells  and  antibiotic  resistant  positive  clones 
selected  for  by  growing  on  LBAmp  plates. 
The  Ndel  site  at  the  5'  end  regenerates  the  ATG  start  codon  and,  unlike  the  Ncol 
used  in  the  cloning  of  mg11,  does  not  enforce  any  changes  in  the  ORF  (McKie  et 
al.,  1998).  A  Safi  site  was  used  at  the  3'  end  of  the  gene  to  provide  a  compatible 
overhang  to  the  linearised  plasmid.  This  site  was  chosen  in  preference  to  an  Xhol 
site  because  of  an  internal  Xhol  site  20  bp  downstream  of  the  start  codon.  The 
two  restriction  enzymes  have  different  recognition  sites  but  cleavage  results  in 
complementary  overhangs.  Had  an  Xhol  site  been  used  it  would  have  required  a 
partial  Ndel/Xhol  double  digest  to  excise  only  the  899  bp  fragment.  There  would 
have  been  difficulty  in  distinguishing  between  this  and  the  smaller  879  bp 
fragment  resulting  from  cleavage  at  the  internal  Xhol  site.  Ligating  together  these 
ends  results  in  the  loss  of  both  the  Sall  and  Xhol  sites  but  this  was  not  deemed  to 
be  detrimental. 
Thus  the  predicted  expressed  recombinant  protein  would  possess  two  residues 
encoded  by  the  chimeric  SaMChol  restriction  site  (aspartic  acid  and  glutamic  acid) 
and  six  histidine  residues  at  the  C-terminus  in  addition  to  the  original  sequence. 
Positive  clones  were  sequenced  to  confirm  no  nucleotide  errors  had  been 
incorporated  during  the  cloning  process  before  transformation  of  the  plasmid  into 
E.  coil  strain  BL21  DE3(Novagen)  for  expression.  The  complete  nucleotide  and 
predicted  amino  acid  sequence  of  the  cysteine  synthase  gene  is  shown  in  figure 
5.6.  The  location  of  the  restriction  sites  added  in  generation  of  the  expression 
187 construct  are  indicated.  Amino  acid  differences  between  the  original  sequence 
and  the  final  expression  construct  are  shown  in  bold  text. 
NdeI  Xhol 
MIYDNILETIGNTPLV 
1  CATATGATCT  ACGACAACAT  CCTCGAGACA  ATCGGTAACA  CACCACTCGT 
GTATACTAGA  TGCTGTTGTA  GGAGCTCTGT  TAGCCATTGT  GTGGTGAGCA 
Hindill 
RINHLIPNPKVQMYAK 
51  TCGCATCAAT  CATCTCATCC  CAAATCCAAA  GGTCCAGATG  TACGCCAAGC 
AGCGTAGTTA  GTAGAGTAGG  GTTTAGGTTT  CCAGGTCTAC  ATGCGGTTCG 
HindIII 
LEGFNPTGSVKDRIALK 
101  TTGAAGGTTT  CAACCCAACA  GGTTCCGTCA  AGGATCGTAT  CGCTCTTAAG 
AACTTCCAAA  GTTGGGTTGT  CCAAGGCAGT  TCCTAGCATA  GCGAGAATTC 
MIEQAEAEGKLHPGSTI 
151  ATGATTGAGC  AGGCAGAAGC  CGAAGGCAAG  CTCCATCCAG  GATCAACAAT 
TACTAACTCG  TCCGTCTTCG  GCTTCCGTTC  GAGGTAGGTC  CTAGTTGTTA 
IEATSGNTGIGLAMIG 
201  CATCGAGGCT  ACATCCGGAA  ACACAGGTAT  CGGCCTTGCT  ATGATTGGCC 
GTAGCTCCGA  TGTAGGCCTT  TGTGTCCATA  GCCGGAACGA  TACTAACCGG 
RVKGYNVIIVMSEGVSI 
251  GTGTCAAGGG  CTACAACGTC  ATCATCGTTA  TGAGTGAGGG  CGTTTCAATC 
CACAGTTCCC  GATGTTGCAG  TAGTAGCAAT  ACTCACTCCC  GCAAAGTTAG 
ERRKMIKAFGAEIILTD 
301  GAACGCCGTA  AGATGATCAA  GGCCTTCGGT  GCTGAAATCA  TCCTTACAGA 
CTTGCGGCAT  TCTACTAGTT  CCGGAAGCCA  CGACTTTAGT  AGGAATGTCT 
KKLGTDGAIRKVAELV 
351  CAAGAAGCTC  GGCACAGATG  GCGCCATCCG  TAAGGTTGCT  GAACTCGTTA 
GTTCTTCGAG  CCGTGTCTAC  CGCGGTAGGC  ATTCCAACGA  CTTGAGCAAT 
KENP 
401  AGGAGAACCC 
TCCTCTTGGG 
NKI4 
451  AACAAGATCG 
TTGTTCTAGC 
GKYFNPNQFSNEY 
AGGCAAGTAC  TTCAACCCTA  ACCAGTTCTC  TAACGAATAC 
TCCGTTCATG  AAGTTGGGAT  TGGTCAAGAG  ATTGCTTATG 
AHYKTTAEEIWAQT 
CCCACTACAA  GACAACAGCA  GAAGAAATCT  GGGCCCAGAC 
GGGTGATGTT  CTGTTGTCGT  CTTCTTTAGA  CCCGGGTCTG 
KGTVTHFVAAVGTSGT 
501  AAAGGGAACA  GTTACCCACT  TCGTTGCTGC  TGTCGGCACA  TCCGGCACAC 
TTTCCCTTGT  CAATGGGTGA  AGCAACGACG  ACAGCCGTGT  AGGCCGTGTG 
LMGVGKNLREKNPEIKI 
551  TCATGGGTGT  TGGCAAGAAC  CTTCGTGAGA  AGAACCCAGA  AATCAAGATC 
AGTACCCACA  ACCGTTCTTG  GAAGCACTCT  TCTTGGGTCT  TTAGTTCTAG 
188 IEAQPTKGHYIQGLKSM 
601  ATTGAAGCTC  AGCCAACAAA  GGGCCACTAT  ATCCAGGGCT  TGAAGTCCAT 
TAACTTCGAG  TCGGTTGTTT  CCCGGTGATA  TAGGTCCCGA  ACTTCAGGTA 
EEAIVPAIYQADKIDE 
651  GGAAGAAGCT  ATTGTCCCAG  CTATTTACCA  GGCTGACAAG  ATTGATGAGC 
CCTTCTTCGA  TAACAGGGTC  GATAAATGGT  CCGACTGTTC  TAACTACTCG 
HILIESEEAFAKAREIV 
701  ACATCCTCAT  CGAGTCTGAA  GAGGCATTCG  CCAAGGCACG  TGAAATCGTT 
TGTAGGAGTA  GCTCAGACTT  CTCCGTAAGC  GGTTCCGTGC  ACTTTAGCAA 
AQEGIFIGMSSGAAMLA 
751  GCTCAGGAAG  GCATCTTCAT  CGGCATGAGC  TCTGGCGCTG  CTATGCTCGC 
CGAGTCCTTC  CGTAGAAGTA  GCCGTACTCG  AGACCGCGAC  GATACGAGCG 
HindIII 
AQKLAEKIDSGVIVVL 
801  TGCTCAGAAG  CTTGCTGAGA  AGATTGACAG  CGGTGTCATT  GTTGTTCTCT 
ACGAGTCTTC  GAACGACTCT  TCTAACTGTC  GCCACAGTAA  CAACAAGAGA 
FADRGEKYLSTKLFDTE 
851  TCGCTGATCG  CGGTGAGAAA  TACCTTTCAA  CAAAGCTCTT  CGACACAGAA 
AGCGACTAGC  GCCACTCTTT  ATGGAAAGTT  GTTTCGAGAA  GCTGTGTCTT 
VEHHHHHH* 
901  GTCGAGCACC  ACCACCACCA  CCACTGA 
CAGCTCGTGG  TGGTGGTGGT  GGTGACT 
Figure  5.6:  Nucleotide  and  single  letter  amino  acid  code  sequence  of  plasmid  CSpET.  Changes 
introduced  in  cloning  are  shown  in  bold  teed. 
5.2.2  Expression  and  Purification  of  Recombinant  Cysteine  Synthase 
5.2.2.1  Test  Induction  and  Expression  of  Recombinant  Cysteine  Synthase 
Small  scale  test  expressions  of  recombinant  enzyme  produced  in  E.  coli  were 
carried  out  before  proceeding  on  to  larger  scale  preparations.  Single  colonies  of 
E.  coli  containing  plasmid  CSpET  were  obtained  by  streaking  out  cells  onto 
ampicillin-containing  LB  agar  plates  and  growing  overnight  at  37  T.  An  overnight 
culture  was  produced  by  inoculating  10  ml  LB  with  a  single  colony  and  growing 
overnight  at  37  °C  with  shaking.  5  ml  of  this  was  added  to  50  ml  LBAMP  and  grown 
at  37  OC  with  shaking  until  the  OD6w  reached  0.6-0.8.  Recombinant  enzyme 
189 expression  was  induced  by  the  addition  of  0.2,0.5,1.0  and  2.0  mM  IPTG.  5  ml 
samples  were  taken  at  hourly  intervals  from  0  to  4  hours  post  induction,  harvested 
by  centrifugation  at  3200  g  for  15  minutes  and  stored  at  -20  °C.  Cells  were  lysed 
as  detailed  in  section  2.3.7.  The  resulting  supernatant  was  analysed  under 
reducing  conditions  on  10%  SDS-PAGE  and  stained  with  Coomassie  blue  (Figure 
5.7). 
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Figure  5.7:  Coomassie  blue  stained  SDS-PAGE  of  E.  coli  soluble  proteins  from  test  inductions  of 
recombinant  cysteine  synthase  expression.  Image  I-0.5  mM  IPTG,  II  -  2.0  mM  IPTG.  Lanes  A- 
protein  standards,  B-0  hours  induction,  C-1  hour  post-induction,  D-2  hours  post-induction,  E-3 
hours  post-induction,  F-4  hours  post-induction. 
A  prominent  band  of  between  30  and  35  kDa  was  clearly  visible  in  the  non- 
precipitated  portion  of  the  bacterial  lysate  after  induction.  This  situation  was 
highly  similar  with  all  concentrations  of  IPTG  (data  not  shown  for  0.2  and  1.0  mM 
IPTG).  There  was  no  apparent  increase  in  recombinant  protein  production  after  3 
hours  of  induction.  The  insoluble  fraction  of  the  E.  coli  lysate  was  not  examined 
for  recombinant  protein  due  to  the  high  levels  of  soluble  protein  evident. 
190 The  results  of  these  experiments  confirmed  high  level  expression  of  a  soluble 
protein  of  the  expected  size  and  provided  a  set  of  standard  conditions  to  enable 
purification  of  the  recombinant  enzyme. 
5.2.2.2  Routine  Expression  and  Purification  of  Recombinant  Cysteine 
Synthase 
Following  the  conditions  found  above,  a  single  E.  coli  colony  containing  plasmid 
CSpET  was  used  to  inoculate  50  ml  LBAmp  to  provide  a  starter  culture.  This  was 
grown  overnight  at  37  °C  with  shaking  and  added  the  next  day  to  500  ml  LBAMP 
and  again  grown  at  37  °C  with  shaking  until  reaching  an  ODD  of  0.6-0.8.  The 
production  of  recombinant  enzyme  was  induced  by  the  addition  of  0.5  mM  IPTG. 
The  culture  was  grown  for  a  further  3  hours  before  harvesting  by  centrifugation  at 
4000  g  at  which  point  the  cells  were  stored  at  -20  °C  until  required.  The 
. cell  pellet 
was  resuspended  in  -5  ml  50  mM  sodium  phosphate  pH  8.0  with  20  µM  PLP  and 
lysed  by  sonication  at  maximum  amplitude  with  a  Soniprep  1000.10  rounds  of 
sonication  were  performed  to  adequately  lyse  the  cells.  Each  round  was  of  10,1 
second  pulses  with  a1  second  pause  between  each  pulse  and  a1  minute  pause 
between  each  round.  The  cytosolic  fraction  containing  soluble  enzyme  was 
separated  from  intact  cells  and  insoluble  debris  by  centrifugation  at  10  000.  g  for 
30  minutes  at  4  °C  before  clarification  through  a  0.22  µm  syringe  filter.  The 
soluble  crude  lysate  preparation  was  then  loaded  onto  a  pre-equilibrated  Ni-NTA 
column  and  purified  in  an  identical  manner  to  that  used  for  rMGL  as  detailed 
already  in  this  thesis  in  section  3.2.1.  The  purification  profile  output  is  shown  in 
191 figure  5.8.  Figure  5.9  shows  the  results  of  a  routine  preparation  with  samples  of 
each  eluate  loaded  onto  SDS-PAGE  for  examination. 
... 
_ 
ýý.. 
_i.,.  _. 
i 
_..  __...  __.  _  ..  i_.  _... 
:. 
i 
i 
I 
\ý  i 
c 
:v 
V 
Figure  5.8:  FPLC  profile  of  recombinant  cysteine  synthase.  The  blue  line  represents  the 
absorbance  at  a  wavelength  of  280  nm  of  the  column  eluate  (limit  of  absorbance  is  2.0  AU).  The 
red  line  represents  the  proportion  of  imidazole  containing  buffer  (500  mM)  loaded. 
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Figure  5.9:  Coomassie  blue  stained  10  %  SDS-PAGE  of  a  standard  purification  of  recombinant 
cysteine  synthase.  Lane  A-  10  kDa  ladder,  B-E.  coli  supernatant,  C-  column  flow  through,  D- 
first  wash,  E-  75  mM  imidazole  wash,  F  to  L-  successive  1  ml  fractions  from  linear  imidazole 
gradient. 
The  flow  through  collected  when  loading  the  column  shows  the  great  reduction  in 
the  prominent  band  at  -35  kDa  when  compared  with  the  E.  coli  supernatant.  The 
first  wash  step  and  the  75  mM  imidazole  wash  step  removed  a  large  number  of  E. 
coli  contaminating  proteins.  Although  not  easily  seen  in  figure  5.9  this  was  most 
evident  in  figure  5.8  where  it  was  shown  as  a  sharp  peak,  partially  obscured  by 
the  background  absorbance  of  the  imidazole  containing  buffer.  Subsequent 
elution  at  apparent  imidazole  concentrations  of  between  90  and  130  mM 
produced  a  single  major  band  which  ran  as  an  -35  kDa  protein  in  direct 
agreement  with  the  predicted  mass  of  the  enzyme.  Sample  homogeneity  was 
routinely  checked  by  SDS-PAGE  stained  with  Coomassie  blue.  The  purest 
fractions  were  pooled  and  dialysed  at  4  °C  overnight,  at  a  concentration  of 
1  mg/ml,  into  100  mM  sodium  phosphate  pH  7.5  with  300  mM  NaCl.  It  has  been 
noted  for  MGL  that  the  presence  of  imidazole  in  the  storage  buffer  has  a 
193 away.  The  action  of  imidazole  as  a  chaotrophe  is  probably  responsible  for  this 
and  therefore  the  decision  was  taken  to  remove  this  after  purification  of  cysteine 
synthase  prior  to  storage. 
This  method  of  purification  has  been  shown  to  be  simple  and  highly  effective  in 
the  preparation  of  recombinant  MGLI.  Approximately  10  mg  of  highly  pure 
recombinant  cysteine  synthase  was  produced  from  a  500  ml  culture.  The  cloning 
strategy  used  resulted  in  a  recombinant  protein  with  a  small  C-terminal  extension 
which,  unlike  other  larger  constructs,  is  unlikely  to  interfere  with  the  enzyme's 
activity  and  so  should  not  need  to  be  removed. 
5.2.3  In  vitro  Assay  of  Recombinant  Cysteine  Synthase 
Enzyme  was  assayed  using  the  method  detailed  in  section  2.3.8.  The  following 
sections  describe  the  processes  involved  in  finding  the  optimal  conditions  and  the 
results  of  investigations  into  the  kinetics. 
5.2.3.1  Optimisation  of  Buffer  and  pH 
The  initial  step  in  the  optimisation  of  the  cysteine  synthase  assay  was  to 
determine  the  buffer  and  pH  preferences.  The  enzyme  mechanism  dictates  the 
pH  optimum  but  it  is  evident  by  the  preferences  for  certain  buffers  in  in  vitro 
assays  that  the  buffer  molecule  itself  can  have  an  effect.  Thus  the  rate  of  the 
reaction  was  first  checked  using  fixed  levels  of  substrates  while  varying  the  pH 
between  5.5  and  9.5  with  a  variety  of  buffers.  The  pH  optimum  was  apparently 
between  7.0  and  8.5  but  it  was  also  possible  that  the  buffer  itself  played  an 
important  role  (Figure  5.10). 
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important  role  (Figure  5.10). 
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Figure  5.10:  Apparent  cysteine  synthase  activities  at  different  pH.  Buffer  concentrations  were  100 
mM  in  all  cases.  Activities  are  given  as  nmoles  of  cysteine  produced  per  reaction  using  identical 
amounts  of  enzyme  for  each  assay.  Activities  are  mean  values,  error  bars  are  S.  D.  with  n=3. 
The  apparent  pH  optimum  in  these  experiments  seemed  to  be  around  8.5  with 
little  activity  below  pH  7.0  or  above  8.5.  It  was  considered  however  that  the 
buffers  may  affect  the  activity.  Thus  activities  were  assayed  again  using  HEPES, 
IRIS  and  sodium  phosphate  buffers.  The  results  showed  that  enzyme  activity  at 
equivalent  pH  was  apparently  lowest  in  HEPES  with  the  highest  activity  measured 
in  sodium  phosphate  (data  not  shown).  This  was  then  selected  as  the  buffer  of 
choice  for  the  in  vitro  assay  and  a  closer  examination  of  the  activity  over  a  pH 
r  undertaken.  The  results  of  these  experiments  showed  an  optimum  pH  with 
100  mM  sodium  phosphate  at  pH  7.3  (Figure  5.11).  No  titration  of  the  ionic 
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=2  waV strength  of  the  buffer  was  performed.  In  common  with  many  other  assays  it  was 
expected  that  100  mM  would  provide  sufficient  buffering  capacity  and  not  interfere 
with  the  mechanism. 
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Figure  5.11:  Cysteine  synthase  activities  in  sodium  phosphate  buffer  at  varying  pH.  Relative 
activities  are  given  between  samples  with  identical  amounts  of  enzyme  and  substrate  used  in  each 
assay.  Activities  are  mean  values,  error  bars  are  S.  D.  with  n=3. 
5.2.3.2  The  Use  of  Thiols  in  Assaying  Cysteine  Synthase 
Reducing  agents  are  often  added  when  assaying  cysteine  synthase  in  vitro  with 
no  explanation  for  their  role  (for  example  Warrilow  and  Hawkesford,  1998).  DTT 
or  ß-mercaptoethanol  are  commonly  used  at  concentrations  up  to  10  mM. 
However  these  compounds  are  also  omitted  from  other  published  protocols  (for 
example  Masada  et  al.,  1975).  These  compounds  may  have  a  number  of  effects, 
e.  g.  involvement  in  the  mechanism  directly,  stabilisation  of  the  enzyme  in  some 
way  or  interaction  with  substrate  or  product.  In  the  investigation  it  was  decided  to 
196 such  as  a  ß-replacement  with  the  thiol  and  OAS.  This  concern  arises  as  both 
cysteine  synthase  and  0-acyl  homoserine  suiphydrase  enzymes  have  been 
shown  to  utilise  other  thiols  in  vitro  such  as  methanethiol.  Experiments  were 
conducted  with  a  variety  of  concentrations  of  DTT  and  it  was  found  that  initial 
results  varied  between  replicates.  It  was  apparent  though  that  the  presence  of 
DTT  did  give  an  increase  in  the  level  of  cysteine  produced.  Both  substrates  in  the 
assay  (Na2S  and  O-acetyl-L-serine)  were  freshly  prepared  for  each  experiment 
and  DTT  was  stored  at  -20  °C  in  single  use  aliquots.  Thus  the  variability  in 
results  was  unexplained  simply  by  reagents  deteriorating. 
The  role  of  a  reducing  agent  is  likely  to  be  important  to  both  the  substrate  and 
products  of  the  enzyme  reaction.  Na2S,  the  sulphur  donor  in  the  formation  of 
cysteine,  is  readily  oxidised  and  cysteine  produced  may  dimerise  to  form  cystine 
under  the  influence  of  oxygen  in  solution.  It  is  assumed  that  DTT  would  be  able 
to  counteract  both  of  these  reactions.  However  the  use  of  DTT  in  the  assays  still 
did  not  prevent  considerable  variation  in  the  results.  To  further  counteract  the 
possible  oxidation  effects  upon  substrate  and  product,  the  buffer  and  water  used 
in  the  assays  was  deoxygenated  by  "bubbling"  with  nitrogen  gas  for  15  minutes 
prior  to  use.  This  improved  the  assay  greatly  and  gave  much  more  repeatable 
results,  but  did  not  alleviate  the  need  for  exogenous  thiol  (as  shown  in  Figure 
5.12). 
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Figure  5.12:  Effect  of  DTT  on  in  vitro  cysteine  synthase  activity.  Activites  are  given  as 
absorbance  at  560  nm  with  identical  levels  of  substrates  and  enzyme.  Absorbance  values  are 
mean  values,  error  bars  are  S.  D.  with  n=3. 
This  experiment  appeared  to  show  that  a  concentration  of  1  mM  DTT  was 
saturating  for  whatever  its  function  was.  The  addition  of  higher  concentrations 
seemed  to  have  little  further  effect.  There  were  no  attempts  at  titrating  the  amount 
of  DTT  below  1  mM.  At  this  point  the  standardised  conditions  were  chosen  for 
routine  use  to  investigate  the  activity  of  the  cysteine  synthase. 
5.2.3.3  "Activated  Serine  Sulphydrase"  Activity 
T.  vaginalis  has  been  shown  to  possess  what  has  been  termed  "activated  serine 
sulphydrase"  activity  due  to  its  similarity  to  serine  suiphydrase  activity  but 
denoting  the  substantial  increase  seen  when  ß-mercaptoethanol  (n-me)  is  added. 
The  reaction  produces  H2S  from  L-cysteine  in  the  presence  of  ß-me,  however  the 
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mechanisms  occurring:  an  aß-elimination  reaction  analogous  to  that  carried  out 
by  MGL,  a  NifS-like  cysteine  desulphurase,  or  a  ß-replacement  reaction  as  used 
in  the  synthesis  of  cysteine.  T.  vaginalis  does  apparently  possess  two  NifS 
homologues  (J  Tachezy,  personal  communication)  but  it  is  not  possible  to  say  at 
this  time  whether  these  are  partly  or  wholly  responsible  for  the  "activated  serine 
sulphydrase"  activity  seen.  MGL  does  not  exhibit  an  increase  in  activity  toward 
cysteine  in  the  presence  of  ß-me  (McKie,  1997).  Neither  is  "activated  serine 
sulphydrase"  activity  abolished  by  propargylglycine,  a  suicide  inhibitor  of  MGL. 
This  was  investigated  by  substrate  native  PAGE  as  previously  published  (Thong 
and  Coombs,  1987)  and  the  results  indicated  that  MGL  is  not  responsible  for  the 
activity.  Using  the  published  method  (see  section  2.3.10),  purified  recombinant 
cysteine  synthase  exhibited  no  detectable  cysteine  desulphurase  activity. 
However,  in  the  presence  of  ß-me,  H2S  was  produced  at  significant  levels.  A  very 
brief  investigation  also  confirmed  the  data  from  substrate  native  PAGE,  the  results 
are  summarised  in  Table  5.2. 
Specific  activity  24.5  µmol/min/mg  protein 
Km  (estimated)  12  mM 
Vmax  (estimated)  32  µmol/min/mg  protein 
Inhibition  by  DL-propargylglycine  Non-suicide/competitive 
Inhibition  by  DL-allylglycine  Non-suicide/competitive 
Table  5.2:  "Activated  serine  suiphydrase"  activity  of  recombinant  cysteine  synthase.  Km  and  Vmax 
values  were  estimated  from  a  limited  number  of  datasets. 
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Cysteine  synthase  from  various  sources  has  been  investigated  in  great  detail  and 
the  mechanism  of  action  well  characterised  (for  review  see  Tai  and  Cook,  2000). 
It  was  planned  to  examine  the  inhibitor  profile  and  substrate  preferences  of  the 
enzyme.  The  inhibitory  profile  was  particularly  interesting  because  of  any 
differences  that  may  exist  between  this  and  MGL.  However,  insufficient  time  was 
remaining  in  the  project  for  a  thorough  characterisation  of  the  recombinant 
cysteine  synthase.  The  work  carried  out  is  detailed  below. 
5.2.4.1  Calculation  of  Km  and  Vmax  for  Cysteine  Synthase  Substrates 
The  primary  substrates  for  cysteine  synthase  as  mentioned  are  O-acetyl-L-serine 
(OAS)  and  a  sulphur  source.  The  in  vivo  sulphur  group  is  likely  to  be  hydrogen 
sulphide  (H2S)  and  the  in  vitro  assay  utilises  commercially  available  sodium 
sulphide  (Na2S).  Thus  kinetic  parameters  were  calculated  for  both  compounds. 
When  setting  out  to  calculate  the  kinetic  parameters  for  the  enzyme,  preliminary 
experiments  were  performed  to  estimate  the  likely  Km  values  for  both  substrates. 
This  then  allowed  the  design  of  experiments  which  would  obtain  all  the  data 
necessary  to  calculate  values  with  a  good  degree  of  accuracy.  These  preliminary 
experiments  carried  out  in  parallel  with  optimisation  of  the  assay  conditions 
showed  a  likely  Km  of  -6  mM  for  OAS  and  -1-2  mM  for  Na2S.  From  these 
estimated  values,  assays  were  carried  out  for  OAS  and  Na2S  which  gave  the 
results  shown  in  figures  5.13  and  5.14,  respectively.  For  the  determination  of 
OAS  saturation,  Na2S  was  maintained  at  a  concentration  of  5  mM  and  for  Na2S 
saturation,  OAS  was  maintained  at  10  mM. 
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Figure  5.13:  O-acetyl-L-serine  saturation  curve  of  recombinant  cysteine  synthase.  Data  points 
are  mean  values,  error  bars  are  S.  D.  with  n=3. 
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Figure  5.14:  Na2S  saturation  curve  of  recombinant  cysteine  synthase.  Data  points  are  mean 
values,  error  bars  are  S.  D.  with  n=3. 
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Na2S  (mM) Both  results  above  show  the  hyperbolic  curves  commensurate  with  Michaelis- 
Menten  kinetics.  For  both  substrates  it  was  intended  to  assay  the  enzyme  in 
triplicate  with  a  range  of  concentrations  from  0.25  to  10  times  the  Km  value.  This 
should  allow  an  accurate  calculation  of  Km  and  Vmax  values.  The  calculations  of 
the  Km  and  Vmax  were  performed  using  a  Hanes  plot  as  shown  below  in  figures 
5.15  and  5.16  for  OAS  and  Na2S  respectively. 
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Figure  5.15:  Hanes  plot  of  OAS  for  recombinant  cysteine  synthase. 
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Figure  5.16:  Hanes  plot  of  Na2S  for  recombinant  cysteine  synthase. 
Thus  after  optimisation  of  the  assay  and  investigation  of  the  enzyme's  kinetics  the 
following  results  were  calculated: 
Specific  Activity  42.7  ±  3.6  µmol/min/mg 
O-Acetyl-L-Serine  Km  6.9  mM 
Vmax  61  µmol/min/mg  protein 
Na2S  Km  2.8  mM 
Vmax  33  µmol/min/mg  protein 
Table  5.3:  Kinetic  parameters  calculated  for  in  vitro  assays  of  recombinant  cysteine  synthase. 
Specific  activity  is  given  ±  S.  D.  with  n=11. 
The  enzyme  was  also  assayed  to  determine  if  the  production  of  cysteine  using  L- 
serine  as  the  carbon  backbone  donor  was  possible.  Assays  were  performed  as 
detailed  in  section  2.3.9  with  the  substitution  of  L-serine  for  O-acetyl-L-serine. 
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[Na2S]  (MM) Concentrations  of  Na2S  between  0.5  and  5  mM  and  L-serine  between  I  and  20 
mM  respectively  were  examined  for  the  production  of  L-cysteine  with  25  µg  of 
purified  enzyme.  The  production  of  cysteine  could  not  be  detected  with  any  of 
these  conditions.  No  other  O-acyl-L-serine  derivatives  were  commercially 
available  to  test  as  carbon  donors. 
Recombinant  enzyme  was  also  assayed  for  inhibition  by  mechanism  based  PLP- 
dependent  enzyme  inhibitors  allyiglycine  and  propargylglycine.  Both  act  as 
suicide  inhibitors,  irreversibly  inactivating  some  enzymes.  Assays  were  carried 
out  as  detailed  in  section  2.3.9  with  varying  concentrations  of  inhibitors.  The 
results  of  the  experiments  are  given  in  table  5.4. 
Inhibitor  Concentration  Rate  (nmol/min/ml) 
+  DL-allylglycine 
Rate  (nmol/min/mI) 
+  DL-propargylglycine 
0mM  20.1±1.4  21.0±1.1 
1.0  mm  18.6  ±  0.46  (7.5)  20.7  ±  0.36  (1.5) 
5.0  mM  15.6  ±  0.98  (22)  17.5  ±  0.26  (17) 
10.0  mm  12.9  ±  0.67  (36)  13.9  ±  0.25  (34) 
25.0  mM  9.8  ±  0.9  (51)  11.2±0.49(47) 
Table  5.4:  Inhibition  of  cysteine  synthase  by  allyiglycine  and  propargyglycine.  Rates  are  given  ±  S.  D. 
with  n=3.  Numbers  gin  in  parenthesis  are  percentage  activity  remaining. 
Neither  inhibitor  displayed  total  inactivation  of  the  enzyme  even  at  concentrations 
of  25  mM.  Assuming  the  ratio  of  D  to  L  forms  of  compounds  is  1:  1,  there  was  still 
204 12.5  µmoles  of  inhibitor  present.  The  amount  of  enzyme  used  was  approximately 
20  nmoles  of  monomer  per  assay.  This  gives  more  than  sufficient  inhibitor  for 
total  inactivation. 
5.2.5  Stabilisation  Studies  of  Recombinant  Cysteine  Synthase 
A  recovery  of  around  20  mg  of  pure  recombinant  enzyme  per  litre  of  starter  culture 
was  easily  obtainable.  To  ensure  the  enzyme  used  for  these  studies  was  in 
optimal  condition,  it  was  necessary  to  find  suitable  short  and  long  term  storage 
conditions.  Following  standard  principles,  a  number  of  different  conditions  were 
investigated.  It  was  clearly  impossible  to  examine  every  possible  condition  when 
one  considers  the  number  of  variables  involves  and  therefore  it  was  important  to 
make  some  initial  estimates  of  the  most  favourable  storage  conditions. 
5.2.5.1  Temperature  Stability 
The  conditions  chosen  reflected  general  principles  of  the  best  methods  to  store 
enzymes,  published  data  on  other  cysteine  synthase  enzymes  and  also 
information  gained  from  the  previous  work  on  MGL.  Analysis  began  with 
temperature  stability  and  then  extended  to  buffer  composition  and  additives.  The 
enzyme  was  examined  for  retention  of  activity  when  stored  at  4  °C,  -20  °C  and  -70 
°C  with  and  without  glycerol  in  identical  buffer  conditions.  The  results  of  this 
initial  analysis  are  shown  in  table  5.5. 
205 Time  (Days) 
1  3  7  14  21  28 
4  °C  100  108  102  85.6  84.4  79.6 
4  °C,  40%  glycerol  110  128  135  133  104  88.2 
-20  °C  19.1  51.7  53.6  27.3  18.4  15.2 
-20  °C,  40%  glycerol  93.2  119  115  108  112  107 
-70  °C  90.0  96.3  113  97.4  91.1  74.2 
-70  °C,  40%  glycerol  79.3  115  122  114  84.3  87.6 
Table  5.5:  Cysteine  synthase  activities  recorded  over  time  after  storage  under  different  conditions. 
Data  given  are  means  from  2  experiments.  Relative  activities  are  given  with  results  of  storage  at  4  °C 
for  1  day  arbitrarily  chosen  as  100%. 
Subsequent  to  purification,  enzyme  was  dialysed  overnight  at  4  °C  against  100 
mM  sodium  phosphate  buffer  pH  7.5  with  300  mM  NaCl  and  then  combined  with 
glycerol  as  appropriate.  These  experiments  began  the  day  following  the 
purification  of  the  recombinant  enzyme  and  the  activity  of  the  enzyme  stored  at  4 
°C  was  arbitrarily  chosen  as  100%  and  the  relative  levels  to  this  value  are  shown 
above. 
Glycerol  is  a  very  commonly  used  cryoprotectant  for  storing  enzymes  and  it  is  not 
surprising  that  at  -20  °C  the  enzyme  without  glycerol  lost  much  of  its  activity 
quickly.  This  is  almost  certainly  due  to  the  formation  of  ice  crystals  and  the 
repeated  freeze-thaw  action.  These  problems  are  avoided  by  the  addition  of  40% 
glycerol.  However,  the  stored  enzyme  was  not  subject  to  the  same  losses  in 
activity  when  stored  at  -70  °C  without  a  cryoprotectant.  This  may  be  due  to  the 
rapid  freezing  at  the  lower  temperatures  moderating  the  damage  done  by  ice 
206 crystals.  Due  to  time  constraints,  the  long  term  effects  of  storage  at  -70  °C  could 
not  be  investigated.  The  enzyme  may  behave  as  MGL2  does,  losing  more  than 
90%  of  it's  activity  after  storage  at  -70  °C  for  longer  than  12  months  (unpublished 
data).  At  this  point  it  was  decided  that  for  routine  storage  -20  °C  with  40% 
glycerol  added  would  be  pursued  as  there  was  no  evidence  at  this  stage  that  it 
adversely  affected  the  enzyme  activity. 
5.2.5.2-  Selecting  the  Correct  Buffer  for  Storage 
The  choice  of  buffer  was  made  reflecting  the  published  data  on  the  activities  of 
other  cysteine  synthase  enzymes.  Initially  the  pH  range  checked  was  6.2-8.0 
using  the  suiphonic  acid  derived  buffers  (Good  eta/.,  1966).  PIPES  and  HEPES 
were  used  and  an  apparent  optimum  of  100  mM  HEPES  pH  7.2  was  found. 
However  the  enzyme  lost  activity  over  a  period  of  2  to  3  weeks  when  stored  at  -20 
°C  in  glycerol  with  these  buffers.  It  is  apparent  that  these  buffers  adversely  affect 
the  enzyme  and  are  not  suitable  for  storage  for  an  unknown  reason.  This 
observation  is  not  unusual  though  and  highlights  the  need  to  make  a  suitably 
broad  choice  of  buffers  to  sample.  In  the  production  of  a  new  construct  of  MGL2, 
as  detailed  in  section  2.2.16,  similar  experiments  were  carried  out  on  the  stability 
of  the  enzyme  under  different  storage  conditions  (3.2.5).  Here  it  was  found  that 
the  sulphonic  acid  buffers  were  particularly  favourable  when  compared  to  the 
large  loss  of  activity  exhibited  when  TRIS  buffers  were  used.  Thus  the  pH 
preferences  indicated  by  the  data  were  utilised,  but  a  new  buffer  had  to  be  found. 
Because  enzyme  used  to  monitor  the  effects  of  temperature  on  storage  had 
retained  greater  activity  while  stored  in  sodium  phosphate  buffer,  it  was  decided 
207 to  examine  this.  Due  to  a  lack  of  time  it  was  not  possible  to  monitor  the  effect  on 
activity  of  storage  in  a  number  of  buffers.  Instead  enzyme  was  dialysed  into  100 
mM  sodium  phosphate  pH  7.5,300  mM  NaCl,  100  µM  PLP,  100  µM  DTT  plus 
glycerol  to  40%.  This  enzyme  was  then  used  for  the  remainder  of  this  work  and 
showed  no  loss  of  activity  over  approximately  6  weeks. 
5.2.5.3  Effects  of  Cofactor  and  Reducing  Agents 
The  use  of  thiol  reducing  agents  and  cofactor  to  retain  activity  during  storage  was 
also  considered.  Previous  work  on  MGL  had  shown  that  excess  cofactor  and 
reductant  were  required  and  it  was  decided  that  in  an  analogous  fashion,  cofactor 
and  DTT  would  be  added  to  cysteine  synthase  in  order  to  prevent  loss  of  activity. 
Thus  100  µM  PLP  and  100  IN  DTT  were  added.  Extensive  investigations  were 
not  carried  out  on  the  merits  of  including  these  compounds  because  of  insufficient 
time  remaining  in  the  project  and  also  because  initial  results  showed  no 
detrimental  effects  of  including  them. 
5.2.6  Western  Blot  Analysis  of  Cysteine  Synthase 
Polyclonal  antibodies  were  raised  in  a  rabbit  against  purified  recombinant 
cysteine  synthase.  These  were  to  be  used  in  Western  blot  analysis  as  time 
permitted.  Figure  5.17  shows  the  result  of  a  Western  blot  using  the  antiserum 
against  a  parasite  whole  cell  lysate  and  purified  recombinant  enzyme. 
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Figure  5.17:  Western  blot  using  purified  cysteine  synthase  antiserum.  Lane  A-  Purified 
recombinant  enzyme  probed  with  antiserum;  B-T.  vaginalis  whole  cell  lysate  probed  with 
antiserum;  C-  10  kDa  protein  standards;  D-  Purified  recombinant  enzyme  probed  with  pre- 
immune  sera;  E-T.  vaginalis  whole  cell  lysate  probed  with  pre-immune  serum. 
The  polyclonal  antiserum  raised  against  purified  recombinant  cysteine  synthase 
reacted  as  expected  with  the  recombinant  enzyme  (Figure  5.17,  lane  A).  This 
migrated  to  approximately  35  kDa  in  agreement  with  the  predicted  molecular  mass 
of  33.8  kDa  for  a  single  recombinant  enzyme  monomer.  There  was  no  reaction  of 
the  pre-immune  serum  with  the  purified  recombinant  enzyme  (lane  D).  The 
antiserum  reacted  with  a  large  number  of  proteins  in  the  parasite  lysate  (lane  B) 
and  many  of  these  interactions  are  also  seen  in  with  the  pre-immune  serum  (lane 
E).  There  were  at  least  two  additional  bands  detected  by  the  immune  serum 
(comparing  lanes  B  and  E).  Assuming  that  the  polyclonal  antiserum  is  specific  for 
cysteine  synthase,  this  would  indicate  at  least  two  cysteine  synthase  proteins  or 
fragments  present  in  T.  vaginalis.  The  major  band  migrated  slightly  further  than 
the  recombinant  enzyme  (lane  A)  which  is  consistent  with  the  predicted  size  of 
32.7  kDa  for  the  enzyme  encoded  by  the  isolated  cDNA.  However,  there  also 
209 appeared  to  be  a  second,  less  intense  band  which  was  partially  obscured  by  the 
strong  signal  of  the  major  band.  This  appeared  to  be  of  the  same  size  as  the 
recombinant  enzyme. 
5.2.6.1  Expression  of  T.  vaginalis  Cysteine  Synthase  Under  Different  Growth 
Conditions 
The  parasite  was  cultured  under  different  growth  conditions  and  cysteine 
synthase  mRNA  and  protein  levels  analysed  to  determine  the  effect  of 
environmental  factors  and  help  elucidate  the  role  of  the  enzyme  in  the  parasite. 
Culturing  of  the  parasite  was  performed  as  detailed  in  section  2.4.2.  Parasites 
were  harvested  and  washed  as  detailed  in  section  2.4.4  and  cell  pellets  stored  at  - 
70  °C.  Western  blots  were  carried  out  as  specified  in  section  2.3.4.  The 
preparation  and  development  of  Western  and  Northern  blots  was  done  by  Dr.  GH 
Westrop. 
To  help  define  the  role  of  cysteine  synthase  in  vivo  the  parasite  was  cultured 
under  various  conditions.  Medium  was  supplemented  with  amino  acids  to 
examine  their  effect  on  the  expression  of  the  enzyme.  Amino  acids  chosen  for 
this  were  L-cysteine,  L-methionine,  L-serine  and  DL-homocysteine.  Previous 
work  had  shown  a  decrease  in  cysteine  synthase  activity  in  parasite  lysates  after 
growth  in  medium  supplemented  with  10  mM  L-cysteine  (P.  Suchan,  unpublished 
data).  Therefore  the  concentration  of  amino  acids  used  was  10  mM.  Parasites 
were  also  cultured  in  conditions  to  mimic  oxidative  stress,  which  the  parasites  may 
experience  as  a  result  of  host  immune  responses.  Cultures  were  produced 
aerobically  with  exposure  to  normal  environmental  oxygen  levels  and  in  media 
210 lacking  the  reducing  agent  ascorbate.  Media  was  also  supplemented  with  0.2  mM 
hydrogen  peroxide  (H202)  or  2  mM  methyl  viologen  (MV)  (a  catalyst  for  the 
production  of  superoxide  radicals).  Concentrations  of  MV  and  H202  used,  were 
decided  upon  by  first  titrating  them  to  levels  where  they  inhibited  growth  of  the 
parasite  by  -  50%  (data  not  shown).  The  parasite  was  also  grown  in  the 
presence  of  100  µM  DL-propargylglycine.  Previously  this  concentration  of 
inhibitor  has  been  shown  to  abolish  MGL  activity  but  also  result  in  elevated  levels 
of  "activated  serine  suiphydrase"  activity  (Thong  and  Coombs,  1987).  As  the 
isolated  cysteine  synthase  enzyme  possesses  this  activity  this  constitutes  some 
evidence  that  inhibition  of  MGL  leads  to  upregulation  of  enzyme.  The  effect  on 
growth  of  the  parasite  has  been  shown  to  be  small  at  these  concentrations  of 
propargylglycine.  The  culturing  of  the  parasites  for  these  experiments  is  detailed 
in  section  2.4.2.  The  numbers  of  parasites  harvested  from  each  of  the  conditions 
are  listed  below  in  table  5.6.  These  cells  were  used  for  protein  and  RNA  isolation 
for  subsequent  Western  and  Northern  blotting  as  described  below. 
211 Growth  Conditions  Parasites  (cells  x  10  /ml) 
Control  (Anaerobic)  1.44 
Aerobic  3.94 
Without  Ascorbate  1.70 
10  mM  L-Cysteine  2.88 
10  mM  L-Methionine  1.36 
10  mM  L-Serine  2.80 
10  mM  DL-Homocysteine  1.80 
100  µM  DL-propargylglycine  0.52 
0.2  mM  H202  2.44 
2.0  mM  Methyl  Viologen  1.40 
Table  5.6:  Parasite  densities  in  modified  medium.  Numbers  are  counts  from  a  single  culture, 
cultures  were  performed  in  triplicate. 
Western  blots  using  whole  cell  lysates  were  performed  using  recombinant 
cysteine  synthase  antiserum:  Equal  volumes  of  lysate  were  loaded  in  each  lane 
(Figure  5.18). 
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Figure  5.18:  Western  blot  using  parasites  cultured  under  different  conditions.  Lanes  A- 
Anaerobic,  B-  Aerobic,  C-  No  ascorbate,  D-  L-Cysteine,  E-  L-Methionine,  F-  L-Serine,  G-  DL- 
Homocysteine,  H-  10  kDa  protein  ladder,  I-0.2  mM  H202,  J-2  mM  MV. 
Two  bands  were  clearly  visible  in  several  lanes  of  the  blot  confirming  the 
presence  of  at  least  two  likely  cysteine  synthase  enzymes.  Due  to  the  equal 
volume  loading  of  lysates,  rather  than  equal  cell  numbers,  it  was  difficult  to 
quantify  any  apparent  changes  in  enzyme  levels  present.  There  was  no  apparent 
relative  difference  in  the  signal  from  cells  grown  in  aerobic  conditions  and  without 
ascorbate  (lanes  B  and  C)  compared  to  anaerobically  cultured  parasites  (lane  A). 
Of  the  medium  supplemented  with  amino  acids  the  largest  change  appeared  to  be 
with  L-cysteine  where  there  was  a  significantly  reduced  signal  (lane  D).  However 
each  of  lanes  D  to  G  had  less  intense  bands  than  lane  A  after  taking  into  account 
the  cell  densities.  The  parasites  grown  in  the  presence  of  H102  and  MV  (lanes  I 
and  J)  both  appeared  to  produce  more  enzyme  as  was  evident  from  the  increased 
intensity  of  bands. 
213 To  further  examine  the  effects  of  culturing  parasites  under  these  different 
conditions,  Northern  blots  were  performed  (Figure  5.19).  Blots  were  hybridised 
with  both  a  cysteine  synthase  specific  probe  and  also  an  actin  probe.  Actin 
expression  was  assumed  to  be  identical  in  all  cells  and  could  therefore  be  used  to 
quantify  RNA  levels  and  thus  loading. 
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Figure  5.19:  Northern  blots  of  parasites  grown  under  different  conditions.  Image  I-  Blot 
hybridised  with  actin  probe,  Image  II  -  Blot  hybridised  with  cysteine  synthase  probe.  Lanes  A- 
Anaerobic,  B-  Aerobic,  C-  No  ascorbate,  D-  L-Cysteine,  E-  L-Methionine,  F-  L-Serine,  G-  DL- 
Homocysteine,  H-  100  µM  DL-Propargylglycine,  I-0.2  mM  H202,  J-2  mM  MV. 
214 The  hybridisation  of  an  actin  specific  probe  (Figure  5.19,  I)  showed  similar  levels 
of  RNA  in  all  lanes  except  H.  These  levels  generally  reflected  the  parasite 
numbers  harvested  from  the  cultures  shown  in  table  5.6.  The  variation  in  lane  H 
was  proposed  to  be  due  to  both  the  lower  number  of  cells  used  and  difficulty  in 
isolating  a  sizable  RNA  sample  (G  H  Westrop  personal  communication).  A 
comparison  of  the  signal  intensities  showed  that  relative  to  lane  A  there  were  a 
number  of  changes.  The  most  dramatic  were  a  fall  in  the  signals  in  lanes  D  and  G 
(L-cysteine  and  DL-homocysteine  respectively)  and  an  increase  in  the  signal  in 
lane  H  (propargylglycine).  The  changes  observed  in  the  other  lanes  were  not  as 
marked.  Although  the  signal  in  both  lanes  I  and  J  (H202  and  MV)  were  much  less 
pronounced  than  lane  A,  the  level  of  cysteine  synthase  mRNA  was  apparently 
higher  in  lane  J.  Lanes  E  and  F  (methionine  and  serine)  showed  similar  sized 
bands  to  each  other,  although  again,  these  did  seem  smaller  than  the  control 
lane.  The  effect  of  omitting  ascorbate  from  the  medium  (lane  C)  was  an  apparent 
fall  in  the  levels  of  cysteine  synthase  mRNA.  The  effect  of  cysteine  synthase 
expression  by  culturing  the  parasites  with  exposure  to  normal  atmospheric  oxygen 
levels  was  difficult  to  distinguish  from  anaerobic  growth.  Surprisingly  the  cell 
growth  was  higher  with  oxygen  present  and  enzyme  levels  seemed  comparable. 
5.3  DISCUSSION 
A  putative  cysteine  synthase  gene  from  T.  vaginalis  was  cloned  into  a  prokaryotic 
expression  vector  and  recombinant  protein  produced.  The  strategy  adopted  to  do 
this,  introduced  eight  additional  amino  acids  into  the  mature  enzyme  not  encoded 
by  the  original  cDNA  sequence.  Though  not  ideal,  it  would  be  preferable  to  retain 
the  original  sequence  intact,  the  presence  of  a  hexahistidine  tag  allowed  the  use 
215 of  a  single  column  chromatography  step  for  purification.  High  levels  of  active, 
soluble  enzyme  were  obtained  easily  which  was  apparently  stable  over  a  period  of 
several  weeks.  The  specific  activity  of  the  enzyme  is  below  that  published  for 
many  other  cysteine  synthase  enzymes  and  the  Km  values  for  both  substrates  are 
higher.  There  is  no  reason  though  to  believe  that  this  is  due  to  the  method  of 
expression  or  purification  of  the  enzyme.  With  the  possibility  of  several  isoforms 
of  enzyme  present  within  the  parasite  these  differences  may  be  a  reflection  of  a 
specific  role. 
The  enzyme  sequence  is  highly  homologous  to  other  cysteine  synthases  and 
important  residues  in  the  active  site  are  conserved.  The  results  of  the  alignment 
and  clustering  distinguished  the  enzyme  clearly  from  plant  species  and  indicated 
it  to  be  more  similar  to  bacterial  type  B  enzymes.  The  type  B  enzymes  from 
enteric  bacteria  are  proposed  to  be  expressed  under  anaerobic  conditions  and 
are  able  to  utilise  more  reduced  substrates  such  as  thiosulphate  (Nakamura  et  al., 
1983,1984).  This  finding  is  consistent  with  the  normal  environmental  growth 
conditions  of  T.  vaginalis  in  vivo.  However  with  this  in  mind,  it  may  be  that  the 
lower  activity  exhibited  by  the  trichomonad  enzyme  compared  with  others  may  be 
due  to  inappropriate  assay  conditions,  for  example  the  choice  of  sulphur  donor. 
Deoxygenation  and  addition  of  reducing  agents  was  highly  effective  in  increasing 
activity  but  perhaps  this  is  insufficient.  Further  biochemical  investigation  of  the 
recombinant  enzyme  could  centre  around  the  substrate  profile  of  the  enzyme. 
Additionally  the  ability  of  the  enzyme  to  utilise  alternative  sulphur  donors  may 
provide  an  insight  on  the  likely  physiological  substrate. 
216 The  failure  of  5'  RACE  experiments  to  confirm  the  validity  of  the  proposed  start 
codon  did  not  hinder  the  production  of  an  active  recombinant  enzyme.  The  short 
5'  UTR  isolated  with  the  cDNA  clone  was  consistent  with  the  findings  from  other 
genes  from  T.  vaginalis.  It  does  not  however,  possess  the  consensus  sequence 
for  the  ubiquitous  promoter  element  identified  and  analysed  (Quon  et  al.,  1994; 
Liston  and  Johnson,  1999).  Therefore  there  are  concerns  arising  from  the 
inability  in  confirming  the  entire  gene  sequence  at  the  5'  end  and  thus  the  correct 
start  codon.  Not  least  of  these  is  the  possibility  that  a  truncated  enzyme  may 
have  biochemical  characteristics  considerably  different  from  the  full  length 
enzyme  in  vivo  (e.  g.  lower  catalytic  activity,  changed  substrate  affinities). 
The  results  of  Southern  blot  analysis  were  consistent  with  the  presence  of  a 
single  copy  of  this  cysteine  synthase  gene.  The  appearance  of  other  lower 
intensity  bands  suggested,  however,  that  T.  vaginalis  contains  closely  related 
homologues.  The  identical  pattern  seen  in  a  repeated  experiment  makes  non- 
specific  interactions  very  unlikely,  despite  the  obvious  hybridisation  to  the  DNA 
markers.  This  observation  is  a  consequence  of  the  large  amount  of  DNA  bound 
and  is  a  common  effect  seen  in  this  laboratory  with  a  number  of  unrelated  probes. 
The  concern  that  the  multiple  bands  may  be  present  because  of  incomplete 
digestion  of  the  gDNA  prior  to  transfer  was  addressed.  As  mentioned  in  the  text, 
efforts  were  made  to  ensure  that  this  was  not  the  case.  The  second  proteinase  K 
treatment  of  gDNA  prior  to  the  restriction  digest  abolished  the  discrete  bands 
seen  previously  (not  shown  due  to  poor  image  reproduction).  However  the 
variation  in  the  number  of  bands  seen  in  the  different  lanes  does  still  seem  to 
point  to  the  possibility  that  one  or  more  of  the  digests  is  incomplete.  Nevertheless 
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of  multiple  cysteine  synthase  isozymes  in  T.  vaginalis.  The  high  stringency 
conditions  of  hybridisation  and  washing  should  have  prevented  any  low  affinity 
binding  and  implied  that  these  proposed  homologues  of  the  cysteine  synthase 
were  likely  to  have  considerable  sequence  similarity.  It  is  unlikely  that  the  probe 
hybridised  with  PLP-dependent  enzymes  from  the  a  or  y  families,  as  the 
sequences  are  typically  quite  diverse.  Also  the  position  of  the  bands  did  not 
correspond  to  those  identified  for  mgll  and  mg/2  (McKie  et  al.,  1998)  and  so 
hybridisation  to  these  can  be  excluded.  The  identity  between  these  proposed 
cysteine  synthase  homologue  sequences  is  likely  to  be  greater  than  70%  as  no 
cross  reaction  is  seen  between  mgl1  and  mg!  2  which  share  this  identity.  As  was 
described  in  section  5.2.1.3,  the  similarities  between  cysteine  synthase 
sequences  can  be  very  high  and  so  this  allows  for  the  possibility  of  very  similar 
isoforms. 
The  polyclonal  antisera  produced  against  recombinant  cysteine  synthase  reacts 
strongly  with  the  purified  enzyme  and  also  with  at  least  two  proteins  in  the 
parasite  lysates.  The  apparent  size  of  the  strongest  signal  in  the  parasite  lysate 
corresponded  to  the  predicted  size  of  the  native  enzyme  from  the  cDNA 
sequence.  Additionally,  although  unclear,  there  was  a  second  species  of  a 
slightly  larger  size  also  identifiable  in  the  lysate.  This  was  most  obvious  in  figure 
5.17  where  two  bands  were  clearly  seen  in  lanes  D,  E  and  G.  Assuming  that 
there  is  no  cross  reactivity  with  other  non-cysteine  synthase  enzymes,  then  this 
indicated  the  likelihood  of  at  least  one  other  isoform.  It  is  also  possible,  however, 
that  this  band  represented  an  immature  form  of  the  enzyme  with  a  targeting  signal 
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then  shown  independently  in  Western  blots  using  parasites  grown  under  various 
conditions  (Figure  5.18).  In  both  blots  there  was  a  high  level  of  background.  This 
was  a  consequence  of  the  large  amount  of  immune  sera  used  in  primary  antibody 
binding.  Dot  blots  had  been  used  to  estimate  the  primary  antibody  dilution 
required,  suggesting  a  dilution  of  1:  4000  was  sufficient,  but  it  is likely  that  a  higher 
dilution  is  likely  to  be  optimal.  There  was  insufficient  time  remaining  to  titrate 
these  levels. 
The  results  of  culturing  parasites  with  different  stimuli  was  quite  successful.  The 
parasites  exhibited  varying  levels  of  expression  which  was  evident  in  mRNA  and 
protein  levels.  The  Western  blot  results  could  be  improved  significantly  by 
eliminating  much  of  the  background  with  lower  amounts  of  immune  sera.  The 
success  of  this  technique  though  should  be  extended  to  examine  other  proteins 
(specifically  MGL)  and  other  stimuli.  The  results  and  possible  future  work  will  be 
discussed  in  the  final  chapter. 
During  the  course  of  this  study,  additional  work  by  others  identified  cysteine 
synthase  activity  in  parasite  lysates  confirming  the  presence  of  at  least  one 
functional  enzyme.  The  work  also  showed  that  after  subcellular  fractionation, 
activity  was  localised  to  the  cytosolic  and  hydrogenosomal  fractions  of  the 
parasite  (P  Suchan,  unpublished).  Western  blots  have  now  confirmed  the 
presence  of  at  least  two  isoforms  of  cysteine  synthase  in  T.  vaginalis.  It  has  also 
been  seen  previously  that  "activated  serine  sulphydrase"  activity  is  attributable  to 
multiple  proteins  (Thong  and  Coombs,  1987).  Recombinant  cysteine  synthase 
219 was  shown  to  have  this  activity  and  thus  presumably  the  enzyme  accounts  for  two 
of  the  proteins  responsible.  Along  with  the  continued  attempts  to  identify  the  5' 
UTR  of  the  cysteine  synthase  gene  it  would  be  desirable  to  attempt  to  clone  this 
second  cysteine  synthase  gene  in  the  future.  Other  work  that  could  be  carried  out 
would  include  subcellular  localisation  of  enzyme  activity  by  immunomicroscopy. 
This  may  prove  difficult  though,  if  it  is  not  possible  to  distinguish  between  the  two 
enzymes  using  the  polyclonal  antisera. 
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6.1  INTRODUCTION 
The  overall  aim  of  this  study  was  to  investigate  sulphur  amino  acid  metabolism  in 
T.  vaginalis.  A  variety  of  approaches  were  employed  to  achieve  this.  Discussions 
upon  the  experimental  results  obtained  have  been  given  in  relevant  chapters.  In 
this  chapter  it  is  intended  to  relate  these  results  and  other  data  to  the  situation  in 
vivo. 
Prior  to  this  study,  with  little,  if  any,  experimental  data  available,  it  was  possible  to 
suggest  a  number  of  fates  for  the  products  of  MGL's  action  and  thus  roles  for  the 
enzyme  in  vivo.  These  possible  functions  included: 
1.  The  production  of  ATP  from  the  a-keto  acids,  as  detailed  in  section  1.6.3.3 
2.  The  use  of  ammonia  for  combating  the  low  pH  of  the  vagina 
3.  Utilising  sulphide  for  deoxygenation  of  the  environment  via  conversion  to 
sulphate 
4.  The  use  of  free  thiols  as  reducing  agents  or  free  radical  scavengers  in  the  cell 
or  to  cause  damage  to  host  cells  as  an  immune  evasion  strategy  or  method  to 
obtain  extra  nutrients. 
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There  is  some  experimental  evidence  that  the  a-keto  acid  product  of 
homocysteine  and  methionine  catabolism,  2-oxobutyrate,  can  be  utilised  to 
generate  ATP  (GH  Coombs,  unpublished).  The  contribution  of  this  energy 
generation  pathway  may  be  very  different  though  for  in  vivo  and  in  vitro  growth.  It 
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produce  ATP  when  necessary,  but  is  not  essential  and  probably  not  utilised  when 
more  abundant  energy  sources,  i.  e.  sugars  such  as  glucose,  are  available. 
There  is,  at  present,  no  experimental  evidence  for  the  use  of  either  NH4+  or  H2S  to 
modify  the  extracellular  environment  beneficially.  The  parasite  is  sensitive  to 
oxygen  though  (Paget  and  Lloyd;  1990)  and  so  the  possible  use  of  H2S  in  this  way 
is  still  worthy  of  investigation. 
The  use  of  the  thiols,  released  by  the  action  of  MGL,  is  probably  fundamental  to 
the  enzyme's  role  in  the  parasite.  The  abundance  of  these  thiols  in  cultured 
parasite  preparations  is  immediately  evident  by  the  smell.  Experiments  using 
radiolabelled  35S  compounds  have  shown  little  specific  incorporation  of  the 
isotope  within  the  parasite  (Thong,  1985).  The  measurement  of  thiols  released  by 
parasites  cultured  in  complete  MDM  has  revealed  high  quantities  of  CH3SH 
released  but  no  detectable  H2S  (Thong  et  a/.,  1987).  CH3SH  levels  were  elevated 
when  medium  was  supplemented  with  L-methionine  but  no  H2S  was  detected 
even  when  high  levels  of  DL-homocysteine  were  added.  Methionine  could  be 
substituted  for  compounds  such  as  methyl-L-cysteine  and  L-ethionine  and  similar 
levels  of  CH3SH  were  released.  This  implies  that  H2S,  the  thiol  product  of  MGL 
catabolism  of  homocysteine,  does  not  escape  the  parasite  cell.  However,  the 
detection  of  the  two  thiols  was  achieved  differently,  CH3SH  using  DTNB  (5,5'- 
dithio-bis-2-nitrobenzoic  acid)  and  H2S  with  lead  acetate.  It  may  be  that  the  lack 
of  any  detectable  of  H2S  was  due  to  the  compound  rapidly  oxidising  or  dimerising. 
This  may  not  have  reacted  with  lead  acetate  to  form  lead  sulphide  and  thus  no 
222 H2S  would  have  been  detected.  CH3SH  rapidly  dimerises  to  form  dimethyl 
sulphide  (CH3S2CH3)  which  loses  its  disulphide  upon  reaction  with  DTNB  and  is 
thus  detected.  Thiols  such  as  H2S  and  CH3SH  are  both  active  reducing  agents 
and  toxic  in  high  concentrations,  but  with  no  experimental  evidence  for  their  use  in 
the  parasite,  possible  functions  remain  speculative. 
It  has  been  well  established  through  the  use  of  irreversible  inhibitors,  that  MGL  is 
not  essential  for  growth  in  vitro  (Thong  and  Coombs,  1987).  The  growth  rate  is 
reduced  at  high  concentrations  of  propargyiglycine,  but  there  are  no 
morphological  changes.  However,  at  this  point  it  is  well  worth  considering  the 
nature  of  propagating  parasites  in  sterile  cultures.  Such  parasites  are  provided 
with  all  the  nutrients  required  for  apparent  optimum  growth  and  simultaneously 
exposed  to  minimal  stress.  This  is  undoubtedly  significantly  different  from  the 
conditions  found  within  the  host's  uro-genitary  tract.  For  example,  in  vivo  the 
parasite  will  be  exposed  to  damaging  host  immune  responses  and  the  nutritional 
demands  may  not  be  so  readily  met.  In  this  situation,  MGL  may  play  a  critical  role 
and  therefore  be  suitable  for  investigation  as  a  possible  target  for  chemotherapy. 
6.1.1  MGL  in  Iron-Sulphur  (Fe-S)  Cluster  Production 
With  biochemical  information  and  the  structure  of  MGL1  available,  we  are  able  to 
postulate  a  catalytic  mechanism  for  the  enzyme  (see  section  3.2.10).  The 
structure  also  revealed  a  possible  role  for  the  enzyme  in  vivo.  The  position  of 
Cys113  in  the  active  site  of  MGL1  is  very  similar  to  that  of  a  cysteine  residue 
found  in  NifS-like  enzymes,  whose  role  in  vivo  is  the  production  and  repair  of  Fe-S 
clusters.  Iron-containing  proteins  play  central  roles  in  T.  vaginalis  metabolism  (for 
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there  is  as  yet  no  experimental  evidence  on  how  Fe-S  clusters  are  produced. 
There  is  an  unconfirmed  report  that  there  are  2  nifS  gene  homologues  in  the 
parasite  (J.  Tachezy,  personal  communication),  but  MGL  could  nevertheless  also 
have  a  role.  As  there  are  established  in  vitro  assays  for  NifS  enzymes  measuring 
the  production  of  functional  Fe-S  clusters  (Zheng  et  al.,  1993),  it  should  be 
straightforward  to  verify  whether  MGL  has  this  ability. 
6.1.2  Sulphydration  and  Transsulphuration  in  T.  vaginalis 
The  results  presented  in  chapter  5  of  this  thesis  confirm  the  presence  of  a 
functional  cysteine  synthase  enzyme  in  T.  vaginalis.  Despite  the  presence  of 
direct  suiphydration  in  the  form  of  cysteine  synthesis,  there  remains  no  firm 
evidence  for  a  functional  transsulphuration  pathway.  The  previously  reported  low 
CGL  activity  in  the  parasite  was  detected  in  whole  cell  lysates  (Thong,  1985)  and 
no  homogenous  protein  preparation  or  gene  has  been  isolated.  Indeed,  the 
isolation  of  mgl  genes  utilised  degenerate  oligonucleotide  PCR  with  primers 
designed  to  highly  conserved  regions  of  CGL  sequences  (McKie,  1997).  As  no 
CGL  (or  CGS,  CBL  or  CBS)  homologue  was  isolated  using  this  approach  or 
identified  from  the  sequencing  of  cDNA  clones,  this  points  to  the  absence  of  these 
.  enzymes  in  the  parasite. 
This  proposed  lack  of  CGL  in  T.  vaginalis  (along  with  the  presence  of  2  mgI 
genes),  shows  a  further  similarity  to  the  situation  in  P.  putida.  In  this  bacteria, 
MGL  is  postulated  to  have  an  alternative  pathway  to  the  standard  reverse 
transsulphuration  pathway  (conversion  of  homocysteine  to  cysteine  via 
224 cystathionine)  (Vermeij  and  Kertesz,  1999).  In  this  hypothesis,  the  breakdown  of 
homocysteine  by  MGL  yields  H2S  which  is  the  substrate  for  cysteine  synthase.  In 
addition,  CH3SH  from  the  catabolism  of  methionine  is  proposed  to  be  converted 
by  an  unknown  process  to  H2S  and  so  also  to  provide  the  thiol  group  for  cysteine 
synthesis.,  The  results  of  culturing  parasites  with  propargylglycine  described  in 
this  thesis  are  explainable  in  terms  of  this  proposal.  Inhibition  of  MGL  leads  to  an 
increased  expression  of  cysteine  synthase,  presumably  in  an  attempt  to 
compensate  for  the  lack  of  thiol  donors  available  and  so  maintain  cellular  cysteine 
levels.  The  hypothesis  is  also  consistent  with  the  results  of  culturing  the  parasites 
in  excess  cysteine;  where  there  was  a  decrease  in  the  expression  of  cysteine 
synthase.  This  may  not  only  reflect  L-cysteine  specific  feedback  inhibition  of 
cysteine  synthase  gene  expression  but  also  the  overall  concentration  of  thiols. 
There  may  be  a  demand  for  cysteine  as  a  specific  amino  acid  and  also  for  thiol 
containing  compounds  as  general  reductants.  These  general  reducing  agents 
may  include  both  low  molecular  weight  thiols  (e.  g.  H2S,  CH3SH)  and  amino  acids. 
The  response  to  high  levels  of  homocysteine  was  a  fall  in  levels  of  cysteine 
synthase  expression  but  not  of  the  same  magnitude  as  seen  with  excess  cysteine. 
Thus  exogenous  homocysteine  may  have  satisfied  the  requirements  of  the 
parasite  for  thiols  but  there  still  remained  the  need  for  cysteine  for  other  purposes, 
such  as  protein  synthesis. 
It  would  be  very  interesting  to  examine  the  effects  of  the  same  conditions  upon 
MGL  levels.  -Experiments  are  planned  to  reproduce  Western  and  Northern  blots 
using  MGL  antibodies  and  nucleotide  probes.  The  working  hypothesis  described 
would  predict  decreased  levels  of  MGL  expression  when  the  parasites  are 
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synthesis.,  The  predicted  response  to  elevated  levels  of  methionine  or 
homocysteine  would  be  little  or  no  change  in  MGL  levels.  It  would  be  much  more 
interesting  to  deplete  the  medium  of  one  or  more  sulphur  containing  amino  acids 
and  examine  the  response  then. 
6.1.3  Thiols  as  Reducing  Agents  or  Free  Radical  Scavengers 
Despite  the  presence  of  an  active  cysteine  synthase,  there  may  be  a  role  for 
compounds  such  as  H2S  and  CH3SH  as  reducing  agents  for  the  parasite.  It  should 
be  remembered  that  the  parasite  shows  sensitivity  to  both  intra-  and  extracellular 
thiol  blocking'reagents  (define)  which  act  as  potent  anti-trichomonad  compounds 
in  culture  (Gillin  et  al.,  1984).  However  from  the  observation  that  these  thiols  are 
mostly  excreted  from  the  cell  they  may  be  required  extracellularly.  It  is  possible 
that  extracellular  reducing  agents  may  be  required  and  the  transport  of  small 
thiols  across  the  cell  membrane  to  satisfy  this  need  is  easier  and  more 
energetically  efficient  than  excreting,  for  example,  cysteine. 
Determining  the  MGL  levels  under  different  growth  conditions  may  also  prove 
informative  in  indicating  whether  these  low  molecular  weight  thiols  (H2S  and 
CH3SH)  function  as  reducing  agents  or  free  radical  scavengers.  Only  when  the 
parasite  was  cultured  with  propargylglycine  did  we  see  any  dramatic  upregulation 
of  cysteine  synthase  activity.  This  was  a  little  surprising,  given  that  compounds 
such  as  H202  and  methyl  viologen  were  used  to  induce  oxidative  stress.  It  would 
be  interesting  to  see  if  there  was  an  upregulation  of  MGL  under  these  conditions. 
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response  to  damaging  oxygen  free  radicals. 
6.1.4  Low  Molecular  Weight  Thiols  in  Haemolysis 
Several  examples  of  cysteine  desulphurase  enzymes  have  recently  had  their  3- 
dimensional  structures  solved  and  have  already  been  discussed  in  chapter  3  of 
this  thesis.  One  of  these,  cystalysin,  has  been  shown  to  be  responsible  for 
haemolytic  activity  in  the  oral  pathogen  Treponema  denticola  (Chu  et  al.,  1997; 
Krupka  et  al.,  2000).  It  is  unclear  whether  the  protein  itself  or  the  H2S  it  produces 
from  the  aß-elimination  of  cysteine  is  responsible  for  this  damage  to  host  red 
blood  cells.  The'toxicity  of  compounds  such  as  H2S  and  CH3SH  to  mammalian 
cells  has  been  documented  (Beauchamp  et  al.,  1984)  and  T.  vaginalis  is  also 
haemolytic  (Krieger  et  al.,  1983;  Dailey  et  al.,  1990).  The  hypothesis  that  the 
action  of  MGL  may  be  responsible  for  the  haemolytic  activity  of  T.  vaginalis  would 
appear  to  be  simple  to  test.  For  instance,  MGL  activity  can  be  inhibited  by  using 
propargylglycine  and  the  haemolytic  activity  of  the  cells  measured.  However  the 
cysteine  desulphurase  activity  of  cystalysin  has  been  shown  to  be  elevated  in  the 
presence  of  ß-mercaptoethanol.  This  has  similarities  to  the  "activated  serine 
sulphydrase  activity"  seen  in  T.  vaginalis  and  although  cysteine  synthase  has 
been  shown  to  exhibit  this  activity,  it  is  not  certain  that  it  is  solely  responsible.  It 
has  been  shown  that  several  enzymes  can  be  resolved  from  parasite  lysates  with 
this  activity,  one  or  more  of  which  may  be  cystalysin  (Thong  and  Coombs,  1987). 
Thus,  although  culturing  parasites  in  the  presence  of  propargylglycine  may 
eliminate  haemolytic  activity  due  to  MGL,  haemolysis  may  remain  due  to  another, 
227 unidentified  factor.  However,  such  an  experiment  would  give  some  information 
upon  whether  or  not  MGL  may  be  involved  in  haemolysis. 
6.2  Future  Work 
A  number  of  experiments  that  could  be  carried  out  immediately  in  attempts  to 
answer  specific  questions  have  been  mentioned  already.  MGL  could  be  assayed 
for  its  ability  to  repair  or  construct  functional  Fe-S  clusters  and  also  to  cause 
haemolysis.  Parasite  growth  under  various  conditions  could  also  be  repeated  and 
examined  for  its  effect  upon  MGL  expression.  There  are  also  a  number  of  other 
stimuli  that  the  parasites  could  be  exposed  to  such  as  excess  or  reduced  levels  of 
iron,  variations  in  pH  or  high  levels  of  D-cysteine.  It  may  also  prove  very  useful  to 
use  a  defined  medium  for  culturing  trichomonads  (Linstead,  1981).  The  ability  to 
easily  omit  medium  components  would  be  highly  useful  in  examining  the  roles  of 
enzymes  in  culture.  The  knowledge  of  exact  levels  of  reducing  agents,  for 
example,  could  be  exploited  by  examining  which  compounds  could  be  substituted 
for  others.  With  the  probes  for  examining  MGL  and  cysteine  synthase  expression, 
these  experiments  could  prove  highly  informative. 
In  the  longer  term,  the  continued  sequencing  of  the  parasite  EST  library  is  likely  to 
be  particularly  fruitful.  The  identification  and  characterisation  of  other  genes  may 
give  further  insights  into  the  metabolism  of  sulphur  amino  acids.  A  continuing 
problem  though  is  the  inability  to  perform  reverse  genetics  experiments  upon  the 
parasite. 
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